Download:
pdf |
pdfFR Y‐14A Schedule A ‐ Summary
Summary Submission Cover Sheet
All BHCs and IHCs are expected to complete a version of the Summary template for each required scenario ‐ BHC Baseline, BHC Stress, Supervisory Baseline, and Supervisory Severely Adverse ‐ and additional scenarios that are
named accordingly.
BHCs, SLHCs, and IHCs should complete all relevant cells in the corresponding worksheets, including this cover page. BHCs, SLHCs, and IHCs should not complete any shaded cells.
Please ensure that the data submitted in this Summary Template match what was submitted in other data templates.
Please do not change the structure of this workbook.
Please note that unlike FR Y‐9C reporting, all actual and projected income statement figures should be reported on a quarterly basis, and not on a cumulative basis
Institution Name:
RSSD ID:
Source:
Submission Date (MM/DD/YYYY):
When Received:
BHC, SLHC, or IHC
Please indicate the scenario associated with this submission using the following drop‐down menu:
Briefly describe the scenario below:
FR Y‐14A Schedule A.1.a ‐ Income Statement
Actual in
$Millions
Item
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
Projected in $Millions
as of date
LOSSES ASSOCIATED WITH LOANS HELD FOR INVESTMENT AT AMORTIZED COST
Real Estate Loans (in Domestic Offices)
First Lien Mortgages
First Lien Mortgages
First Lien HELOAN
Second / Junior Lien Mortgages
Closed‐End Junior Liens
HELOCs
CRE Loans
Construction
Multifamily
Nonfarm, Non‐residential
Owner‐Occupied
Non‐Owner‐Occupied
Loans Secured by Farmland
Real Estate Loans (Not in Domestic Offices)
First Lien Mortgages
Second / Junior Lien Mortgages
CRE Loans
Construction
Multifamily
Nonfarm, Non‐residential
Owner‐Occupied
Non‐Owner‐Occupied
Loans Secured by Farmland
C&I Loans
C&I Graded
Small Business (Scored/Delinquency Managed)
Business and Corporate Card
Credit Cards
Other Consumer
Auto Loans
Student Loans
Other loans backed by securities (non‐purpose lending)
Other
Other Loans
Loans to Foreign Governments
Agricultural Loans
Loans for purchasing or carrying securities (secured or unsecured)
Loans to Depositories and Other Financial Institutions
All Other Loans and Leases
All Other Loans (exclude consumer loans)
All Other Leases
Total Loans and Leases
CASIP521
CASIP522
CASIP386
CASIP394
CASIP523
CASIP402
CASIP412
CASIP524
CASIP525
CASIP526
CASIP527
CASIP528
CASIP529
CASIP530
CASIP531
CASIP420
CASIP428
CASIP532
CASIP533
CASIP534
CASIP535
CASIP536
CASIP537
CASIP538
CASIP539
CASIP540
CASIP541
CASIP542
CASIP543
CASIP544
CASIP545
CASIP496
CASIP546
CASIP547
CASIP548
CASIP549
CASIP550
CASIP551
CASIP552
CASIP553
CASIP554
CASIP555
CASIP556
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
CPSIP521
CPSIP522
CPSIP386
CPSIP394
CPSIP523
CPSIP402
CPSIP412
CPSIP524
CPSIP525
CPSIP526
CPSIP527
CPSIP528
CPSIP529
CPSIP530
CPSIP531
CPSIP420
CPSIP428
CPSIP532
CPSIP533
CPSIP534
CPSIP535
CPSIP536
CPSIP537
CPSIP538
CPSIP539
CPSIP540
CPSIP541
CPSIP542
CPSIP543
CPSIP544
CPSIP545
CPSIP496
CPSIP546
CPSIP547
CPSIP548
CPSIP549
CPSIP550
CPSIP551
CPSIP552
CPSIP553
CPSIP554
CPSIP555
CPSIP556
PQ 1
PQ 2
PQ 3
PQ 4
PQ 5
PQ 6
PQ 7
PQ 8
PQ 9
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
FR Y‐14A Schedule A.1.a ‐ Income Statement
Sums in $Millions
Item
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
PQ 2 ‐ PQ 5
LOSSES ASSOCIATED WITH LOANS HELD FOR INVESTMENT AT AMORTIZED COST
Real Estate Loans (in Domestic Offices)
First Lien Mortgages
First Lien Mortgages
First Lien HELOAN
Second / Junior Lien Mortgages
Closed‐End Junior Liens
HELOCs
CRE Loans
Construction
Multifamily
Nonfarm, Non‐residential
Owner‐Occupied
Non‐Owner‐Occupied
Loans Secured by Farmland
Real Estate Loans (Not in Domestic Offices)
First Lien Mortgages
Second / Junior Lien Mortgages
CRE Loans
Construction
Multifamily
Nonfarm, Non‐residential
Owner‐Occupied
Non‐Owner‐Occupied
Loans Secured by Farmland
C&I Loans
C&I Graded
Small Business (Scored/Delinquency Managed)
Business and Corporate Card
Credit Cards
Other Consumer
Auto Loans
Student Loans
Other loans backed by securities (non‐purpose lending)
Other
Other Loans
Loans to Foreign Governments
Agricultural Loans
Loans for purchasing or carrying securities (secured or unsecured)
Loans to Depositories and Other Financial Institutions
All Other Loans and Leases
All Other Loans (exclude consumer loans)
All Other Leases
Total Loans and Leases
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
PQ 6 ‐ PQ 9
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
9‐Quarter
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
FR Y‐14A Schedule A.1.a ‐ Income Statement
Actual in
$Millions
Item
Projected in $Millions
as of date
PQ 1
PQ 2
PQ 3
PQ 4
PQ 5
PQ 6
PQ 7
PQ 8
PQ 9
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
CPSIC216
CPSIP577
CPSIP578
CPSIP579
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
44
45
46
47
48
49
50
51
52
53
54
55
56
57
LOSSES ASSOCIATED WITH HELD FOR SALE LOANS AND LOANS ACCOUNTED FOR UNDER THE FAIR VALUE OPTION
‐
Real Estate Loans (in Domestic Offices)
CASIP557
First Lien Mortgages
CASIP558
Second / Junior Lien Mortgages
CASIP559
CRE Loans
CASIP560
Loans Secured by Farmland
CASIP561
‐
Real Estate Loans (Not in Domestic Offices)
CASIP562
Residential Mortgages
CASIP563
CASIP564
CRE Loans
CASIP565
Loans Secured by Farmland
CASIP566
C&I Loans
CASIP567
Credit Cards
Other Consumer
CASIP568
All Other Loans and Leases
CASIP569
‐
Total Loans Held for Sale and Loans Accounted for under the Fair Value Option
CASIP570
CPSIP557
CPSIP558
CPSIP559
CPSIP560
CPSIP561
CPSIP562
CPSIP563
CPSIP564
CPSIP565
CPSIP566
CPSIP567
CPSIP568
CPSIP569
CPSIP570
58
59
60
61
62
TRADING ACCOUNT
Trading MTM Losses
Trading Issuer Default Losses
Counterparty Credit MTM Losses (CVA losses)
Counterparty Default losses
Total Trading and Counterparty
CPSIP571
CPSIP572
CPSIP573
CPSIP574
CPSIP576
63
64
65
66
OTHER LOSSES
Goodwill impairment
Valuation Adjustment for firm's own debt under fair value option (FVO)
Other losses (describe in supporting documentation)
Total Other Losses
CASIC216
CASIP577
CASIP578
CASIP579
67
Total Losses
CASIP580
CPSIP580
‐
68
68a
68b
68c
ALLOWANCE FOR LOAN and LEASE LOSSES (1)
Total allowance for loan and lease losses, prior quarter
ALLL, prior quarter
Allowance for credit losses on held‐to‐maturity debt securities, prior quarter (2)
Allowance for credit losses on available‐for‐sale debt securities, prior quarter (2)
CASIKU69
CASIP581
CASIKU70
CASIKU71
CPSIKU69
CPSIP581
CPSIKU70
CPSIKU71
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
CASIKU72
CASIP582
CASIP583
CASIP584
CASIP585
CASIP586
CASIP587
CASIP588
CASIP589
CASIP590
CPSIKU72
CPSIP582
CPSIP583
CPSIP584
CPSIP585
CPSIP586
CPSIP587
CPSIP588
CPSIP589
CPSIP590
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
68d Allowance for credit losses on all other financial assets, prior quarter (2)
69
70
71
72
73
74
75
76
77
Real Estate Loans (in Domestic Offices)
Residential Mortgages
First Lien Mortgages
Closed‐End Junior Liens
HELOCs
CRE Loans
Construction
Multifamily
Nonfarm, Non‐residential
FR Y‐14A Schedule A.1.a ‐ Income Statement
Sums in $Millions
PQ 2 ‐ PQ 5
Item
PQ 6 ‐ PQ 9
9‐Quarter
44
45
46
47
48
49
50
51
52
53
54
55
56
57
LOSSES ASSOCIATED WITH HELD FOR SALE LOANS AND LOANS ACCOUNTED FOR U
Real Estate Loans (in Domestic Offices)
First Lien Mortgages
Second / Junior Lien Mortgages
CRE Loans
Loans Secured by Farmland
Real Estate Loans (Not in Domestic Offices)
Residential Mortgages
CRE Loans
Loans Secured by Farmland
C&I Loans
Credit Cards
Other Consumer
All Other Loans and Leases
Total Loans Held for Sale and Loans Accounted for under the Fair Value Option
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
58
59
60
61
62
TRADING ACCOUNT
Trading MTM Losses
Trading Issuer Default Losses
Counterparty Credit MTM Losses (CVA losses)
Counterparty Default losses
Total Trading and Counterparty
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
63
64
65
66
OTHER LOSSES
Goodwill impairment
Valuation Adjustment for firm's own debt under fair value option (FVO)
Other losses (describe in supporting documentation)
Total Other Losses
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
67
Total Losses
‐
‐
‐
68
68a
68b
68c
ALLOWANCE FOR LOAN and LEASE LOSSES (1)
Total allowance for loan and lease losses, prior quarter
ALLL, prior quarter
Allowance for credit losses on held‐to‐maturity debt securities, prior quarter (2)
Allowance for credit losses on available‐for‐sale debt securities, prior quarter (2)
68d Allowance for credit losses on all other financial assets, prior quarter (2)
69
70
71
72
73
74
75
76
77
Real Estate Loans (in Domestic Offices)
Residential Mortgages
First Lien Mortgages
Closed‐End Junior Liens
HELOCs
CRE Loans
Construction
Multifamily
Nonfarm, Non‐residential
FR Y‐14A Schedule A.1.a ‐ Income Statement
Actual in
$Millions
Item
78
79
80
81
82
83
84
85
86
87
88
89
90
Projected in $Millions
as of date
Loans Secured by Farmland
Real Estate Loans (Not in Domestic Offices)
Residential Mortgages
CRE Loans
Farmland
C&I Loans
C&I Graded
Small Business (Scored/Delinquency Managed)
Corporate and Business Cards
Credit Cards
Other Consumer
All Other Loans and Leases
Unallocated
91 Total Provisions during the quarter
91a Provisions for loan and lease losses during the quarter (3)
Provisions for credit losses on held‐to‐maturity debt securities during the quarter
91b
(4)
Provisions for credit losses on available‐for‐sale debt securities during the quarter
91c
(4)
91d Provisions for credit losses on all other financial assets during the quarter (4)
92 Real Estate Loans (in Domestic Offices)
93 Residential Mortgages
94 First Lien Mortgages
95 Closed‐End Junior Liens
96 HELOCs
97 CRE Loans
98 Construction
99 Multifamily
100 Nonfarm, Non‐residential
101 Loans Secured by Farmland
102 Real Estate Loans (Not in Domestic Offices)
103 Residential Mortgages
104 CRE Loans
105 Farmland
106 C&I Loans
107 C&I Graded
108 Small Business (Scored/Delinquency Managed)
109 Corporate and Business Cards
110 Credit Cards
111 Other Consumer
112 All Other Loans and Leases
113 Unallocated
114 Total Net charge‐offs during the quarter
114a Net charge‐offs during the quarter on loans and leases (5)
114b Net charge‐offs during the quarter on held‐to‐maturity debt securities (6)
114c Net charge‐offs during the quarter on available‐for‐sale debt securities (6)
114d Net charge‐offs during the quarter on all other financial assets (6)
115 Total Other ALLL Changes
115a Other ALLL Changes (7)
115b Other allowances for credit losses changes on held‐to‐maturity debt securities (8)
115c Other allowances for credit losses changes on available‐for‐sale debt securities (8)
115d Other allowances for credit losses changes on all other financial assets(8)
116 Total Allowances, current quarter
116a ALLL, current quarter (9)
Allowances for credit losses on held‐to‐maturity debt securities, current quarter
116b
(10)
Allowances for credit losses on available‐for‐sale debt securities, current quarter
116c
(10)
116d Allowances for credit losses on all other financial assets, current quarter (10)
CASIP591
CASIP592
CASIP593
CASIP594
CASIP595
CASIP596
CASIP597
CASIP598
CASIP599
CASIP600
CASIP601
CASIP602
CASIP603
CPSIP591
CPSIP592
CPSIP593
CPSIP594
CPSIP595
CPSIP596
CPSIP597
CPSIP598
CPSIP599
CPSIP600
CPSIP601
CPSIP602
CPSIP603
CASIKU79
CASI4230
CPSIKU79
CPSI4230
CASIKU80
CPSIKU80
CASIKU81
CASIKU82
CASIP604
CASIP605
CASIP606
CASIP607
CASIP608
CASIP609
CASIP610
CASIP611
CASIP612
CASIP613
CASIP614
CASIP615
CASIP616
CASIP617
CASIP618
CASIP619
CASIP620
CASIP621
CASIP622
CASIP623
CASIP624
CASIP625
CASIKU83
CASIP626
CASIKU84
CASIKU85
CASIKU86
CASIKU87
CASIP627
CASIKU88
CASIKU89
CASIKU90
CASIKU91
CASI3123
CPSIKU81
CPSIKU82
CPSIP604
CPSIP605
CPSIP606
CPSIP607
CPSIP608
CPSIP609
CPSIP610
CPSIP611
CPSIP612
CPSIP613
CPSIP614
CPSIP615
CPSIP616
CPSIP617
CPSIP618
CPSIP619
CPSIP620
CPSIP621
CPSIP622
CPSIP623
CPSIP624
CPSIP625
CPSIKU83
CPSIP626
CPSIKU84
CPSIKU85
CPSIKU86
CPSIKU87
CPSIP627
CPSIKU88
CPSIKU89
CPSIKU90
CPSIKU91
CPSI3123
PQ 1
PQ 2
PQ 3
PQ 4
PQ 5
PQ 6
PQ 7
PQ 8
PQ 9
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
CASIKU92
CPSIKU92
‐
‐
‐
‐
‐
‐
‐
‐
‐
CASIKU93
CASIKU94
CPSIKU93
CPSIKU94
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
FR Y‐14A Schedule A.1.a ‐ Income Statement
Sums in $Millions
PQ 2 ‐ PQ 5
Item
78
79
80
81
82
83
84
85
86
87
88
89
90
PQ 6 ‐ PQ 9
9‐Quarter
Loans Secured by Farmland
Real Estate Loans (Not in Domestic Offices)
Residential Mortgages
CRE Loans
Farmland
C&I Loans
C&I Graded
Small Business (Scored/Delinquency Managed)
Corporate and Business Cards
Credit Cards
Other Consumer
All Other Loans and Leases
Unallocated
91 Total Provisions during the quarter
91a Provisions for loan and lease losses during the quarter (3)
Provisions for credit losses on held‐to‐maturity debt securities during the quarter
91b
(4)
Provisions for credit losses on available‐for‐sale debt securities during the quarter
91c
(4)
91d Provisions for credit losses on all other financial assets during the quarter (4)
92 Real Estate Loans (in Domestic Offices)
93 Residential Mortgages
94 First Lien Mortgages
95 Closed‐End Junior Liens
96 HELOCs
97 CRE Loans
98 Construction
99 Multifamily
100 Nonfarm, Non‐residential
101 Loans Secured by Farmland
102 Real Estate Loans (Not in Domestic Offices)
103 Residential Mortgages
104 CRE Loans
105 Farmland
106 C&I Loans
107 C&I Graded
108 Small Business (Scored/Delinquency Managed)
109 Corporate and Business Cards
110 Credit Cards
111 Other Consumer
112 All Other Loans and Leases
113 Unallocated
114 Total Net charge‐offs during the quarter
114a Net charge‐offs during the quarter on loans and leases (5)
114b Net charge‐offs during the quarter on held‐to‐maturity debt securities (6)
114c Net charge‐offs during the quarter on available‐for‐sale debt securities (6)
114d Net charge‐offs during the quarter on all other financial assets (6)
115 Total Other ALLL Changes
115a Other ALLL Changes (7)
115b Other allowances for credit losses changes on held‐to‐maturity debt securities (8)
115c Other allowances for credit losses changes on available‐for‐sale debt securities (8)
115d Other allowances for credit losses changes on all other financial assets(8)
116 Total Allowances, current quarter
116a ALLL, current quarter (9)
Allowances for credit losses on held‐to‐maturity debt securities, current quarter
116b
(10)
Allowances for credit losses on available‐for‐sale debt securities, current quarter
116c
(10)
116d Allowances for credit losses on all other financial assets, current quarter (10)
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
FR Y‐14A Schedule A.1.a ‐ Income Statement
Actual in
$Millions
Item
Projected in $Millions
as of date
PQ 1
PQ 2
PQ 3
PQ 4
PQ 5
PQ 6
PQ 7
PQ 8
PQ 9
117
118
119
120
PRE‐PROVISION NET REVENUE
Net interest income
Noninterest income
Noninterest expense
Pre‐Provision Net Revenue
CASI4074
CASI4079
CASIP630
CASIP631
CPSI4074
CPSI4079
CPSIP630
CPSIP631
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
121
122
123
124
125
126
127a
127b
128
CONDENSED INCOME STATEMENT
Pre‐Provision Net Revenue
Provisions during the quarter
Total Trading and Counterparty Losses
Total Other Losses
Other I/S items ‐ describe in supporting documentation
Realized Gains (Losses) on available‐for‐sale securities, including OTTI (11)
Realized Gains (Losses) on held‐to‐maturity securities, including OTTI (11)
Unrealized holding gains (losses) on equity securities not held for trading
Income (loss) before applicable income taxes and discontinued operations
CASIP632
CASIKU79
CASIP633
CASIP634
CASIP635
CASI3196
CASI3521
CASIHT70
CASI4310
CPSIP632
CPSIKU79
CPSIP633
CPSIP634
CPSIP635
CPSI3196
CPSI3521
CPSIHT70
CPSI4310
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
129 Applicable income taxes (foreign and domestic)
130 Income (loss) before discontinued operations and other adjustments
CASI4302
CASI4300
CPSI4302
CPSI4300
‐
‐
‐
‐
‐
‐
‐
‐
‐
131 Discontinued operations, net of applicable income taxes
132 Net income (loss) attributable to BHC and minority interests
CASI4320
CASIG104
CPSI4320
CPSIG104
‐
‐
‐
‐
‐
‐
‐
‐
‐
133 Net income (loss) attributable to minority interests
134 Net income (loss) attributable to BHC
CASIG103
CASI4340
CPSIG103
CPSI4340
‐
‐
‐
‐
‐
‐
‐
‐
‐
135 Effective Tax Rate (%)
CASIP636
CPSIP636
CASIP637
CASIP638
CASIP195
CASIP639
CPSIP637
CPSIP638
CPSIP195
CPSIP639
136
137
138
139
REPURCHASE RESERVE/LIABILITY FOR MORTGAGE REPS AND WARRANTIES
Reserve, prior quarter
Provisions during the quarter
Net charges during the quarter
Reserve, current quarter
‐na‐
‐
‐
‐
‐
‐na‐
‐
‐
‐
‐
‐na‐
‐
‐
‐
‐
‐na‐
‐
‐
‐
‐
‐na‐
‐
‐
‐
‐
‐na‐
‐
‐
‐
‐
‐na‐
‐
‐
‐
‐
‐na‐
‐
‐
‐
‐
‐na‐
‐
‐
‐
‐
FR Y‐14A Schedule A.1.a ‐ Income Statement
Sums in $Millions
Item
PQ 2 ‐ PQ 5
117
118
119
120
PRE‐PROVISION NET REVENUE
Net interest income
Noninterest income
Noninterest expense
Pre‐Provision Net Revenue
121
122
123
124
125
126
127a
127b
128
CONDENSED INCOME STATEMENT
Pre‐Provision Net Revenue
Provisions during the quarter
Total Trading and Counterparty Losses
Total Other Losses
Other I/S items ‐ describe in supporting documentation
Realized Gains (Losses) on available‐for‐sale securities, including OTTI (11)
Realized Gains (Losses) on held‐to‐maturity securities, including OTTI (11)
Unrealized holding gains (losses) on equity securities not held for trading
Income (loss) before applicable income taxes and discontinued operations
PQ 6 ‐ PQ 9
9‐Quarter
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
129 Applicable income taxes (foreign and domestic)
130 Income (loss) before discontinued operations and other adjustments
‐
‐
‐
‐
‐
‐
131 Discontinued operations, net of applicable income taxes
132 Net income (loss) attributable to BHC and minority interests
‐
‐
‐
‐
‐
‐
133 Net income (loss) attributable to minority interests
134 Net income (loss) attributable to BHC
‐
‐
‐
‐
‐
‐
135 Effective Tax Rate (%)
136
137
138
139
REPURCHASE RESERVE/LIABILITY FOR MORTGAGE REPS AND WARRANTIES
Reserve, prior quarter
Provisions during the quarter
Net charges during the quarter
Reserve, current quarter
‐na‐
‐
‐
‐na‐
‐
‐
‐na‐
‐
‐
FR Y‐14A Schedule A.1.a ‐ Income Statement
Actual in
$Millions
Item
(1)
(2)
(3)
(4)
(5)
(6)
(7)
as of date
Footnotes to the Income Statement Worksheet
Institutions that have adopted ASU 2016‐13 should report the allowance and
provision for credit losses in items 68 through 116.
Items 68b and 68c are only reported by institutions that have adopted ASU 2016‐
13.
Institutions that have adopted ASU 2016‐13 should report the provision for credit
losses on loans and leases.
Items 91b and 91c are only reported by institutions that have adopted ASU 2016‐
13.
Institutions that have adopted ASU 2016‐13 should report net charge‐offs during
the quarter on loans and leases in item 114a.
Items 114b and 114c are only reported by institutions that have adopted ASU
2016‐13.
Institutions that have adopted ASU 2016‐13 should report other changes to the
allowances for credit losses on loans and leases in item 115a.
Items 115b and 115c are only reported by institutions that have adopted ASU
2016‐13.
Institutions that have adopted ASU 2016‐13 should report the allowance for credit
(9)
losses on loans and leases in item 116a.
Items 116b and 116c are only reported by institutions that have adopted ASU
(10)
2016‐13.
Institutions that have adopted ASU 2016‐13 should not include OTTI in items 126
(11)
and 127a.
(8)
Projected in $Millions
PQ 1
PQ 2
PQ 3
PQ 4
PQ 5
PQ 6
PQ 7
PQ 8
PQ 9
FR Y‐14A Schedule A.1.a ‐ Income Statement
Sums in $Millions
Item
(1)
(2)
(3)
(4)
(5)
(6)
(7)
PQ 2 ‐ PQ 5
Footnotes to the Income Statement Worksheet
Institutions that have adopted ASU 2016‐13 should report the allowance and
provision for credit losses in items 68 through 116.
Items 68b and 68c are only reported by institutions that have adopted ASU 2016‐
13.
Institutions that have adopted ASU 2016‐13 should report the provision for credit
losses on loans and leases.
Items 91b and 91c are only reported by institutions that have adopted ASU 2016‐
13.
Institutions that have adopted ASU 2016‐13 should report net charge‐offs during
the quarter on loans and leases in item 114a.
Items 114b and 114c are only reported by institutions that have adopted ASU
2016‐13.
Institutions that have adopted ASU 2016‐13 should report other changes to the
allowances for credit losses on loans and leases in item 115a.
Items 115b and 115c are only reported by institutions that have adopted ASU
2016‐13.
Institutions that have adopted ASU 2016‐13 should report the allowance for credit
(9)
losses on loans and leases in item 116a.
Items 116b and 116c are only reported by institutions that have adopted ASU
(10)
2016‐13.
Institutions that have adopted ASU 2016‐13 should not include OTTI in items 126
(11)
and 127a.
(8)
PQ 6 ‐ PQ 9
9‐Quarter
FR Y‐14A Schedule A.1.b ‐ Balance Sheet
PQ 1
Item
PQ 2
PQ 3
Projected in $Millions
PQ 4
PQ 5
PQ 6
PQ 7
PQ 8
PQ 9
Assets
4
5
SECURITIES
Held to Maturity (HTM) (1)
Available for Sale (AFS)
Equity securities with readily determinable fair values not held for trading
Total Securities
Of which:
Securitizations (investment grade)
Securitizations (non‐investment grade)
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
Total Loans and Leases
Real Estate Loans (in Domestic Offices)
First Lien Mortgages
First Lien Mortgages
First Lien HELOAN
Second / Junior Lien Mortgages
Closed‐End Junior Liens
HELOCs
CRE Loans
Construction
Multifamily
Nonfarm, Non‐residential
Owner‐Occupied
Non‐Owner‐Occupied
Loans Secured by Farmland
Real Estate Loans (Not in Domestic Offices)
First Lien Mortgages
Second / Junior Lien Mortgages
CRE Loans
Construction
Multifamily
Nonfarm, Non‐residential
Owner‐Occupied
Non‐Owner‐Occupied
Loans Secured by Farmland
1
2a
2b
3
CPSB1754
CPSB1773
CPSBJA22
CPSBP640
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
CPSBP641
CPSBP642
CPSBP643
CPSB5367
CPSBP644
CPSBP645
CPSBP646
CPSB5368
CPSB1797
CPSBP647
CPSBP648
CPSB1460
CPSBP649
CPSBF160
CPSBF161
CPSB1420
CPSBP650
CPSBP651
CPSBP652
CPSBP653
CPSBP654
CPSBP655
CPSBP656
CPSBP657
CPSBP658
CPSBP659
FR Y‐14A Schedule A.1.b ‐ Balance Sheet
Item
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
PQ 1
C&I Loans
C&I Graded
Small Business (Scored/Delinquency Managed)
Corporate Card
Business Card
Credit Cards
Charge Card
Bank Card
Other Consumer
Auto Loans
Student Loans
Other loans backed by securities (non‐purpose lending)
Other
Other Loans and Leases
Loans to Foreign Governments
Agricultural Loans
Loans for purchasing or carrying securities (secured or unsecured)
Loans to Depositories and Other Financial Institutions
All Other Loans and Leases
All Other Loans (exclude consumer loans)
All Other Leases
Total Loans and Leases
CPSBP660
CPSBP661
CPSBP662
CPSBP663
CPSBP664
CPSBP665
CPSBP666
CPSBP667
CPSBP668
CPSBK137
CPSBP669
CPSBP670
CPSBP671
CPSBP672
CPSB2081
CPSB1590
CPSB1545
CPSBP673
CPSBP674
CPSBJ451
CPSBF163
CPSBP675
PQ 2
PQ 3
Projected in $Millions
PQ 4
PQ 5
PQ 6
PQ 7
PQ 8
PQ 9
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
FR Y‐14A Schedule A.1.b ‐ Balance Sheet
PQ 1
Item
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
LOANS HELD FOR INVESTMENT AT AMORTIZED COST
Real Estate Loans (in Domestic Offices)
First Lien Mortgages
First Lien Mortgages
First Lien HELOAN
Second / Junior Lien Mortgages
Closed‐End Junior Liens
HELOCs
CRE Loans
Construction
Multifamily
Nonfarm, Non‐residential
Owner‐Occupied
Non‐Owner‐Occupied
Loans Secured by Farmland
Real Estate Loans (Not in Domestic Offices)
First Lien Mortgages
Second / Junior Lien Mortgages
CRE Loans
Construction
Multifamily
Nonfarm, Non‐residential
Owner‐Occupied
Non‐Owner‐Occupied
Loans Secured by Farmland
C&I Loans
C&I Graded
Small Business (Scored/Delinquency Managed)
Business and Corporate Card
Credit Cards
CPSBP676
CPSBP677
CPSBP381
CPSBP389
CPSBP678
CPSBP397
CPSBP405
CPSBP679
CPSBP680
CPSBP681
CPSBP682
CPSBP683
CPSBP684
CPSBP685
CPSBP686
CPSBP415
CPSBP423
CPSBP687
CPSBP688
CPSBP689
CPSBP690
CPSBP691
CPSBP692
CPSBP693
CPSBP694
CPSBP695
CPSBP696
CPSBP697
CPSBP698
PQ 2
PQ 3
Projected in $Millions
PQ 4
PQ 5
PQ 6
PQ 7
PQ 8
PQ 9
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
FR Y‐14A Schedule A.1.b ‐ Balance Sheet
Item
81
82
83
84
85
86
87
88
89
90
91
92
93
94
PQ 1
Other Consumer
Auto Loans
Student Loans
Other loans backed by securities (non‐purpose lending)
Other
Other Loans and Leases
Loans to Foreign Governments
Agricultural Loans
Loans for purchasing or carrying securities (secured or unsecured)
Loans to Depositories and Other Financial Institutions
All Other Loans and Leases
All Other Loans (exclude consumer loans)
All Other Leases
Total Loans and Leases
Loans Held for Sale and Loans Accounted for under the Fair Value Option
Real Estate Loans (in Domestic Offices)
First Lien Mortgages
Second / Junior Lien Mortgages
CRE Loans
Loans Secured by Farmland
Real Estate Loans (Not in Domestic Offices)
Residential Mortgages
CRE Loans
Loans Secured by Farmland
C&I Loans
Credit Cards
Other Consumer
Other Loans and Leases
Total Loans Held for Sale and Loans Accounted for under the Fair Value
108
Option
95
96
97
98
99
100
101
102
103
104
105
106
107
PQ 2
PQ 3
Projected in $Millions
PQ 4
PQ 5
PQ 6
PQ 7
PQ 8
PQ 9
CPSBP699
CPSBP700
CPSBP491
CPSBP701
CPSBP702
CPSBP703
CPSBP704
CPSBP705
CPSBP706
CPSBP707
CPSBP708
CPSBP709
CPSBP710
CPSBP711
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
CPSBP712
CPSBP713
CPSBP714
CPSBP715
CPSBP716
CPSBP717
CPSBP718
CPSBP719
CPSBP720
CPSBP721
CPSBP722
CPSBP723
CPSBP724
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
CPSBP725
‐
‐
‐
‐
‐
‐
‐
‐
‐
FR Y‐14A Schedule A.1.b ‐ Balance Sheet
PQ 1
Item
CPSB2123
109 Unearned Income on Loans
CPSB3123
110 Allowance for Loan and Lease Losses (2)
Loans and Leases (Held for Investment and Held for Sale), Net of Unearned
111
CPSBP726
Income and Allowance for Loan and Lease Losses (3)
TRADING
112 Trading Assets
113
114
115
116
117
INTANGIBLES
Goodwill
Mortgage Servicing Rights
Not applicable
All Other Identifiable Intangible Assets
Total Intangible Assets
OTHER
118 Cash and cash equivalent
119 Federal funds sold
120 Securities purchased under agreements to resell (4)
121
122
123
124
125
126
127
128
129
130
Premises and Fixed Assets
OREO
Commercial
Residential
Farmland
Collateral Underlying Operating Leases for Which the Bank is the Lessor (5)
Autos
Other
Other Assets (6)
Total Other
131 TOTAL ASSETS
PQ 2
PQ 3
Projected in $Millions
PQ 4
PQ 5
PQ 6
PQ 7
PQ 8
PQ 9
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
CPSB3545
CPSB3163
CPSB3164
CPSB5507
CPSBP727
CPSBP728
CPSBB987
CPSBB989
CPSB2145
CPSB2150
CPSBP729
CPSBP730
CPSBP731
CPSBP732
CPSBP733
CPSBP734
CPSBP735
CPSBP736
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
CPSB2170
‐
‐
‐
‐
‐
‐
‐
‐
‐
FR Y‐14A Schedule A.1.b ‐ Balance Sheet
PQ 1
Item
Projected in $Millions
PQ 4
PQ 5
PQ 6
PQ 2
PQ 3
PQ 7
PQ 8
PQ 9
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
Liabilities
132 Deposits in domestic offices
133 Deposits in foreign offices, Edge and Agreement subsidiaries, and IBFs
134 Deposits
Federal funds purchased and securities sold under agreements to
135
repurchase
136 Trading Liabilities
137 Other Borrowed Money
138 Subordinated Notes and Debentures
Subordinated Notes Payable to Unconsolidated Trusts Issuing TruPS and
139
TruPS Issued by Consolidated Special Purpose Entities
140 Other Liabilities
141 Memo: Allowance for off‐balance sheet credit exposures
142 Total Liabilities
CPSBP737
CPSBP738
CPSBP739
CPSBP740
CPSB3548
CPSB3190
CPSB4062
CPSBC699
CPSB2750
CPSBB557
CPSB2948
Equity Capital
143
144
145
146
147
148
149
Perpetual Preferred Stock and Related Surplus
Common Stock (Par Value)
Surplus (Exclude All Surplus Related to Preferred Stock)
Retained Earnings
Accumulated Other Comprehensive Income (AOCI)
Other Equity Capital Components
Total BHC Equity Capital
150 Noncontrolling (Minority) Interests in Consolidated Subsidiaries
151 Total Equity Capital
CPSB3283
CPSB3230
CPSB3240
CPSB3247
CPSBB530
CPSBA130
CPSB3210
‐
‐
‐
‐
‐
‐
‐
‐
‐
CPSB3000
CPSBG105
‐
‐
‐
‐
‐
‐
‐
‐
‐
Other
152 Unused Commercial Lending Commitments and Letters of Credit
(1)
(2)
(3)
(4)
CPSBP741
Footnotes to the Balance Sheet Worksheet
Institutions that have adopted ASU 2016‐13 should report item 1 net of any applicable allowance for credit losses.
For institutions that adopted ASU 2016‐13, this item will represent the allowance for credit losses on loans and leases.
For institutions that adopted ASU 2016‐13, this item will be net of unearned income and allowance for credit losses on loans and leases.
Institutions that adopted ASU 2016‐13 should report item 120 net of any applicable allowance for credit losses.
Refers to the balance sheet carrying amount of any equipment or other asset rented to others under operating leases, net of accumulated depreciation.
(5) The total should correspond to the amount provided in Y‐9C Schedule HC‐F Line 6, item 13 in the instructions. The amount included should only reflect
collateral rented under operating leases and not include collateral subject to capital/ financing type leases.
(6) Institutions that adopted ASU 2016‐13, should report item 129 net of any applicable allowance for credit losses.
FR Y‐14A Schedule A.1.c.1 Standardized RWA
Actual in
$Millions
as of date
PQ 1
PQ 2
PQ 3
‐
‐
‐
Projected in $Millions
PQ 4
PQ 5
PQ 6
PQ 7
PQ 8
PQ 9
‐
‐
‐
Standardized Approach (Revised regulatory capital rule, July 2013)
Balance Sheet Asset Categories
1 Cash and balances due from depository institutions
2a Securities: Held‐to‐maturity
Securities: Available‐for‐sale and equity securities with readily determinable fair values not
2b held for trading
3 Federal funds sold
CASS0010
CASS1754
CPSS0010
CPSS1754
CASS1773
CASSB987
CPSS1773
CPSSB987
4a
4b
4c
4d
Loans and leases on held for sale
Residential Mortgage exposures
High Volatility Commercial Real Estate (HVCRE) exposures
Exposures past due 90 days or more or on nonaccrual
All other exposures
CASSS413
CASSS419
CASSS423
CASSS431
CPSSS413
CPSSS419
CPSSS423
CPSSS431
5a
5b
5c
5d
Loans and leases, net of unearned income
Residential mortgage exposures
High Volatility Commercial Real Estate (HVCRE) exposures
Exposures past due 90 days or more or on nonaccrual
All other exposures
CASSS439
CASSS445
CASSS449
CASSS457
CPSSS439
CPSSS445
CPSSS449
CPSSS457
6
7a
7b
7c
Trading assets (excluding securitizations that receive standardized charges)
All Other assets
Separate account bank‐owned life insurance
Default fund contributions to central counterparties
CASS3545
CASSB639
CASSR644
CASSR645
CPSS3545
CPSSB639
CPSSR644
CPSSR645
8a
8b
8c
8d
On‐balance sheet securitization exposures
Held‐to‐maturity securities
Available‐for‐sale securities
Trading assets that receive standardized charges
All other on‐balance sheet securitization exposures
CASSS475
CASSS480
CASSS485
CASSS490
CPSSS475
CPSSS480
CPSSS485
CPSSS490
CASSS495
CPSSS495
9 Off‐balance sheet securitization exposures
10 RWA for Balance Sheet Asset Categories (sum of items 1 though 8d)
Derivatives and Off‐Balance‐Sheet Asset Categories (Excluding Securitization Exposures)
11 Financial standby letters of credit
12 Performance standby letters of credit and transaction related contingent items
13 Commercial and similar letters of credit with an original maturity of one year or less
14 Retained recourse on small business obligations sold with recourse
15 Repo‐style transactions
16 All other off‐balance sheet liabilities
17a Unused commitments: Original maturity of one year or less, excluding ABCP conduits
17b Unused commitments: Original maturity of one year or less to ABCP conduits
17c Unused commitments: Original maturity exceeding one year
18 Unconditionally cancelable commitments
19 Over‐the‐counter derivatives
20 Centrally cleared derivatives
21 Unsettled transactions (failed trades)
CASSS625
CASSB546
CASS6570
CASS3411
CASSA250
CASSS515
CASSB681
CASSS525
CASSG591
CASS6572
CASSS540
CASSS626
CASSS627
CASSH191
‐
CPSSS625
CPSSB546
CPSS6570
CPSS3411
CPSSA250
CPSSS515
CPSSB681
CPSSS525
CPSSG591
CPSS6572
CPSSS540
CPSSS626
CPSSS627
CPSSH191
‐
‐
‐
FR Y‐14A Schedule A.1.c.1 Standardized RWA
RWA for Assets, Derivatives and Off‐Balance‐Sheet Asset Categories (sum of items 9
22 through 21)
CASSS628
RWA for purposes of calculating the allowance for loan and lease losses 1.25 percent
23 threshold
CASSS580
CPSSS580
CASSN811
CASSN812
CPSSN811
CPSSN812
CASSS305
CASSS306
CPSSS305
CPSSS306
CASSS307
CPSSS307
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
Items 31 through 36 are not applicable to an institution that does not have a comprehensive risk model; such an institution should go to item 37.
Comprehensive risk capital requirement
Modeled comprehensive risk measure
CPSSS316
CASSS316
Standardized specific risk add‐ons for net long correlation trading positions
CPSSS325
CASSS325
Standardized specific risk add‐on for net short correlation trading positions
CASSS333
CPSSS333
CASSS335
‐
CPSSS335 ‐
Standardized measure of specific risk add‐ons (greater of item 32 or 33)
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
Market Risk
24 Value‐at‐risk (VaR) with Multiplier
25 Stressed VaR with Multiplier
Specific risk add‐on
Debt positions
Equity positions
Capital requirements for securitization positions using the Simplified Supervisory
Formula Approach (SSFA) or applying a specific risk‐weighting factor of 1250% percent
28
26
27
29
Standardized measure of specific risk add‐ons (sum of items 26, 27, and 28)
incremental risk.
30 Incremental risk capital requirement
31
32
33
34
CASSS311
‐
‐
CPSSS628
CPSSS311
CPSSN813
CASSN813
35 Surcharge for modeled correlation trading positions (item 34 multiplied by 0.08)
36 Comprehensive risk measure requirement
CASSS336
CASSN814
De minimis positions and other adjustments
37 Capital requirement for all de minimis exposures
38 Additional capital requirement
39 Sum of items 37 and 38
CASSB825
CASSS344
CASSS345
‐
CPSSN825
CPSSS344
CPSSS345
Market risk‐weighted assets
Standardized market risk‐weighted assets: Sum of items 24, 25, 29, 30 (if applicable), 36 (as
40 appropriate), and 39
CASSS581
‐
CPSSS581
‐
‐
‐
‐
‐
‐
‐
‐
‐
Risk‐weighted assets before deductions for excess allowance of loan and lease losses and
41 allocated risk transfer risk reserve (sum of items 22 and 40)
CASSB704
‐
CPSSB704
‐
‐
‐
‐
‐
‐
‐
‐
‐
42 LESS: Excess allowance for loan and lease losses
CASSA222
CPSSA222
43 LESS: Allocated transfer risk reserve
CASS3128
CPSS3128
44 Total risk‐weighted assets (item 41 minus items 42 and 43)
CASSA223
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
CPSSS336
CPSSN814
CPSSA223
FR Y‐14A Schedule A.1.c.1 Standardized RWA
Memoranda Items ‐‐ Derivatives
45 Current credit exposure across all derivative contracts covered by the regulatory capital rule
CASS8764
Notional principal amounts of over‐the‐counter derivative contracts (sum of lines 47a
through 47g)
Interest rate
Foreign exchange rate and gold
Credit (investment grade reference asset)
Credit (non‐investment grade reference asset)
Equity
Precious metals (except gold)
Other
CASSS629
46
47a
47b
47c
47d
47e
47f
47g
CASSS630
CASSS631
CASSS632
CASSS633
CASSS634
CASSS635
CASSS636
48
49a
49b
49c
49d
49e
49f
49g
Notional principal amounts of centrally cleared derivative contracts (sum of lines 49a
Interest rate
Foreign exchange rate and gold
Credit (investment grade reference asset)
Credit (non‐investment grade reference asset)
Equity
Precious metals (except gold)
Other
CASSS637
CASSS638
CASSS639
CASSS640
CASSS641
CASSS642
CASSS643
CASSS644
CPSS8764
CPSSS629
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
CPSSS630
CPSSS631
CPSSS632
CPSSS633
CPSSS634
CPSSS635
CPSSS636
‐
CPSSS637
CPSSS638
CPSSS639
CPSSS640
CPSSS641
CPSSS642
CPSSS643
CPSSS644
FR Y‐14A Schedule A.1.d. ‐ 1. Capital ‐ CCAR and 2. Capital ‐ DFAST
Submission Indicator ‐ Indicate if this Capital sub‐schedule pertains
to Capital ‐ CCAR or Capital ‐ DFAST
CCARP005
Projected in $Millions
Adjusted
Starting
1
Value
Item
As of Date
3
Schedule HI‐A—Changes in Bank Holding Company Equity Capital
Total bank holding company equity capital most recently reported for the end of
previous QUARTER
Effect of changes in accounting principles and corrections of material accounting
errors
Balance end of previous QUARTER as restated (sum of items 1 and 2)
4
Net income (loss) attributable to bank holding company
1
2
Sums in $Millions
PQ 2 ‐
PQ 5
PQ 6 ‐
PQ 9
PQ 1
PQ 2
PQ 3
PQ 4
PQ 5
PQ 6
PQ 7
PQ 8
PQ 9
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
9‐Quarter
CASK3217
CPSK3217
‐
CASKB507
CPSKB507
CASKB508
CPSKB508
CASK4340
CPSK4340
‐
‐
‐
CASK3577
CASK3578
CPSK3577
CPSK3578
‐
‐
‐
‐
‐
‐
CASK3579
CASK3580
CASK4782
CASK4783
CASK4356
CASK4598
CPSK3579
CPSK3580
CPSK4782
CPSK4783
CPSK4356
CPSK4598
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
Sale of perpetual preferred stock (excluding treasury stock transactions):
5
6
7
8
9
10
11
12
13
Sale of perpetual preferred stock, gross
Conversion or retirement of perpetual preferred stock
Sale of common stock:
Sale of common stock, gross
Conversion or retirement of common stock
Sale of treasury stock
Purchase of treasury stock
Changes incident to business combinations, net
Cash dividends declared on preferred stock
Cash dividends declared on common stock
CASK4460
CPSK4460
‐
‐
‐
14
Other comprehensive income
CASKB511
CPSKB511
‐
‐
‐
15
Change in the offsetting debit to the liability for Employee Stock Ownership Plan
(ESOP) debt guaranteed by the bank holding company
CASK4591
CPSK4591
‐
‐
‐
16
Other adjustments to equity capital (not included above)*
CASK3581
CPSK3581
‐
‐
‐
17
Total bank or intermediate B24holding company equity capital end of current
period (sum of items 3, 4, 5, 6, 7, 8, 9, 11, 14, 15, 16, less items 10, 12, 13)
CASK3210
‐
‐
‐
Schedule HC‐R per Regulatory Capital Rule (12 CFR 217)
AOCI opt‐out election? (enter "1" for Yes; enter "0" for No)
CASDP838
CPSDP838
CASDP742
CASK3247
CASDB530
CASDP839
CPSDP742
CPSK3247
CPSDB530
CPSDP839
18
19
20
21
22
23
Common equity tier 1
Common stock and related surplus, net of treasury stock and unearned
employee stock ownership plan (ESOP) shares
Retained earnings
Accumulated other comprehensive income (AOCI)
Common equity tier 1 minority interest includable in common equity tier 1
Common equity tier 1 before adjustments and deductions (sum of items 19
through 22)
‐
CPSK3210
CASDP840 ‐ CPSDP840
Common equity tier 1 capital: adjustments and deductions
24
25
26
Goodwill net of associated deferred tax liabilities (DTLs)
Intangible assets (other than goodwill and mortgage servicing assets (MSAs)),
net of associated DTLs
Deferred tax assets (DTAs) that arise from net operating loss and tax credit
carryforwards, net of any related valuation allowances and net of DTLs
If Item 18 is “1” for “Yes”, complete items 27 through 31 only for AOCI related
adjustments.
CASDP841
CPSDP841
CASDP842
CPSDP842
CASDP843
CPSDP843
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐ ‐ ‐ ‐ ‐ ‐ ‐ ‐ ‐
FR Y‐14A Schedule A.1.d. ‐ 1. Capital ‐ CCAR and 2. Capital ‐ DFAST
Projected in $Millions
Adjusted
Starting
1
Value
Item
As of Date
27
28
29
30
31
32
33
34
35
36
37a
37b
38
39
40
41
42
43
AOCI related adjustments: Net unrealized gains (losses) on available‐for‐sale
securities (if a gain, report as a positive value; if a loss, report as a negative
AOCI related adjustments: Net unrealized loss on available‐for‐sale preferred
stock classified as an equity security under GAAP and available‐for‐sale equity
exposures (report loss as a positive value)
AOCI related adjustments: Accumulated net gains (losses) on cash flow hedges (if
a gain, report as a positive value; if a loss, report as a negative value)
AOCI related adjustments: Amounts recorded in AOCI attributed to defined
benefit postretirement plans resulting from the initial and subsequent
application of the relevant GAAP standards that pertain to such plans (if a gain,
report as a positive value; if a loss, report as a negative value)
AOCI related adjustments: Net unrealized gains (losses) on held‐to‐maturity
securities that are included in AOCI (if a gain, report as a positive value; if a loss,
report as a negative value)
If Item 18 is “0” for “No”, complete item 32 only for AOCI related adjustments.
AOCI related adjustments: Accumulated net gain (loss) on cash flow hedges
included in AOCI, net of applicable tax effects, that relate to the hedging of items
that are not recognized at fair value on the balance sheet (if a gain, report as a
positive value; if a loss, report as a negative value)
Other deductions from (additions to) common equity tier capital 1 before
threshold‐based deductions: Unrealized net gain (loss) related to changes in the
fair value of liabilities that are due to changes in own credit risk (if a gain, report
as a positive value; if a loss, report as a negative value)
Other deductions from (additions to) common equity tier capital 1 before
threshold‐based deductions: All other deductions from (additions to) common
equity tier 1 capital before threshold‐based deductions
Non‐significant investments in the capital of unconsolidated financial institutions
in the form of common stock that exceed the 10 percent threshold for non‐
significant investments
Subtotal (item 23 minus items 24 through 35)
Significant investments in the capital of unconsolidated financial institutions in
the form of common stock, net of associated DTLs, that exceed the 10 percent
common equity tier 1 capital deduction threshold (item 71)
Investments in the capital of unconsolidated financial institutions, net of
associated DTLs, that exceed 25 percent common equity tier 1 capital deduction
threshold
MSAs, net of associated DTLs, that exceed the common equity tier 1 capital
deduction threshold
DTAs arising from temporary differences that could not be realized through net
operating loss carrybacks, net of related valuation allowances and net of DTLs,
that exceed the common equity tier 1 capital deduction threshold
Amount of significant investments in the capital of unconsolidated financial
institutions in the form of common stock; MSAs, net of associated DTLs; and
DTAs arising from temporary differences that could not be realized through net
operating loss carrybacks, net of related valuation allowances and net of DTLs;
that exceeds the 15 percent common equity tier 1 capital deduction threshold
(item 84 )
Deductions applied to common equity tier 1 capital due to insufficient amount of
additional tier 1 capital and tier 2 capital to cover deductions
Total adjustments and deductions for common equity tier 1 capital (sum of items
37a through 41)
Common equity tier 1 capital (item 36 minus 42)
CASDP844
CPSDP844
CASDP845
CPSDP845
CASDP846
CPSDP846
CASDP847
CPSDP847
CASDP848
CPSDP848
CASDP849
CPSDP849
CASDQ258
CPSDQ258
CASDP850
CPSDP850
CASDP851
CPSDP851
CASDP852 ‐ CPSDP852
CASKP853
CPSKP853
CASKLF29
CPSKLF29
CASKP854
CPSKP854
CASKP855
CPSKP855
CASKP856
CPSKP856
CASDP857
CPSDP857
CASDP858 ‐ CPSDP858
CASDP859 ‐ CPSDP859
PQ 1
PQ 2
PQ 3
PQ 4
PQ 5
PQ 6
Sums in $Millions
PQ 7
PQ 8
PQ 9
‐ ‐ ‐ ‐ ‐ ‐ ‐ ‐ ‐
‐ ‐ ‐ ‐ ‐ ‐ ‐ ‐ ‐
‐ ‐ ‐ ‐ ‐ ‐ ‐ ‐ ‐
PQ 2 ‐
PQ 5
PQ 6 ‐
PQ 9
9‐Quarter
FR Y‐14A Schedule A.1.d. ‐ 1. Capital ‐ CCAR and 2. Capital ‐ DFAST
Projected in $Millions
Adjusted
Starting
1
Value
Item
As of Date
Additional tier 1 capital
Additional tier 1 capital instruments plus related surplus
CASDP860
CPSDP860
45
Non‐qualifying capital instruments subject to phase out from additional tier 1
capital
CASDP861
CPSDP861
46
Tier 1 minority interest not included in common equity tier 1 capital
CASDP862
CPSDP862
47
Additional tier 1 capital before deductions
CASDP863
CPSDP863
48
Additional tier 1 capital deductions
CASDP864
CPSDP864
49
Additional tier 1 capital
CASDP865
CPSDP865
50
Tier 1 capital
Tier 1 capital (sum of items 43 and 49)
CASD8274
44
51
52
53
54
55
56
57
58
59
60
61
62
63
Tier 2 capital
Tier 2 capital instruments plus related surplus
Non‐qualifying capital instruments subject to phase out from tier 2 capital
Total capital minority interest that is not included in tier 1 capital
Allowance for loan and lease losses includable in tier 2 capital (2)
(Advanced approaches holding companies that exit parallel run only): eligible
credit reserves includable in tier 2 capital
Unrealized gains on available‐for‐sale preferred stock classified as an equity
security under GAAP and available‐for‐sale equity exposures includable in tier 2
capital
Tier 2 capital before deductions (sum of items 51, 52, 53, 54 and 56)
(Advanced approaches holding companies that exit parallel run only): Tier 2
capital before deductions
Tier 2 capital deductions
Tier 2 capital (item 57 minus 59)
(Advanced approaches holding companies that exit parallel run only): Tier 2
capital
Total capital
Total capital, (sum of items 50 and 60)
(Advanced approaches holding companies that exit parallel run only): Total
capital (sum of items 50 and 61)
‐
CPSD8274
Sums in $Millions
PQ 1
PQ 2
PQ 3
PQ 4
PQ 5
PQ 6
PQ 7
PQ 8
PQ 9
‐
‐
‐
‐
‐
‐
‐
‐
‐
CASDP866
CASDP867
CASDP868
CASD5310
CPSDP866
CPSDP867
CPSDP868
CPSD5310
CASE5310
CPSE5310
CASDQ257
CASDP870 ‐
CPSDQ257
CPSDP870
‐
‐
‐
‐
‐
‐
‐
‐
‐
CASEP870
CASDP872
CASD5311 ‐
CPSEP870
CPSDP872
CPSD5311
‐
‐
‐
‐
‐
‐
‐
‐
‐
CASE5311
CPSE5311
‐
‐
‐
‐
‐
‐
‐
‐
‐
CASD3792
CASE3792
‐
CPSD3792
CPSE3792
PQ 2 ‐
PQ 5
PQ 6 ‐
PQ 9
9‐Quarter
FR Y‐14A Schedule A.1.d. ‐ 1. Capital ‐ CCAR and 2. Capital ‐ DFAST
Projected in $Millions
Adjusted
Starting
1
Value
Item
As of Date
64a
64b
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
Threshold Deductions Calculations
Items 64‐71 should only be filed by firms subject to Category I and II standards
Non‐significant investments in the capital of unconsolidated financial institutions
in the form of common stock, net of associated DTLs
Aggregate non‐significant investments in the capital of unconsolidated financial
institutions, including in the form of common stock, additional tier 1, and tier 2
capital
Aggregate non‐significant investments in the capital of unconsolidated financial
institutions in the form of common stock
10 percent common equity tier 1 deduction threshold for non‐significant
investments in the capital of unconsolidated financial institutions in the form of
common stock
Amount of non‐significant investments that exceed the 10 percent deduction
threshold for non‐significant investments
Significant investments in the capital of unconsolidated financial institutions in
the form of common stock, net of associated DTLs
Gross significant investments in the capital of unconsolidated financial
institutions in the form of common stock
Permitted offsetting short positions in relation to the specific gross holdings
included above
Significant investments in the capital of unconsolidated financial institutions in
the form of common stock net of short positions (greater of item 67 minus 68 or
zero)
10 percent common equity tier 1 deduction threshold (10 percent of item 36)
Amount to be deducted from common equity tier 1 due to 10 percent deduction
threshold (greater of item 69 minus item 70 or zero), prior to transition
provisions
Investments in the capital of unconsolidated financial institutions (firms subject
to Category III and IV standards only)
Aggregate amount of investments in the capital of unconsolidated financial
institutions, net of associated DTLs
25 percent common equity tier 1 deduction threshold (25 percent of item 36)
Amount to be deducted from common equity tier 1 due to 25 percent deduction
threshold (greater of item 72 minus item 73 or zero)
Items 75‐82 should be filed by all firms
MSAs, net of associated DTLs
Total mortgage servicing assets classified as intangible
Associated deferred tax liabilities which would be extinguished if the intangible
becomes impaired or derecognized under the relevant accounting standards
Mortgage servicing assets net of related deferred tax liabilities (item 75 minus
item 76)
Common equity tier 1 deduction threshold
Amount to be deducted from common equity tier 1 due to the deduction
threshold
DTAs arising from temporary differences that could not be realized through net
operating loss carrybacks, net of related valuation allowances and net of DTLs
DTAs arising from temporary differences that could not be realized through net
operating loss carrybacks, net of related valuation allowances and net of DTLs
Common equity tier 1 deduction threshold
Amount to be deducted from common equity tier 1 due to the deduction
threshold
Items 83‐86 should only be filed by firms subject to Category I and II standards
PQ 1
PQ 2
PQ 3
PQ 4
PQ 5
PQ 6
Sums in $Millions
PQ 7
PQ 8
PQ 9
CASDR643
CPSDR643
CASDLG29
CPSDLG29
CASDR646 ‐
CPSDR646
‐ ‐ ‐ ‐ ‐ ‐ ‐ ‐ ‐
CASDR647 ‐
CPSDR647
‐ ‐ ‐ ‐ ‐ ‐ ‐ ‐ ‐
CASDQ259
CPSDQ259
CASDQ260
CPSDQ260
CASDQ261
CASDQ262
‐
‐
CPSDQ261
CPSDQ262
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
CASDP853
‐
CPSDP853
‐
‐
‐
‐
‐
‐
‐
‐
‐
CASDLF18
CASDLF19
‐
CPSDLF18
CPSDLF19
‐
‐
‐
‐
‐
‐
‐
‐
‐
CASDLF20
‐
CPSDLF20
‐
‐
‐
‐
‐
‐
‐
‐
‐
CASDQ263
CPSDQ263
CASDQ264
CPSDQ264
CASDQ265
CASDQ262
‐
‐
CPSDQ265
CPSDQ262
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
CASDP854
‐
CPSDP854
‐
‐
‐
‐
‐
‐
‐
‐
‐
CASDQ296 ‐ CPSDQ296
CASDQ262 ‐
CPSDQ262
CASDP855
‐
CPSDP855
‐ ‐ ‐ ‐ ‐ ‐ ‐ ‐ ‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
PQ 2 ‐
PQ 5
PQ 6 ‐
PQ 9
9‐Quarter
FR Y‐14A Schedule A.1.d. ‐ 1. Capital ‐ CCAR and 2. Capital ‐ DFAST
Projected in $Millions
Adjusted
Starting
1
Value
Item
As of Date
83
Aggregate of items subject to the 15% limit (significant investments, mortgage
servicing assets and deferred tax assets arising from temporary differences)
Sum of items 69, 77, and 80
CASDQ266
‐
CPSDQ266
Sums in $Millions
PQ 1
PQ 2
PQ 3
PQ 4
PQ 5
PQ 6
PQ 7
PQ 8
PQ 9
‐
‐
‐
‐
‐
‐
‐
‐
‐
PQ 2 ‐
PQ 5
PQ 6 ‐
PQ 9
9‐Quarter
FR Y‐14A Schedule A.1.d. ‐ 1. Capital ‐ CCAR and 2. Capital ‐ DFAST
Projected in $Millions
Adjusted
Starting
1
Value
Item
As of Date
100
106
107
Common equity tier 1 ratio (%)
(Advanced approaches holding companies that exit parallel run only): Common
equity tier 1 ratio (%)
Tier 1 capital ratio (%)
(Advanced approaches holding companies that exit parallel run only): Tier 1
capital ratio (%)
Total capital ratio (%)
(Advanced approaches holding companies that exit parallel run only): Total
capital ratio (%)
Tier 1 leverage ratio (%)
Supplementary leverage ratio (%)
108
101
102
103
104
105
Sums in $Millions
PQ 1
PQ 2
PQ 3
PQ 4
PQ 5
PQ 6
PQ 7
PQ 8
PQ 9
CASDP793
#DIV/0!
CPSDP793
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
CASEP793
CASD7206
#DIV/0!
CPSEP793
CPSD7206
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
CASE7206
CASD7205
#DIV/0!
CPSE7206
CPSD7205
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
CASE7205
CASD7204
#DIV/0!
CPSE7205
CPSD7204
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
CASKHK23
CPSKHK23
Schedule HC‐F—Other Assets
Net deferred tax assets
CASK2148
CPSK2148
109
Schedule HC‐G—Other Liabilities
Net deferred tax liabilities
CASK3049
CPSK3049
110
111
Issuances associated with the U.S. Department of Treasury Capital Purchase
Program:
Senior perpetual preferred stock or similar items
Warrants to purchase common stock or similar items
CASKG234
CASKG235
CPSKG234
CPSKG235
CASDQ275
CASDLC30
CASDLC31
CASDLC32
CPSDQ275
CPSDLC30
CPSDLC31
CPSDLC32
Deferred Tax Asset Information
Taxes previously paid that the bank holding company could recover through
allowed carrybacks if the bank holding company's DTAs on net operating loss,
tax credits and temporary differences (both deductible and taxable) fully reverse
at the report date
112a U.S. Federal Government
112b U.S. State Governments
112c All non‐U.S. tax jurisdictions
112
113
Deferred tax assets that arise from net operating loss and tax credit
carryforwards, net of DTLs, but gross of related valuation allowances
CASDR648
CPSDR648
114
Valuation allowances related to deferred tax assets that arise from net operating
loss and tax credit carryforwards
CASDR649
CPSDR649
114a U.S. Federal Government
114b U.S. State Governments
114c All non‐U.S. tax jurisdictions
115
Deferred tax assets arising from temporary differences, net of DTLs
CASDLC33
CPSDLC33
CASDLC34
CPSDLC34
CASDLC35
CPSDLC35
CASDR650
CPSDR650
115a U.S. Federal Government
CASDLC36
CPSDLC36
115b U.S. State Governments
CASDLC37
CPSDLC37
115c All non‐U.S. tax jurisdictions
CASDLC38
CPSDLC38
116
CASDR651
CPSDR651
116a U.S. Federal Government
CASDLC39
CPSDLC39
116b U.S. State Governments
CASDLC40
CASDLC41
CPSDLC40
CPSDLC41
Valuation allowances related to DTAs arising from temporary differences
116c All non‐U.S. tax jurisdictions
Supplemental Capital Action Information (report in $Millions unless otherwise
noted)***
117 Cash dividends declared on common stock
118
Common shares outstanding (Millions)
119
Common dividends per share ($)
CASD4460
CPSD4460
CASDQ946
CASDQ282 ‐
CPSDQ946
CPSDQ282
‐
‐
‐
‐
‐
‐
‐
‐
‐
PQ 2 ‐
PQ 5
PQ 6 ‐
PQ 9
9‐Quarter
FR Y‐14A Schedule A.1.d. ‐ 1. Capital ‐ CCAR and 2. Capital ‐ DFAST
Projected in $Millions
Adjusted
Starting
1
Value
Item
PQ 1
PQ 2
PQ 3
PQ 4
PQ 5
PQ 6
PQ 7
PQ 8
PQ 9
‐
CPSDQ283
CPSDQ284
CPSDQ285
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
CPSDQ286
CPSDQ287
CPSDQ288
‐
‐
‐
‐
‐
‐
‐
‐
‐
As of Date
120
121
122
Issuance of common stock for employee compensation
Other issuance of common stock
Total issuance of common stock
CASDQ283
CASDQ284
CASDQ285
123
124
125
Share repurchases to offset issuance for employee compensation
Other share repurchase
Total share repurchases
CASDQ286
CASDQ287
CASDQ288
126
127
Supplemental Information on Trust Preferred Securities Subject to Phase‐Out
from Tier 1 Capital
Outstanding trust preferred securities
Trust preferred securities included in Item 49
CASKC699
CASDQ289
CPSKC699
CPSDQ289
CASDLE84
CASDLE85
CASDLE86
CASDLE87
CASDH311
CPSDLE84
CPSDLE85
CPSDLE86
CPSDLE87
CPSDH311
CASDLE88
CASDLE89
CASDLE90
CPSDLE88
CPSDLE89
CPSDLE90
CASDH313
CASDLE91
CASDLE92
CASDH314
CPSDH313
CPSDLE91
CPSDLE92
CPSDH314
CASDLF21
CASDLF22
CPSDLF21
CPSDLF22
CASDNL23
CASDNL24
CASDNL25
CASDNL26
CASDNL27
CASDNL28
CPSDNL23
CPSDNL24
CPSDNL25
CPSDNL26
CPSDNL27
CPSDNL28
CASDNL29
CASDNL30
CPSDNL29
CPSDNL30
CASDLF27
CASDLF28
CPSDLF27
CPSDLF28
128
128(a)
128(b)
128(c)
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
145(a)
145(b)
146
146a
146b
Capital Buffers and Ratios
Capital conservation buffer requirement (sum of items a through c)
of which: Stress capital buffer requirement
of which: GSIB surcharge (if applicable)
of which: Countercyclical capital buffer amount (if applicable)
Capital conservation buffer
Leverage Buffer and Requirements
Total leverage exposure for the supplementary leverage ratio (SLR) (if applicable)
Leverage buffer requirement (if applicable)
Leverage buffer (if applicable)
Maximum Payout Ratio and Amounts
Eligible retained income
Maximum payout ratio
Maximum payout amount
Distributions and discretionary bonus payments during the quarter
Long‐Term Debt and Total Loss Absorbing Capacity
Outstanding eligible long‐term debt
Total loss absorbing capacity
Long‐Term Debt and Total Loss Absorbing Capacity Ratios
LTD standardized risk‐weighted assets ratio
TLAC standardized risk‐weighted assets ratio
LTD advanced approaches risk‐weighted assets ratio
TLAC advanced approaches risk‐weighted assets ratio
LTD leverage ratio
TLAC leverage ratio
Advanced approaches holding companies only: LTD and TLAC supplementary
leverage ratios
LTD supplementary leverage ratio
TLAC supplementary leverage ratio
Institution‐specific buffer necessary to avoid limitations or distributions and
discretionary bonus payments
TLAC risk‐weighted asset buffer
TLAC leverage buffer
Memoranda
*Please break out and explain below other adjustments to equity capital:
CASDQ290
147
148
149
150
Sums in $Millions
**The carryback period is the prior two calendar tax years plus any current taxes paid in the year‐to‐date period. Please provide disaggregated data for item 112 as follows:
Taxes paid during the fiscal year ended two years ago
CASDQ292
Taxes paid during the fiscal year ended one year ago
CASDQ293
Taxes paid through the as‐of date of the current fiscal year
CASDQ294
PQ 2 ‐
PQ 5
PQ 6 ‐
PQ 9
9‐Quarter
FR Y‐14A Schedule A.1.d. ‐ 1. Capital ‐ CCAR and 2. Capital ‐ DFAST
Projected in $Millions
Item
As of Date
***Please reconcile the Supplemental Capital Action and HI‐A projections (i.e.,
allocate the capital actions among the HI‐A buckets):
Adjusted
Starting
1
Value
PQ 1
PQ 2
PQ 3
CASDQ295
151
(1)
(2)
Footnotes to the Capital Worksheet
Firms should only use this column to report an adjusted starting value for an item subject to adjustment or deduction in capital impacted by the global market shock.
Institutions that have adopted ASU 2016‐13 should report in item 54 the adjusted allowances for credit losses, as defined in the regulatory capital rule.
PQ 4
PQ 5
PQ 6
Sums in $Millions
PQ 7
PQ 8
PQ 9
PQ 2 ‐
PQ 5
PQ 6 ‐
PQ 9
9‐Quarter
FR Y‐14A Schedule A.2.a ‐ Retail Balance and Loss Projections
As‐of
Item
PQ 1
First Lien Mortgages (in Domestic Offices)
1
Balances
CASRP381
CPSRP381
1a
Balances ‐‐ PCD (1)
CASRKU95
CPSRKU95
2
New originations
CASRP382
CPSRP382
3
Paydowns
CASRP383
CPSRP383
4
Asset Purchases
CASRP384
CPSRP384
5
Asset Sales
CASRP385
CPSRP385
6
Loan Losses
CASRP386
CPSRP386
6a
Loan Losses ‐‐ PCD (1)
CASRKU97
CPSRKU97
7
Not applicable
8
Not applicable
First Lien HELOANs (in Domestic Offices)
9
Balances
CASRP389
CPSRP389
9a
Balances ‐‐ PCD (1)
CASRKV00
CPSRKV00
10
New originations
CASRP390
CPSRP390
11
Paydowns
CASRP391
CPSRP391
12
Asset Purchases
CASRP392
CPSRP392
13
Asset Sales
CASRP393
CPSRP393
14
Loan Losses
CASRP394
CPSRP394
14a
Loan Losses ‐‐ PCD (1)
CASRKV02
CPSRKV02
15
Not applicable
16
Not applicable
PQ 2
PQ 3
Projected in $Millions
PQ 4
PQ 5
PQ 6
PQ 7
PQ 8
PQ 9
FR Y‐14A Schedule A.2.a ‐ Retail Balance and Loss Projections
As‐of
Item
PQ 1
PQ 2
PQ 3
‐
‐
‐
Projected in $Millions
PQ 4
PQ 5
PQ 6
PQ 7
PQ 8
PQ 9
‐
‐
‐
Closed‐End Junior Liens (in Domestic Offices)
17
Balances
CASRP397
CPSRP397
17a
Balances ‐‐ PCD (1)
CASRKV05
CPSRKV05
18
New originations
CASRP398
CPSRP398
19
Paydowns
CASRP399
CPSRP399
20
Asset Purchases
CASRP400
CPSRP400
21
Asset Sales
CASRP401
CPSRP401
22
Loan Losses
CASRP402
CPSRP402
22a
Loan Losses ‐‐ PCD (1)
CASRKV07
CPSRKV07
23
Not applicable
24
Not applicable
HELOCs (in Domestic Offices)
25
26
26a
27
27a
28
Balances
Balance from vintages < PQ 1
Balances ‐‐ PCD (1)
CASRP405
‐
CPSRP405
CASRP406
CPSRP406
CASRKV10
CPSRKV10
Balance from vintage PQ 1 ‐ PQ 5
CPSRP407
Balances ‐‐ PCD (1)
CPSRLC42
Balance from vintage PQ 6 ‐ PQ 9
CPSRP408
28a
Balances ‐‐ PCD (1)
29
Paydowns
CASRP409
CPSRP409
CPSRLC43
30
Asset Purchases
CASRP410
CPSRP410
31
Asset Sales
CASRP411
CPSRP411
32
Loan Losses
CASRP412
CPSRP412
32a
Loan Losses ‐‐ PCD (1)
CASRKV12
CPSRKV12
33
Not applicable
34
Not applicable
‐
‐
‐
FR Y‐14A Schedule A.2.a ‐ Retail Balance and Loss Projections
As‐of
Item
PQ 1
First Lien Mortgages and HELOANs (International)
35
Balances
CASRP415
CPSRP415
35a
Balances ‐‐ PCD (1)
CASRKV15
CPSRKV15
36
New originations
CASRP416
CPSRP416
37
Paydowns
CASRP417
CPSRP417
38
Asset Purchases
CASRP418
CPSRP418
39
Asset Sales
CASRP419
CPSRP419
40
Loan Losses
CASRP420
CPSRP420
40a
Loan Losses ‐‐ PCD (1)
CASRKV17
CPSRKV17
41
Not applicable
42
Not applicable
Closed‐End Junior Liens and HELOCs (International)
43
Balances
CASRP423
CPSRP423
43a
Balances ‐‐ PCD (1)
CASRKV20
CPSRKV20
44
New originations
CASRP424
CPSRP424
45
Paydowns
CASRP425
CPSRP425
46
Asset Purchases
CASRP426
CPSRP426
47
Asset Sales
CASRP427
CPSRP427
48
Loan Losses
CASRP428
CPSRP428
48a
Loan Losses ‐‐ PCD (1)
CASRKV22
CPSRKV22
49
Not applicable
50
Not applicable
PQ 2
PQ 3
Projected in $Millions
PQ 4
PQ 5
PQ 6
PQ 7
PQ 8
PQ 9
FR Y‐14A Schedule A.2.a ‐ Retail Balance and Loss Projections
As‐of
Item
PQ 1
PQ 2
PQ 3
‐
‐
‐
Projected in $Millions
PQ 4
PQ 5
PQ 6
PQ 7
PQ 8
PQ 9
‐
‐
‐
Corporate Card (Domestic)
51
Balances
CASRP431
CPSRP431
52
Paydowns
CASRP432
CPSRP432
53
Asset Purchases
CASRP433
CPSRP433
54
Asset Sales
CASRP434
CPSRP434
55
Loan Losses
CASRP435
CPSRP435
Business Card (Domestic)
56
Balances
CASRP436
CPSRP436
Paydowns
CASRP437
CPSRP437
58
Asset Purchases
CASRP438
CPSRP438
59
Asset Sales
CASRP439
CPSRP439
60
Loan Losses
CASRP440
CPSRP440
61
Balances
57
Charge Card (Domestic)
62
Balance from vintages < PQ 1
CASRP441
CASRP442
‐
CPSRP441
CPSRP442
63
Balance from vintage PQ 1 ‐ PQ 5
CPSRP443
64
Balance from vintage PQ 6 ‐ PQ 9
CPSRP444
65
Paydowns
66
Asset Purchases
CASRP446
CPSRP446
67
Asset Sales
CASRP447
CPSRP447
68
Loan Losses
CASRP448
CPSRP448
CASRP445
CPSRP445
‐
‐
‐
FR Y‐14A Schedule A.2.a ‐ Retail Balance and Loss Projections
As‐of
Item
PQ 1
PQ 2
PQ 3
‐
‐
‐
Projected in $Millions
PQ 4
PQ 5
PQ 6
PQ 7
PQ 8
PQ 9
‐
‐
‐
Bank Card (Domestic)
69
70
71
72
Balances
Balance from vintages < PQ 1
CASRP449
CASRP450
Balance from vintage PQ 1 ‐ PQ 5
‐
CPSRP449
CPSRP450
CPSRP451
Balance from vintage PQ 6 ‐ PQ 9
CPSRP452
73
Paydowns
CASRP453
CPSRP453
74
Asset Purchases
CASRP454
CPSRP454
75
Asset Sales
CASRP455
CPSRP455
76
Loan Losses
CASRP456
CPSRP456
Business and Corporate Card (International)
77
Balances
CASRP457
CPSRP457
78
Paydowns
CASRP458
CPSRP458
79
Asset Purchases
CASRP459
CPSRP459
80
Asset Sales
CASRP460
CPSRP460
81
Loan Losses
CASRP461
CPSRP461
Balances
CASRP462
CPSRP462
83
Paydowns
CASRP463
CPSRP463
84
Asset Purchases
CASRP464
CPSRP464
85
Asset Sales
CASRP465
CPSRP465
Loan Losses
CASRP466
CPSRP466
CASRP467
CPSRP467
Bank and Charge Card (International)
82
86
Auto Loans (Domestic)
87
Balances
88
New originations
CASRP468
CPSRP468
89
Paydowns
CASRP469
CPSRP469
90
Asset Purchases
CASRP470
CPSRP470
91
Asset Sales
CASRP471
CPSRP471
92
Loan Losses
CASRP472
CPSRP472
‐
‐
‐
FR Y‐14A Schedule A.2.a ‐ Retail Balance and Loss Projections
As‐of
Item
PQ 1
Auto Loans (International)
93
Balances
CASRP473
CPSRP473
94
New originations
CASRP474
CPSRP474
95
Paydowns
CASRP475
CPSRP475
96
Asset Purchases
CASRP476
CPSRP476
97
Asset Sales
CASRP477
CPSRP477
98
Loan Losses
CASRP478
CPSRP478
Auto Leases (Domestic)
99
Balances
CASRP479
CPSRP479
100
New originations
CASRP480
CPSRP480
101
Paydowns
CASRP481
CPSRP481
102
Asset Purchases
CASRP482
CPSRP482
103
Asset Sales
CASRP483
CPSRP483
104
Loan Losses
CASRP484
CPSRP484
Auto Leases (International)
105
Balances
CASRP485
CPSRP485
106
New originations
CASRP486
CPSRP486
107
Paydowns
CASRP487
CPSRP487
108
Asset Purchases
CASRP488
CPSRP488
109
Asset Sales
CASRP489
CPSRP489
Loan Losses
CASRP490
CPSRP490
CASRP491
CPSRP491
110
Student Loan
111
Balances
112
New originations
CASRP492
CPSRP492
113
Paydowns
CASRP493
CPSRP493
114
Asset Purchases
CASRP494
CPSRP494
115
Asset Sales
CASRP495
CPSRP495
116
Loan Losses
CASRP496
CPSRP496
PQ 2
PQ 3
Projected in $Millions
PQ 4
PQ 5
PQ 6
PQ 7
PQ 8
PQ 9
FR Y‐14A Schedule A.2.a ‐ Retail Balance and Loss Projections
As‐of
Item
PQ 1
Small Business Loan ‐ Scored (Domestic)
117
Balances
CASRP497
CPSRP497
118
New originations
CASRP498
CPSRP498
119
Paydowns
CASRP499
CPSRP499
120
Asset Purchases
CASRP500
CPSRP500
121
Asset Sales
CASRP501
CPSRP501
122
Loan Losses
CASRP502
CPSRP502
Small Business Loan ‐ Scored (International)
123
Balances
CASRP503
CPSRP503
124
New originations
CASRP504
CPSRP504
125
Paydowns
CASRP505
CPSRP505
126
Asset Purchases
CASRP506
CPSRP506
127
Asset Sales
CASRP507
CPSRP507
128
Loan Losses
CASRP508
CPSRP508
Other Consumer Loans and Leases (Domestic)
129
Balances
CASRP509
CPSRP509
130
New originations
CASRP510
CPSRP510
131
Paydowns
CASRP511
CPSRP511
132
Asset Purchases
CASRP512
CPSRP512
133
Asset Sales
CASRP513
CPSRP513
Loan Losses
CASRP514
CPSRP514
CASRP515
CPSRP515
134
Other Consumer Loans and Leases (International)
135
Balances
136
New originations
CASRP516
CPSRP516
137
Paydowns
CASRP517
CPSRP517
138
Asset Purchases
CASRP518
CPSRP518
139
Asset Sales
CASRP519
CPSRP519
140
Loan Losses
CASRP520
CPSRP520
(1)
Footnotes to the Retail Balance and Loss Projections Worksheet
This item is only reported by institutions that have adopted ASU 2016‐13.
PQ 2
PQ 3
Projected in $Millions
PQ 4
PQ 5
PQ 6
PQ 7
PQ 8
PQ 9
FR Y‐14A Schedule A.3.b ‐ OTTI Methodology and Assumptions for AFS and HTM Securities by Portfolio
Institutions that have not adopted ASU 2016‐13
should continue to report sub‐schedules A.3.b and
A.3.c. Institutions that have adopted ASU 2016‐13
should report sub‐schedules A.3.f and A.3.g.
Threshold for
Determining OTTI
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
Aggregate Cumulative
Lifetime Loss on
Underlying Collateral
(% Original Balance)
Discount Rate
Methodology
Please provide the name(s)
Were all securities
of any vendor(s) and any
reviewed for potential
vendor model(s) that are OTTI (yes/no) for stress
used
testing?
Macroeconomic/financial
variables used in loss
estimation
AFS and HTM Securities
CASMN243
CCARP084
CPSMN244
CASMN245
CASMN246
CASMN247
CASMN248
Agency MBS
Auction Rate Securities
CDO
CLO
CMBS
Not Applicable
Auto ABS
Credit Card ABS
Student Loan ABS
Other ABS (excl HEL ABS)
Corporate Bond
Covered Bond
Domestic Non‐Agency RMBS
(incl HEL ABS)
Foreign RMBS
Municipal Bond
Mutual Fund
Not Applicable
Sovereign Bond
US Treasuries & Agencies
Other*
*For 'Other' AFS and HTM securities, please provide name of security type in row 20 above (currently labeled "Other"). Please add additional rows if necessary. If adding additional
rows, please ensure that grand totals sum appropriately.
FR Y‐14A Schedule A.3.c ‐Projected OTTI for AFS and HTM Securities by Portfolio
Institutions that have not adopted ASU 2016‐13
should continue to report sub‐schedules A.3.b
and A.3.c. Institutions that have adopted ASU
2016‐13 should report sub‐schedules A.3.f and
A.3.g.
AFS and HTM Securities
CCARP084
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
PQ 1
Actual
Amortized
Cost
Accounting
Intent (AFS, (MM/DD/YYY Credit Loss Non‐ Credit
Y)
Portion
Loss Portion
HTM)
Total OTTI
CCARP092
CPSPP091 CPSPN234
CASPP087
CPSPN234
Agency MBS
Auction Rate Securities
CDO
CLO
CMBS
Common Stock (Equity)
Auto ABS
Credit Card ABS
Student Loan ABS
Other ABS (excl HEL ABS)
Corporate Bond
Covered Bond
Domestic Non‐Agency RMBS
Foreign RMBS
Municipal Bond
Mutual Fund
Preferred Stock (Equity)
Sovereign Bond
US Treasuries & Agencies
Other*
GRAND TOTAL
0
0
0
CPSPN235
PQ 2
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
0 ‐
PQ 3
Credit Loss Non‐ Credit
Portion
Loss Portion
0
CPSPN235
Total OTTI
Credit Loss Non‐ Credit
Portion
Loss Portion
CPSPP091 CPSPN234
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
0 ‐
0
CPSPN235
Total OTTI
CPSPP091
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
0 ‐
*For 'Other' AFS securities, please provide name of security type in row 20 above (currently labeled "Other"). Please add additional rows if necessary. If adding additional rows, please ensure that grand totals sum
appropriately.
FR Y‐14A Schedule A.3.c ‐Projected OTTI for AFS and HTM Securities by Portfolio
Institutions that have not adopted ASU 2016‐13
should continue to report sub‐schedules A.3.b
and A.3.c. Institutions that have adopted ASU
2016‐13 should report sub‐schedules A.3.f and
A.3.g.
AFS and HTM Securities
CCARP084
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
PQ 4
Actual
Amortized
Cost
Accounting
Intent (AFS, (MM/DD/YYY Credit Loss Non‐ Credit
Y)
HTM)
Portion
Loss Portion
Total OTTI
CCARP092
CPSPP091 CPSPN234
CASPP087
CPSPN234
Agency MBS
Auction Rate Securities
CDO
CLO
CMBS
Common Stock (Equity)
Auto ABS
Credit Card ABS
Student Loan ABS
Other ABS (excl HEL ABS)
Corporate Bond
Covered Bond
Domestic Non‐Agency RMBS
Foreign RMBS
Municipal Bond
Mutual Fund
Preferred Stock (Equity)
Sovereign Bond
US Treasuries & Agencies
Other*
GRAND TOTAL
0
0
*For 'Other' AFS securities, please provide name of security type in row 20
appropriately.
0
CPSPN235
PQ 5
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
0 ‐
PQ 6
Credit Loss Non‐ Credit
Portion
Loss Portion
0
CPSPN235
Total OTTI
Credit Loss Non‐ Credit
Portion
Loss Portion
CPSPP091 CPSPN234
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
0 ‐
0
CPSPN235
Total OTTI
CPSPP091
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
0 ‐
FR Y‐14A Schedule A.3.c ‐Projected OTTI for AFS and HTM Securities by Portfolio
Institutions that have not adopted ASU 2016‐13
should continue to report sub‐schedules A.3.b
and A.3.c. Institutions that have adopted ASU
2016‐13 should report sub‐schedules A.3.f and
A.3.g.
AFS and HTM Securities
CCARP084
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
PQ 7
Actual
Amortized
Cost
Accounting
Intent (AFS, (MM/DD/YYY Credit Loss Non‐ Credit
Y)
HTM)
Portion
Loss Portion
Total OTTI
CCARP092
CPSPP091 CPSPN234
CASPP087
CPSPN234
Agency MBS
Auction Rate Securities
CDO
CLO
CMBS
Common Stock (Equity)
Auto ABS
Credit Card ABS
Student Loan ABS
Other ABS (excl HEL ABS)
Corporate Bond
Covered Bond
Domestic Non‐Agency RMBS
Foreign RMBS
Municipal Bond
Mutual Fund
Preferred Stock (Equity)
Sovereign Bond
US Treasuries & Agencies
Other*
GRAND TOTAL
0
0
*For 'Other' AFS securities, please provide name of security type in row 20
appropriately.
0
CPSPN235
PQ 8
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
0 ‐
PQ 9
Credit Loss Non‐ Credit
Portion
Loss Portion
0
CPSPN235
Total OTTI
Credit Loss Non‐ Credit
Portion
Loss Portion
CPSPP091 CPSPN234
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
0 ‐
0
CPSPN235
Total OTTI
CPSPP091
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
0 ‐
FR Y‐14A Schedule A.3.d ‐ Projected OCI and Fair Value for AFS Securities
Total Actual
Fair Market Beginning Fair Value Projected Beginning Fair Value Projected Beginning Fair Value Projected
Value
Fair Market Rate of
OCI ‐
Fair Market Rate of
OCI ‐
Fair Market Rate of
OCI ‐
MM/DD/YYYY Value PQ 1 Change PQ1
PQ 1
Value PQ 2 Change PQ2
PQ 2
Value PQ 3 Change PQ3
PQ 3
CASPP088
CPSPS677 CPSPS678 CPSPB530 CPSPS677 CPSPS678 CPSPB530 CPSPS677 CPSPS678 CPSPB530
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
AFS Securities
CCARP084
Agency MBS
Auction Rate Securities
CDO
CLO
CMBS
Common Stock (Equity)
Auto ABS
Credit Card ABS
Student Loan ABS
Other ABS (excl HEL ABS)
Corporate Bond
Covered Bond
Domestic Non‐Agency RMBS
Foreign RMBS
Municipal Bond
Mutual Fund
Preferred Stock (Equity)
Sovereign Bond
US Treasuries & Agencies
Other*
GRAND TOTAL
‐ ‐ ‐ ‐ ‐ ‐ ‐ ‐ ‐ ‐
* For 'Other' AFS securities, please provide name of security type in row 20 above (currently labeled "Other"). Please add additional rows if necessary. If adding additional
rows, please ensure that grand totals sum appropriately.
FR Y‐14A Schedule A.3.d ‐ Projected OCI and Fair Value for AFS Securities
Projected OCI Based on Macro‐Economic Scenario
Beginning Fair Value Projected Beginning Fair Value Projected Beginning Fair Value Projected Beginning Fair Value Projected
Fair Market Rate of
OCI ‐
Fair Market Rate of
OCI ‐
Fair Market Rate of
OCI ‐
Fair Market Rate of
OCI ‐
Value PQ 4 Change PQ4
PQ 4
Value PQ 5 Change PQ5
PQ 5
Value PQ 6 Change PQ6
PQ 6
Value PQ 7 Change PQ7
PQ 7
CPSPS677 CPSPS678 CPSPB530 CPSPS677 CPSPS678 CPSPB530 CPSPS677 CPSPS678 CPSPB530 CPSPS677 CPSPS678 CPSPB530
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
AFS Securities
CCARP084
Agency MBS
Auction Rate Securities
CDO
CLO
CMBS
Common Stock (Equity)
Auto ABS
Credit Card ABS
Student Loan ABS
Other ABS (excl HEL ABS)
Corporate Bond
Covered Bond
Domestic Non‐Agency RMBS
Foreign RMBS
Municipal Bond
Mutual Fund
Preferred Stock (Equity)
Sovereign Bond
US Treasuries & Agencies
Other*
GRAND TOTAL
‐ ‐ ‐ ‐ ‐ ‐ ‐ ‐ ‐ ‐ ‐ ‐
* For 'Other' AFS securities, please pro
rows, please ensure that grand totals
FR Y‐14A Schedule A.3.d ‐ Projected OCI and Fair Value for AFS Securities
Beginning Fair Value Projected Beginning Fair Value Projected
Fair Market Rate of
OCI ‐
Fair Market Rate of
OCI ‐
Value PQ 8 Change PQ8
PQ 8
Value PQ 9 Change PQ9
PQ 9
CPSPS677 CPSPS678 CPSPB530 CPSPS677 CPSPS678 CPSPB530
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
Total
Projected
OCI in all
Quarters
Estimated Total Fair
Market Value after OCI
Shock applied to all
Quarters
CPSPP088
AFS Securities
CCARP084
Agency MBS
Auction Rate Securities
CDO
CLO
CMBS
Common Stock (Equity)
Auto ABS
Credit Card ABS
Student Loan ABS
Other ABS (excl HEL ABS)
Corporate Bond
Covered Bond
Domestic Non‐Agency RMBS
Foreign RMBS
Municipal Bond
Mutual Fund
Preferred Stock (Equity)
Sovereign Bond
US Treasuries & Agencies
Other*
GRAND TOTAL
‐ ‐ ‐ ‐ ‐ ‐ ‐ ‐
* For 'Other' AFS securities, please pro
rows, please ensure that grand totals
FR Y‐14A Schedule A.3.e ‐ AFS and HTM Fair Market Value Sources by Portfiolio
AFS and HTM Securities
CCARP084
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
Principal Market Value Source
Please state whether a vendor or proprietary model is
used. If using a 3rd party vendor, please provide the
name(s) of the 3rd party vendor(s).
CASMN240
In general, how often are securities normally
marked (e.g., daily, weekly, quarterly, etc.)?
CASMN241
Agency MBS
Auction Rate Securities
CDO
CLO
CMBS
Common Stock (Equity)
Auto ABS
Credit Card ABS
Student Loan ABS
Other ABS (excl HEL ABS)
Corporate Bond
Covered Bond
Domestic Non‐Agency RMBS (incl HEL ABS)
Foreign RMBS
Municipal Bond
Mutual Fund
Preferred Stock (Equity)
Sovereign Bond
US Treasuries & Agencies
Other*
*For 'Other' AFS and HTM securities, please provide name of security type in row 20 above (currently labeled "Other"). Please add additional rows if necessary. If adding additional
rows, please ensure that grand totals sum appropriately.
FR Y‐14A Schedule A.3.f ‐ Expected Credit Loss and Provision for Credit Loss ‐‐ HTM securities
HTM Securities
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
CCARP084
Agency MBS
Auction Rate Securities
CDO
CLO
CMBS
Auto ABS
Credit Card ABS
Student Loan ABS
Other ABS (excl HEL ABS)
Corporate Bond
Covered Bond
Domestric Non‐Agency RMBS
Foreign RMBS
Municipal Bond
Mutual Fund
Sovereign Bond
US Treasuries & Agencies
Other1
Grand Total
Actual Amortized Total Allowance for
Credit Loss
Cost
(MM/DD/YYYY)
(MM/DD/YYYY)
CASSLC44
CASSLC14
PQ1
PQ2
PQ3
Projected Provision for
Projected Provision for
Projected Provision for
Credit Loss
Credit Loss
Amortized Cost Credit Loss
Amortized Cost
Amortized Cost
CPSSLC45
CPSSLC45
CPSSLC45
CPSSLC44
CPSSLC44
CPSSLC44
Note
1. Please provide name of security type in row 18 above (currently labeled 'other'). Please add additional rows if necessary. If adding additional rows, please ensure that
FR Y‐14A Schedule A.3.f ‐ Expected Credit Loss and Provision for Credit Loss ‐‐ HTM securities
PQ4
HTM Securities
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
CCARP084
Agency MBS
Auction Rate Securities
CDO
CLO
CMBS
Auto ABS
Credit Card ABS
Student Loan ABS
Other ABS (excl HEL ABS)
Corporate Bond
Covered Bond
Domestric Non‐Agency RMBS
Foreign RMBS
Municipal Bond
Mutual Fund
Sovereign Bond
US Treasuries & Agencies
Other1
Grand Total
PQ5
PQ6
PQ7
Projected Provision for
Projected Provision for
Projected Provision for
Projected Provision for
Credit Loss
Credit Loss
Credit Loss
Amortized Cost Credit Loss
Amortized Cost
Amortized Cost
Amortized Cost
CPSSLC45
CPSSLC45
CPSSLC45
CPSSLC45
CPSSLC44
CPSSLC44
CPSSLC44
CPSSLC44
Note
1. Please provide name of security t grand totals sum appropriately.
FR Y‐14A Schedule A.3.f ‐ Expected Credit Loss and Provision for Credit Loss ‐‐ HTM securities
PQ8
HTM Securities
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
CCARP084
Agency MBS
Auction Rate Securities
CDO
CLO
CMBS
Auto ABS
Credit Card ABS
Student Loan ABS
Other ABS (excl HEL ABS)
Corporate Bond
Covered Bond
Domestric Non‐Agency RMBS
Foreign RMBS
Municipal Bond
Mutual Fund
Sovereign Bond
US Treasuries & Agencies
Other1
Grand Total
Note
1. Please provide name of security
PQ9
Projected Provision for
Projected Provision for
Credit Loss
Amortized Cost Credit Loss
Amortized Cost
CPSSLC45
CPSSLC45
CPSSLC44
CPSSLC44
FR Y‐14A Schedule A.3.g ‐ Expected Credit Loss and Provision for Credit Loss ‐‐ AFS securities
PQ1
AFS Securities
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
CCARP084
Agency MBS
Auction Rate Securities
CDO
CLO
CMBS
Auto ABS
Credit Card ABS
Student Loan ABS
Other ABS (excl HEL ABS)
Corporate Bond
Covered Bond
Domestric Non‐Agency RMBS
Foreign RMBS
Municipal Bond
Mutual Fund
Sovereign Bond
US Treasuries & Agencies
Other2
Grand Total
Actual Amortized
Cost
(MM/DD/YYYY)
Total Allowance
for Credit Loss
(MM/DD/YYYY)
CASSLC44
CASSLC14
PQ2
Expected
Projected credit loss
Projected
Amortized Cost before
Amortized Cost Expected credit
loss before
applying the
applying the fair Provision for
fair value
Provision for
Credit Loss
Credit Loss
value floor1
floor1
CPSSLC46
CPSSLC45
CPSSLC46
CPSSLC45
CPSSLC44
CPSSLC44
Note
1. Please do not include Expected lifetime loss for securites intended to sell or will be required to sell before the recovery of Amortized Cost.
2. Please provide name of security type in row 18 above (currently labeled 'other'). Please add additional rows if necessary. If adding additional rows, please ensure
that grand totals sum appropriately.
FR Y‐14A Schedule A.3.g ‐ Expected Credit Loss and Provision for Credit Loss ‐‐ AFS securities
PQ3
AFS Securities
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
CCARP084
Agency MBS
Auction Rate Securities
CDO
CLO
CMBS
Auto ABS
Credit Card ABS
Student Loan ABS
Other ABS (excl HEL ABS)
Corporate Bond
Covered Bond
Domestric Non‐Agency RMBS
Foreign RMBS
Municipal Bond
Mutual Fund
Sovereign Bond
US Treasuries & Agencies
Other2
Grand Total
PQ4
PQ5
PQ6
Expected
Expected
Expected
Expected
credit loss
credit loss
credit loss
Projected
Projected
Projected
Projected credit loss
Amortized Cost before
Amortized Cost before
Amortized Cost before
Amortized Cost before
applying the
applying the
applying the
applying the
fair value
fair value
fair value
fair value
Provision for
Provision for
Provision for
Provision for
Credit Loss
Credit Loss
Credit Loss
Credit Loss
floor1
floor1
floor1
floor1
CPSSLC46
CPSSLC45
CPSSLC46
CPSSLC45
CPSSLC46
CPSSLC45
CPSSLC46
CPSSLC45
CPSSLC44
CPSSLC44
CPSSLC44
CPSSLC44
Note
1. Please do not include Expected
2. Please provide name of security
that grand totals sum appropriate
FR Y‐14A Schedule A.3.g ‐ Expected Credit Loss and Provision for Credit Loss ‐‐ AFS securities
PQ7
AFS Securities
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
CCARP084
Agency MBS
Auction Rate Securities
CDO
CLO
CMBS
Auto ABS
Credit Card ABS
Student Loan ABS
Other ABS (excl HEL ABS)
Corporate Bond
Covered Bond
Domestric Non‐Agency RMBS
Foreign RMBS
Municipal Bond
Mutual Fund
Sovereign Bond
US Treasuries & Agencies
Other2
Grand Total
PQ8
PQ9
Expected
Expected
Expected
credit loss
credit loss
Projected
Projected
Projected credit loss
Amortized Cost before
Amortized Cost before
Amortized Cost before
applying the
applying the
applying the
fair value
fair value
fair value
Provision for
Provision for
Provision for
Credit Loss
Credit Loss
Credit Loss
floor1
floor1
floor1
CPSSLC46
CPSSLC45
CPSSLC46
CPSSLC45
CPSSLC46
CPSSLC45
CPSSLC44
CPSSLC44
CPSSLC44
Note
1. Please do not include Expected
2. Please provide name of security
that grand totals sum appropriate
FR Y‐14A Schedule A.4 ‐ Trading
P/L Results in $Millions
(report profits as positive values and losses as negative values)
(A)
(B)
(C)
(A)
(B)
(C)
Trading
CVA Hedges
Total
Trading
CVA Hedges
Total
1 Equity
1A
Delta/Gamma
1B
Vega
1C
Dividends
1D
Correlation
Vanna (dVega / dSpot )
1E
Volgamma (dVega / dVol )
1F
1G
Skew (moneyness)
1H
Higher order
1I
Other (Please describe in documentation)
CPSSLD42
CPSSLD43
CPSSLD44
CPSSLD45
CPSSLD46
CPSSLD47
CPSSLD48
CPSSLD49
CPSSLD50
CPSSLD51
6
Other Credit
CPSSLD91
7
7A
7B
7C
7D
7E
7F
7G
7H
7I
Corporate Credit (Advanced)
Bonds
Loans
Single‐Name CDS
Loan CDS
Covered Bonds
Indices
Index Tranches
Index Options
Other/Unspecified
CPSSLD92
CPSSLD93
CPSSLD94
CPSSLD95
CPSSLD96
CPSSLD97
CPSSLD98
CPSSLD99
CPSSLE00
CPSSLE01
2 FX
2A
Delta/Gamma
2B
Vega
2C
Higher order
2D
Other (Please describe in documentation)
CPSSLD52
CPSSLD53
CPSSLD54
CPSSLD55
CPSSLD56
3 Rates
3A
Delta/Gamma
3B
Vega
3C
Swap Spreads
3D
Basis Spreads
3E
Cross Currency Basis
3F
Inflation
3G
Higher order
3H
Other (Please describe in documentation)
CPSSLD57
CPSSLD58
CPSSLD59
CPSSLD60
CPSSLD61
CPSSLD62
CPSSLD63
CPSSLD64
CPSSLD65
8
8A
8B
8C
8D
8E
8F
8G
8H
8I
Corporate Credit (Emerging Markets)
Bonds
Loans
Single‐Name CDS
Loan CDS
Covered Bonds
Indices
Index Tranches
Index Options
Other/Unspecified
CPSSLE02
CPSSLE03
CPSSLE04
CPSSLE05
CPSSLE06
CPSSLE07
CPSSLE08
CPSSLE09
CPSSLE10
CPSSLE11
9
9A
9B
9C
9D
9E
9F
9G
Sovereign Credit
Advanced Economies
Emerging Europe
LatAm & Caribbean
Asia ex Japan
Middle East/North Africa
Sub‐Saharan Africa
Supranationals
CPSSLE12
CPSSLE13
CPSSLE14
CPSSLE15
CPSSLE16
CPSSLE17
CPSSLE18
CPSSLE19
4 Commodities
4A
Oil Products
4B
Natural Gas
4C
Power
4D
Emissions
4E
Coal
4F
Dry Freight
4G
Structured Products
4H
Precious Metals
4I
Base Metals
4J
Ags & Softs
4K
Indices
4L
Higher order
4M
Other (Please describe in documentation)
CPSSLD66
CPSSLD67
CPSSLD68
CPSSLD69
CPSSLD70
CPSSLD71
CPSSLD72
CPSSLD73
CPSSLD74
CPSSLD75
CPSSLD76
CPSSLD77
CPSSLD78
CPSSLD79
10
11
12
13
14
Munis
ARS
Base Correlation
Higher order
Other (Please describe in documentation)
CPSSLE20
CPSSLE21
CPSSLE22
CPSSLE23
CPSSLE24
15 Private Equity
15A
Funded
15B
Unfunded
15C
Other (Please describe in documentation)
CPSSLE25
CPSSLE26
CPSSLE27
CPSSLE28
FR Y‐14A Schedule A.4 ‐ Trading
5 Securitized Products
Non‐Agency RMBS (exclude Whole Loans)
5A
5B
Residential Whole Loans
5C
ABS
5D
CMBS (exclude Whole Loans)
5E
CRE Whole Loans
5F
Corporate CDO/CLO
5G
Warehouse
5H
Agencies
5I
Higher order
5J
Other (Please describe in documentation)
Severely Adverse
BHC Scenario
CPSSLD80
CPSSLD81
CPSSLD82
CPSSLD83
CPSSLD84
CPSSLD85
CPSSLD86
CPSSLD87
CPSSLD88
CPSSLD89
CPSSLD90
(A)
Trading
(B)
CVA Hedges
(C)
Total
16 Other Fair Value Assets
16A
Debt
Equity
16B
16C
Other (Please describe in documentation)
CPSSLE29
CPSSLE30
CPSSLE31
CPSSLE32
17
Cross Asset Terms
CPSSLE33
18
TOTAL
CPSSLE34
(A)
Trading
(B)
CVA Hedges
(C)
Total
FR Y‐14A Schedule A.5 ‐ Counterparty Credit Risk
$Millions
Losses should be reported as a positive value.
1 Trading Issuer Default Losses
1a
Trading Issuer Default losses from securitized products
1b
Trading Issuer Default losses from other credit sensitive instruments
CPSSN989
CPSSN990
CPSSN991
‐
2 Counterparty Credit MTM Losses (CVA losses)
2a
Counterparty CVA losses
2b
Offline reserve CVA losses
CPSSN992
CPSSN993
CPSSN994
‐
3 Counterparty Default Losses
3a
Impact of Counterparty Default hedges
CPSSN995
CPSSN996
4 Other Counterparty Losses
CPSSN997
5 Funding Valuation Adjustment (FVA) Losses
CPSSJA24
FR Y‐14A Schedule A.6 ‐ Operational Risk Scenario Inputs and Projections
Risk Segment
CPSSN962
Contribution
($millions)
PQ 1
Total ($millions) $ ‐
Note: Please add more rows if needed.
PY 1
PQ 2
$ ‐
PQ 3
$ ‐
Total
($millions)
PY 2
PQ 4
$ ‐
PQ 5
CPSNQ945
$ ‐
PQ 6
$ ‐
PQ 7
$ ‐
PQ 8
$ ‐
PQ 9
$ ‐
$ ‐
$ ‐
$ ‐
$ ‐
$ ‐
FR Y‐14A Schedule A.7.a ‐ PPNR Projections
Projected in $Millions
FR Y9C Codes
PQ 1
PQ 2
PQ 3
PQ 4
PQ 5
PQ 6
PQ 7
PQ 8
PQ 9
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
Net Interest Income by Business Segment: (17)
1
1A
1B
1C
Retail and Small Business
Domestic (11)
Credit and Charge Cards (10)
Mortgages
1D
1E
1F
1G
2
3
4
5
5A
5B
6
7
8
9
10
11
12
Home Equity
Retail and Small Business Deposits
Other Retail and Small Business Lending
International Retail and Small Business (16)
Commercial Lending
Investment Banking
Merchant Banking / Private Equity
Sales and Trading
Prime Brokerage
Other
Investment Management
Investment Services
Treasury Services
Insurance Services
Retirement / Corporate Benefits Products
Corporate / Other
Optional Immaterial Business Segments (7)
CPSNQ159
CPSNQ160
CPSNQ161
CPSNQ162
CPSNQ163
CPSNQ164
CPSNQ165
CPSNQ166
CPSNQ167
CPSNQ168
CPSNQ169
CPSNQ170
CPSNQ171
CPSNQ172
CPSNQ173
CPSNQ174
CPSNQ175
CPSNQ176
CPSNQ177
CPSNQ178
CPSNQ179
13
Total Net Interest Income (1)
CPSN4074
FR Y‐14A Schedule A.7.a ‐ PPNR Projections
Projected in $Millions
FR Y9C Codes
14
14A
14B
14C
14D
14E
14F
14G
14H
14I
14J
14K
14L
14M
14N
14O
14P
14Q
14R
14S
14T
15
16
16A
16B
16C
16D
17
17A
17B
17C
Non Interest Income by Business Segment: (17)
Retail and Small Business
Domestic
Credit and Charge Cards (10)
Credit and Charge Card Interchange Revenues ‐ Gross
Other
Mortgages and Home Equity
Production
Gains/(Losses) on Sale (18)
Other
Servicing
Servicing & Ancillary Fees
MSR Amortization (20)
CPSNQ180
CPSNQ181
CPSNQ182
CPSNQ183
CPSNQ184
CPSNQ185
CPSNQ186
CPSNQ187
CPSNQ188
CPSNQ189
CPSNQ190
CPSNQ191
MSR Value Changes due to Changes in Assumptions/Model Inputs/Other
Net of Hedge Performance (19)(21)
CPSNQ192
Other
CPSNQ193
Provisions to Repurchase Reserve / Liability for Residential Mortgage
Representations and Warranties (contra‐revenue) (12)
Retail and Small Business Deposits
Non Sufficient Funds / Overdraft Fees ‐ Gross
Debit Interchange ‐ Gross
Other (22)
Other Retail and Small Business Lending
International Retail and Small Business (16)
Commercial Lending
Investment Banking
Advisory
Equity Capital Markets
Debt Capital Markets
Syndicated / Corporate Lending
Merchant Banking / Private Equity
Net Investment Mark‐to‐Market
Management Fees
Other
PQ 1
PQ 2
PQ 3
PQ 4
PQ 5
PQ 6
PQ 7
PQ 8
PQ 9
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
CPSNQ194
CPSNQ195
CPSNQ196
CPSNQ197
CPSNQ198
CPSNQ199
CPSNQ200
CPSNQ201
CPSNQ202
CPSNQ203
CPSNQ204
CPSNQ205
CPSNQ206
CPSNQ207
CPSNQ208
CPSNQ209
CPSNQ210
FR Y‐14A Schedule A.7.a ‐ PPNR Projections
Projected in $Millions
FR Y9C Codes
PQ 1
PQ 2
PQ 3
PQ 4
PQ 5
PQ 6
PQ 7
PQ 8
PQ 9
18
18A
18B
18C
18D
18E
18F
18G
18H
18I
18J
18K
18L
18M
19
19A
19B
20
20A
20B
20C
20D
20E
21
22
23
24
25
Sales and Trading
Equities
Commission and Fees
Other (23)
Fixed Income
Rates
Credit
Other
Commodities
Commission and Fees
Other
Prime Brokerage
Commission and Fees
Other
Investment Management
Asset Management
Wealth Management / Private Banking
Investment Services
Asset Servicing
Securities Lending
Other
Issuer Services
Other
Treasury Services
Insurance Services
Retirement / Corporate Benefits Products
Corporate / Other
Optional Immaterial Business Segments (7)
CPSNQ211
CPSNQ212
CPSNQ213
CPSNQ214
CPSNQ215
CPSNQ216
CPSNQ217
CPSNQ218
CPSNQ219
CPSNQ220
CPSNQ221
CPSNQ222
CPSNQ223
CPSNQ224
CPSNQ225
CPSNQ226
CPSNQ227
CPSNQ228
CPSNQ229
CPSNQ230
CPSNQ231
CPSNQ232
CPSNQ233
CPSNQ234
CPSNQ235
CPSNQ236
CPSNQ237
CPSNQ238
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
26
Total Non‐Interest Income (2) (26)
CPSN4079
‐
‐
‐
‐
‐
‐
‐
‐
‐
27
Total Revenues
CPSNQ239
‐
‐
‐
‐
‐
‐
‐
‐
‐
FR Y‐14A Schedule A.7.a ‐ PPNR Projections
Projected in $Millions
FR Y9C Codes
36
37
Non Interest Expense:
Compensation Expense
Salary (14)
Benefits (14)
Commissions (6)
Stock Based Compensation
Cash Variable Pay
Operational Risk Expense (8)
Provisions to Repurchase Reserve / Liability for Residential Mortgage
Representations and Warranties (12)
Professional and Outside Services Expenses (13)
Expenses of Premises and Fixed Assets
Amortization Expense and Impairment Losses for Other Intangible Assets
Marketing Expense
Domestic Credit and Charge Card Marketing Expense (10)(15)(17)
Other
Other Real Estate Owned Expense
Provision for Unfunded Off‐Balance Sheet Credit Exposures (to build/decrease
item 141 (BHCKB557) in Balance Sheet)
Other Non‐Interest Expense (4)
38
Total Non‐Interest Expense (3)
28
28A
28B
28C
28D
28E
29
30
31
32
33
34
34A
34B
35
39
Projected PPNR (5)
40
41
42
Valuation Adjustment for firm's own debt under fair value option (FVO) (9) (27)
Goodwill Impairment
Loss resulting from trading shock exercise (if applicable) (24) (25)
PQ 1
PQ 2
PQ 3
PQ 4
PQ 5
PQ 6
PQ 7
PQ 8
PQ 9
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
CPSNP630
‐
‐
‐
‐
‐
‐
‐
‐
‐
BHCK4074‐
BHCK4079‐
BHCK4093+B CPSNP631
HCKC216‐
Line Item 40
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
CPSNQ240
CPSNQ241
CPSNQ242
CPSNQ243
CPSNQ244
CPSNQ245
CPSNQ246
CPSNQ247
BHCK4217
BHCKC232
CPSNQ248
CPSN4217
CPSNC232
CPSNQ249
CPSNQ250
CPSNQ251
CPSNQ252
CPSNQ253
CPSNQ254
BHCKC216
CPSNQ255
CPSNC216
CPSNQ256
FR Y‐14A Schedule A.7.a ‐ PPNR Projections
Projected in $Millions
FR Y9C Codes
PQ 1
PQ 2
PQ 3
Footnotes to the PPNR Projections Worksheet
(1)
Amount should equal item 49 of the PPNR NII Worksheet, if completed.
(2)
Excludes Valuation Adjustment for firm's own debt under fair value option (FVO) in item 40.
(3)
Excludes Goodwill Impairment included in item 41.
(4)
Provide a further break out of significant items included in Other Non‐Interest Expense such that no more than 5% of Non
Interest Expense are reported without further breakout:
CPSNQ947
CPSNQ949
CPSNQ951
CPSNQ953
CPSNQ955
CPSNQ957
CPSNQ959
CPSNQ961
CPSNQ963
CPSNQ965
CPSNQ967
(5)
(6)
(7)
CPSNQ948
CPSNQ950
CPSNQ952
CPSNQ954
CPSNQ956
CPSNQ958
CPSNQ960
CPSNQ962
CPSNQ964
CPSNQ966
CPSNQ968
By definition, PPNR will calculate as Net Interest Income plus Non‐Interest Income less Non‐Interest Expense, excluding items broken out in items40‐41.
Report commissions only in "Commissions" line item 28C; do not report commissions in any other compensation line items.
See instructions for guidance on related thresholds. List segments included in this line item
CPSNQ969
(8)
All operational loss items, including operational losses that are contra revenue amounts or cannot be separately identified,
should be reported in the operational risk expense. Any legal consultation or retainer fees specifically linked to an operational
risk event should be included in the Operational Risk Expense. Include all Provisions to Litigation Reserves / Liability for Claims
related to Sold Residential Mortgages and all Litigation Settlements & Penalties in this line item and not any other items.
(9)
List segments from which item was excluded:
CPSNQ970
(10)
(11)
(12)
Include domestic BHC/IHC/SLHC issued credit and charge cards including those that result from a partnership agreement.
Applies to line items 1A‐1F; US and Puerto Rico only.
Provisions to build any non‐litigation reserves/accrued liabilities that have been established for losses related to sold or
government‐insured residential mortgage loans (first or second lien). Do not report such provisions in any other items; report
them only in line items 14N or 30, as applicable.
(13)
Include routine legal expenses (i.e legal expenses not related to operational losses) here.
(14)
(15)
Do not report stock based and cash variable pay compensation here.
Include both direct and allocated expenses. Report any expenses that are made to expand the company’s card member and/or merchant base,
facilitate greater segment penetration, enhance the perception of the company’s credit card brand, and/or increase the utilization of the existing card
member base across the spectrum of marketing and advertising mediums.
PQ 4
PQ 5
PQ 6
PQ 7
PQ 8
PQ 9
FR Y‐14A Schedule A.7.a ‐ PPNR Projections
Projected in $Millions
FR Y9C Codes
PQ 1
PQ 2
PQ 3
(16)
(17)
(18)
Revenues from regions outside the US and Puerto Rico.
See Instructions for description of standardized Business Segments/Lines. Unless specified otherwise, all numbers are global
Gains/(Losses) from the sale of mortgages and home equity originated through all production channels (retail, broker, correspondent, etc.) with the
intent to sell. Such gains/losses should include deferred fees and costs that are reported as adjustments to the carrying balance of the sold loan, fair
value changes on loan commitments with rate locks that are accounted for as derivatives, fair value changes on mortgage loans held‐for‐sale
designated for fair value treatment, lower‐of‐cost or market adjustments on mortgage loans held‐for‐sale not designated for fair value treatment, fair
value changes on derivative instruments used to hedge loan commitments and held‐of‐sale mortgages, and value associated with the initial
capitalization of the MSR upon sale of the loan.
(19)
(20)
(21)
(22)
Report changes in the MSR value here and not in any other items. Report changes in the MSR hedges here and not in any other items
Include economic amortization or scheduled and unscheduled payments, net of defaults under both FV and LOCOM accounting methods
Include MSR changes under both FV and LOCOM accounting methods.
Among items included here are debit card contra‐revenues and overdraft waivers, as applicable.
(23)
Report all Non‐Interest Income for Equities Sales and Trading, excluding Prime Brokerage (to be reported as a separate line item) and excluding
Commissions and Fees. This includes trading profits and other non‐interest non‐commission income.
(24)
(25)
Respondents should not report changes in value of the MSR asset or hedges within the trading book
List segments from which item was excluded:
CPSNQ971
(26)
(27)
Exclude result of trading shock exercise (where applicable), as it is reported in item 42.
List FR Y‐9C HI Schedule items in which this item is normally reported although excluded from PPNR for this report
CPSNQ972
PQ 4
PQ 5
PQ 6
PQ 7
PQ 8
PQ 9
FR Y‐14A Schedule A.7.b ‐ PPNR Net Interest Income
FALSE
1
2
2A
2B
3
4
5
6
6A
6B
6C
AverageAsset Balances ($Millions) (1)
First Lien Residential Mortgages (in Domestic Offices)
Second / Junior Lien Residential Mortgages (in Domestic Offices)
Closed‐End Junior Liens
Home Equity Lines Of Credit (HELOCs)
C&I Loans (7)
CRE Loans (in Domestic Offices)
Credit Cards
Other Consumer
Auto Loans
Student Loans
Other, incl. loans backed by securities (non‐purpose lending)
CPSNP975
CPSNP976
CPSNP977
CPSNP978
CPSNP979
CPSNP980
CPSNP981
CPSNP982
CPSNP983
CPSNP984
Projected in $Millions
PQ 4
PQ 5
PQ 6
PQ 1
PQ 2
PQ 3
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
PQ 7
PQ 8
PQ 9
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
CPSNP985
7
Real Estate Loans (Not in Domestic Offices)
CPSNP986
7A
7B
8
9
10
11
12
13
14
15
16
Residential Mortgages (First and Second Lien)
Other
Other Loans & Leases (10)
Nonaccrual Loans (5)
Securities (AFS and HTM) ‐ Treasuries and Agency Debentures
Securities (AFS and HTM) ‐ Agency RMBS (both CMOs and pass‐throughs)
Securities (AFS and HTM) ‐ Other
Trading Assets
Deposits with Banks & Other
Other Interest/Dividend Bearing Assets (2)
Other Assets
CPSNP987
CPSNP988
CPSNP989
CPSNP990
CPSNP991
CPSNP992
CPSNP993
CPSNP994
CPSNP995
CPSNP996
CPSNP997
17
Total Average Asset Balances
CPSNP998
FR Y‐14A Schedule A.7.b ‐ PPNR Net Interest Income
18
19
19A
19B
20
21
22
23
23A
23B
23C
24
24A
24B
25
26
27
28
29
30
31
32
Average Rates Earned (%) (9)
First Lien Residential Mortgages (in Domestic Offices)
Second / Junior Lien Residential Mortgages (in Domestic Offices)
Closed‐End Junior Liens
HELOCs
C&I Loans (7)
CRE Loans (in Domestic Offices)
Credit Cards
Other Consumer
Auto Loans
Student Loans
Other, incl. loans backed by securities (non‐purpose lending
Real Estate Loans (Not in Domestic Offices)
Residential Mortgages (First and Second Lien)
Other
Other Loans & Leases
Nonaccrual Loans (5)
Securities (AFS and HTM) ‐ Treasuries and Agency Debentures
Securities (AFS and HTM) ‐ Agency RMBS (both CMOs and pass‐throughs)
Securities (AFS and HTM) ‐ Other
Trading Assets
Deposits with Banks & Other
Other Interest/Dividend Bearing Assets
CPSNP999
‐
CPSNQ002
CPSNQ003
CPSNQ004
CPSNQ005
CPSNQ006
‐
CPSNQ008
CPSNQ009
CPSNQ010
‐
CPSNQ012
CPSNQ013
CPSNQ014
CPSNQ015
CPSNQ016
CPSNQ017
CPSNQ018
CPSNQ019
CPSNQ020
CPSNQ021
33
Total Interest Income
CPSNQ022
PQ 1
PQ 2
PQ 3
‐
‐
‐
Projected in $Millions
PQ 4
PQ 5
PQ 6
‐
‐
‐
PQ 7
PQ 8
PQ 9
‐
‐
‐
FR Y‐14A Schedule A.7.b ‐ PPNR Net Interest Income
34
34A
34B
34C
34D
34E
35
35A
35B
36
36A
36B
36C
37
38
39
40
41
Average Liability Balances ($Millions)
Deposits‐Domestic (6)
Non‐Interest‐Bearing Demand
Money Market Accounts
Savings
NOW, ATS, and other Transaction Accounts
Time Deposits
Deposits‐Foreign (6)
Foreign Deposits
Foreign Deposits‐Time
Fed Funds, Repos, & Other Short Term Borrowing
Fed Funds
Repos
Other Short Term Borrowing (11)
Trading Liabilities
Subordinated Notes Payable to Unconsolidated Trusts Issuing Trust Preferred
Securities (TruPS) and TruPS Issued by Consolidated Special Purpose Entities
Other Interest‐Bearing Liabilities (3)(11)
Other Liabilities (11)
Total Average Liability Balances
CPSNQ023
CPSNQ024
CPSNQ025
CPSNQ026
CPSNQ027
CPSNQ028
CPSNQ029
CPSNQ030
CPSNQ031
CPSNQ032
CPSNQ033
CPSNQ034
CPSNQ035
CPSNQ036
CPSNQ037
Projected in $Millions
PQ 4
PQ 5
PQ 6
PQ 1
PQ 2
PQ 3
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
PQ 7
PQ 8
PQ 9
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
CPSNQ038
CPSNQ039
CPSNQ040
FR Y‐14A Schedule A.7.b ‐ PPNR Net Interest Income
PQ 1
PQ 2
PQ 3
Projected in $Millions
PQ 4
PQ 5
PQ 6
PQ 7
PQ 8
PQ 9
47
Average Liability Rates (%) (9)
Deposits‐Domestic (6)
Non‐Interest‐Bearing Demand (8)
Money Market Accounts
Savings
Negotiable Order of Withdrawal (NOW), Automatic Transfer Service (ATS), and
other Transaction Accounts
Time Deposits
Deposits‐Foreign (6)
Foreign Deposits
Foreign Deposits‐Time
Fed Funds, Repos, & Other Short Term Borrowing
Fed Funds
Repos
Other Short Term Borrowing
Trading Liabilities
Subordinated Notes Payable to Unconsolidated Trusts Issuing TruPS and TruPS
Issued by Consolidated Special Purpose Entities
Other Interest‐Bearing Liabilities (3)(11)
48
Total Interest Expense
CPSNQ057
‐
‐
‐
‐
‐
‐
‐
‐
‐
49
Total Net Interest Income (4)
CPSS4074
‐
‐
‐
‐
‐
‐
‐
‐
‐
42
42A
42B
42C
42D
42E
43
43A
43B
44
44A
44B
44C
45
46
0.0%
CPSNQ042
CPSNQ043
CPSNQ044
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
CPSNQ045
CPSNQ046
0.0%
CPSNQ048
CPSNQ049
0.0%
CPSNQ051
CPSNQ052
CPSNQ053
CPSNQ054
CPSNQ055
CPSNQ056
FR Y‐14A Schedule A.7.b ‐ PPNR Net Interest Income
PQ 1
PQ 2
PQ 3
Projected in $Millions
PQ 4
PQ 5
PQ 6
PQ 7
PQ 8
Footnotes to the Net Interest Income Worksheet
Exclude nonaccrual loans from lines 1‐8, reporting these balances in item 9. Include purchased credit impaired loans.
(1)
(2)
CPSNQ973
CPSNQ975
CPSNQ977
CPSNQ979
CPSNQ981
(3)
Break out and explain nature of significant items included in Other Interest/Dividend Bearing Assets such that no more than 5% of total Average Asset Balances are reported without a further breakout.
CPSNQ974
CPSNQ976
CPSNQ978
CPSNQ980
CPSNQ982
(4)
Break out and explain nature of significant items included in All Other Interest Bearing Liabilities Balances such that no more than 5% of total Liability Balances are reported without a further breakout.
CPSNQ984
CPSNQ986
CPSNQ988
CPSNQ990
CPSNQ992
Amount should equal item 13 of the PPNR Projections Worksheet.
(5)
(6)
(7)
(8)
(9)
(10)
(11)
Institutions are to provide additional details within the supporting documentation; the composition of the non‐accrual loans by key loan type over the reported time periods for each of the scenarios.
A sum of average domestic and foreign deposits should be equal to a sum of average BHDM6631, BHDM6636, BHFN6631, and BHFN6636
Report C&I Graded, Small Business (Scored/Delinquency Managed), Corporate Card, Business Card
Rates are equal to zero by definition
All rates are annualized.
Include loans secured by farmland here (BHDM1420) and other loans not accounted for in the other categories
Sum of line items 36C and 39 equals sum of BHCK3190, BHCK4062, and interest‐bearing liabilities reported in BHCK2750; item 40 captures non‐interest bearing liabilities in BHCK2750
CPSNQ983
CPSNQ985
CPSNQ987
CPSNQ989
CPSNQ991
PQ 9
FR Y‐14A Scenario Schedule Cover Sheet
In addition to providing the name and RSSD ID of your institution on this cover sheet, all firms are
expected to complete the following three tabs in this workbook: Scenario Variable Definitions, Internal
Baseline Scenario and Internal Stress Scenario . If the firm so chooses, it can provide additional stress
scenarios on additional tabs.
Institution Name:
RSSD ID:
Date of Data Submission:
Supervisory Baseline Scenario (additional variables used beyond those supplied)
Variable
Number
1
2
3
4
5
6
7
8
9
10
Variable Name
Variable Definition
Supervisory Severely Adverse Scenario (additional variables used beyond those supplied)
Variable
Number
1
2
3
4
5
6
7
8
9
10
Variable Name
Variable Definition
Internal Baseline Scenario (variables not included above)
Variable
Number
1
2
3
4
5
6
7
8
9
10
Variable Name
Variable Definition
Internal Stress Scenario (variables not included above)
Variable
Number
1
2
3
4
5
6
7
8
9
10
Variable Name
Variable Definition
Additional Scenario #1 (variables not included above)
Variable
Number
1
2
3
4
5
6
7
8
9
10
Variable Name
Variable Definition
Variable Name
Actual
As of Date
PQ 1
PQ 2
PQ 3
PQ 4
Projected
PQ 5
PQ 6
PQ 7
PQ 8
PQ 9
FR Y‐14A Regulatory Capital Instruments Annual Schedule
Institution Name:
RSSD ID:
Date of Data Submission:
As of Date:
Submission Type:
FR Y‐14A Regulatory Capital Instruments: Schedule C ‐
Notional Amount
Projected
Revised regulatory capital treatment
FR Y‐9C, Schedule HC Reference
Common Equity Tier 1
Tier 1
Common Equity Tier 1
Common Equity Tier 1
Common Equity Tier 1
Common Equity Tier 1
Additional Tier 1
Additional Tier 1
BHCK 3230 + BHCK 3240 + BHCK A130 ‐
BHCK G235
BHCK 3283 + BHCK 3240
BHCK 3230 + BHCK 3240
BHCK 3230 +BHCK G235
BHCK P839
BHCK 3283
BHCK 3283
BHCK 3283
Actual As of date
Quarterly Redemption/Repurchase Activity
1
2
3
4
5
6
7
8
Common Stock (CS)
Common Stock (CS) ‐ Employee Stock Compensation
CS Warrants
CS USG Investment
Capital Instrument Issued by Subsidiary
Other Common Equity Tier 1
Non‐Cumulative Perpetual Preferred (NCPP)
NCPP Convertible
9
Mandatory Convertible Preferred (MCP)
Additional Tier 1
10
11
12
13
14
MCP USG Preferred
Capital Instrument Issued by Subsidiary
Other Additional Tier 1
Cumulative Perpetual Preferred (CPP)
CPP TARP Preferred
Additional Tier 1
Additional Tier 1
Additional Tier 1
Non‐qualifying Instrument in Tier 1
Non‐qualifying Instrument in Tier 1
15
Mandatory Convertible Preferred (MCP)
Non‐qualifying Instrument in Tier 1
16
MCP USG Preferred
Non‐qualifying Instrument in Tier 1
17
Cumulative Dated Preferred (TRUPS)
Non‐qualifying Instrument in Tier 1
18
19
20
21
22
23
24
USG Preferred TRUPS
Other Non‐qualifying Instrument in Tier 1
Subordinated Debt
Capital Instrument Issued by Subsidiary
Other Tier 2
Cumulative Perpetual Preferred (CPP)
CPP TARP Preferred
Non‐qualifying Instrument in Tier 1
Non‐qualifying Instrument in Tier 1
Tier 2
Tier 2
Tier 2
Non‐qualifying Instrument in Tier 2
Non‐qualifying Instrument in Tier 2
25
Mandatory Convertible Preferred (MCP)
Non‐qualifying Instrument in Tier 2
26
MCP USG Preferred
Non‐qualifying Instrument in Tier 2
27
Cumulative Dated Preferred (TRUPS)
Non‐qualifying Instrument in Tier 2
28
29
USG Preferred TRUPS
Other Non‐qualifying Instrument in Tier 2
Non‐qualifying Instrument in Tier 2
Non‐qualifying Instrument in Tier 2
CACIY509
CACIY510
CACIY511
CACIY512
CACIY513
CACIY514
CACIY515
CACIY516
BHCK 3283
BHCK 3283
BHCK G234
BHCK P839
BHCK 3283
BHCK 3283
BHCK 3283
CACIY517
BHCK 3283
BHCK 3283
BHCK G234
BHCK 3283
BHCK 3000
BHCK 3283
BHCK G234
BHCK 3283
BHCA P865
BHCK P839
BHCK 3283
BHCK 3283
BHCK 3283
CACIY523
BHCK 3283
BHCK 3283
BHCK G234
BHCK 3283
BHCK 3000
BHCK 3283
BHCK G234
BHCK 3283
CACIY518
CACIY519
CACIY520
CACIY521
CACIY522
CACIY524
CACIY525
CACIY526
CACIY527
CACIY528
CACIY529
CACIY530
CACIY531
CACIY532
CACIY533
CACIY534
CACIY535
CACIY536
CACIY537
PQ 1
PQ 2
PQ 3
PQ 4
PQ 5
PQ 6
PQ 7
PQ 8
PQ 9
Amount Recognized in Regulatory Capital
Projected
Actual As of date
CACIY509
CACIY510
CACIY511
CACIY512
CACIY513
CACIY514
CACIY515
CACIY516
CACIY517
CACIY518
CACIY519
CACIY520
CACIY521
CACIY522
CACIY523
CACIY524
CACIY525
CACIY526
CACIY527
CACIY528
CACIY529
CACIY530
CACIY531
CACIY532
CACIY533
CACIY534
CACIY535
CACIY536
CACIY537
PQ 1
PQ 2
PQ 3
PQ 4
PQ 5
PQ 6
PQ 7
PQ 8
PQ 9
Page Reference in the
Capital Plan
CACIY814
Comments
CACIQ750
FR Y‐14A Regulatory Capital Instruments: Schedule C ‐
Revised regulatory capital treatment
Notional Amount
Projected
FR Y‐9C, Schedule HC Reference
Actual As of date
Quarterly Issuance Activity
30
31
32
33
34
35
36
37
38
Common Stock (CS)
Common Stock (CS) ‐ Employee Stock Compensation
CS Warrants
CS USG Investment
Capital Instrument Issued by Subsidiary
Other Common Equity Tier 1
Non‐Cumulative Perpetual Preferred (NCPP)
NCPP Convertible
Mandatory Convertible Preferred (MCP)
Common Equity Tier 1
Tier 1
Common Equity Tier 1
Common Equity Tier 1
Common Equity Tier 1
Common Equity Tier 1
Additional Tier 1
Additional Tier 1
Additional Tier 1
39
40
41
42
43
44
MCP USG Preferred
Capital Instrument Issued by Subsidiary
Other Additional Tier 1
Cumulative Perpetual Preferred (CPP)
CPP TARP Preferred
Mandatory Convertible Preferred (MCP)
Additional Tier 1
Additional Tier 1
Additional Tier 1
Non‐qualifying Instrument in Tier 1
Non‐qualifying Instrument in Tier 1
Non‐qualifying Instrument in Tier 1
45
MCP USG Preferred
Non‐qualifying Instrument in Tier 1
46
Cumulative Dated Preferred (TRUPS)
Non‐qualifying Instrument in Tier 1
47
48
49
50
51
52
53
54
USG Preferred TRUPS
Other Non‐qualifying Instrument in Tier 1
Subordinated Debt
Capital Instrument Issued by Subsidiary
Other Tier 2
Cumulative Perpetual Preferred (CPP)
CPP TARP Preferred
Mandatory Convertible Preferred (MCP)
Non‐qualifying Instrument in Tier 1
Non‐qualifying Instrument in Tier 1
Tier 2
Tier 2
Tier 2
Non‐qualifying Instrument in Tier 2
Non‐qualifying Instrument in Tier 2
Non‐qualifying Instrument in Tier 2
55
MCP USG Preferred
Non‐qualifying Instrument in Tier 2
56
Cumulative Dated Preferred (TRUPS)
Non‐qualifying Instrument in Tier 2
57
58
USG Preferred TRUPS
Other Non‐qualifying Instrument in Tier 2
Non‐qualifying Instrument in Tier 2
Non‐qualifying Instrument in Tier 2
BHCK 3230 + BHCK 3240 + BHCK A130 ‐
BHCK G235
BHCK 3283 + BHCK 3240
BHCK 3230 + BHCK 3240
BHCK 3230 +BHCK G235
BHCK P839
BHCK 3283
BHCK 3283
BHCK 3283
BHCK 3283
BHCK 3283
BHCK G234
BHCK P839
BHCK 3283
BHCK 3283
BHCK 3283
BHCK 3283
BHCK 3283
BHCK G234
BHCK 3283
BHCK 3000
BHCK 3283
BHCK G234
BHCK 3283
BHCA P865
BHCK P839
BHCK 3283
BHCK 3283
BHCK 3283
BHCK 3283
BHCK 3283
BHCK G234
BHCK 3283
BHCK 3000
BHCK 3283
BHCK G234
BHCK 3283
CACIY538
CACIY539
CACIY540
CACIY541
CACIY542
CACIY543
CACIY544
CACIY545
CACIY546
CACIY547
CACIY548
CACIY549
CACIY550
CACIY551
CACIY552
CACIY553
CACIY554
CACIY555
CACIY556
CACIY557
CACIY558
CACIY559
CACIY560
CACIY561
CACIY562
CACIY563
CACIY564
CACIY565
CACIY566
PQ 1
PQ 2
PQ 3
PQ 4
PQ 5
PQ 6
PQ 7
PQ 8
PQ 9
Amount Recognized in Regulatory Capital
Projected
Actual As of date
CACIY538
CACIY539
CACIY540
CACIY541
CACIY542
CACIY543
CACIY544
CACIY545
CACIY546
CACIY547
CACIY548
CACIY549
CACIY550
CACIY551
CACIY552
CACIY553
CACIY554
CACIY555
CACIY556
CACIY557
CACIY558
CACIY559
CACIY560
CACIY561
CACIY562
CACIY563
CACIY564
CACIY565
CACIY566
PQ 1
PQ 2
PQ 3
PQ 4
PQ 5
PQ 6
PQ 7
PQ 8
PQ 9
Page Reference in the
Capital Plan
Comments
FR Y‐14A Regulatory Capital Instruments: Schedule C ‐
Revised regulatory capital treatment
Notional Amount
Projected
FR Y‐9C, Schedule HC Reference
Actual As of date
Quarterly Activity ‐ Other than issuances or repurchases
59
60
61
62
63
64
65
66
67
Common Stock (CS)
Common Stock (CS) ‐ Employee Stock Compensation
CS Warrants
CS USG Investment
Capital Instrument Issued by Subsidiary
Other Common Equity Tier 1
Non‐Cumulative Perpetual Preferred (NCPP)
NCPP Convertible
Mandatory Convertible Preferred (MCP)
Common Equity Tier 1
Tier 1
Common Equity Tier 1
Common Equity Tier 1
Common Equity Tier 1
Common Equity Tier 1
Additional Tier 1
Additional Tier 1
Additional Tier 1
68
69
70
71
72
73
MCP USG Preferred
Capital Instrument Issued by Subsidiary
Other Additional Tier 1
Cumulative Perpetual Preferred (CPP)
CPP TARP Preferred
Mandatory Convertible Preferred (MCP)
Additional Tier 1
Additional Tier 1
Additional Tier 1
Non‐qualifying Instrument in Tier 1
Non‐qualifying Instrument in Tier 1
Non‐qualifying Instrument in Tier 1
74
MCP USG Preferred
Non‐qualifying Instrument in Tier 1
75
Cumulative Dated Preferred (TRUPS)
Non‐qualifying Instrument in Tier 1
76
77
78
79
80
81
82
83
USG Preferred TRUPS
Other Non‐qualifying Instrument in Tier 1
Subordinated Debt
Capital Instrument Issued by Subsidiary
Other Tier 2
Cumulative Perpetual Preferred (CPP)
CPP TARP Preferred
Mandatory Convertible Preferred (MCP)
Non‐qualifying Instrument in Tier 1
Non‐qualifying Instrument in Tier 1
Tier 2
Tier 2
Tier 2
Non‐qualifying Instrument in Tier 2
Non‐qualifying Instrument in Tier 2
Non‐qualifying Instrument in Tier 2
84
MCP USG Preferred
Non‐qualifying Instrument in Tier 2
85
Cumulative Dated Preferred (TRUPS)
Non‐qualifying Instrument in Tier 2
86
87
USG Preferred TRUPS
Other Non‐qualifying Instrument in Tier 2
Non‐qualifying Instrument in Tier 2
Non‐qualifying Instrument in Tier 2
BHCK 3230 + BHCK 3240 + BHCK A130 ‐
BHCK G235
BHCK 3283 + BHCK 3240
BHCK 3230 + BHCK 3240
BHCK 3230 +BHCK G235
BHCK P839
BHCK 3283
BHCK 3283
BHCK 3283
BHCK 3283
BHCK 3283
BHCK G234
BHCK P839
BHCK 3283
BHCK 3283
BHCK 3283
BHCK 3283
BHCK 3283
BHCK G234
BHCK 3283
BHCK 3000
BHCK 3283
BHCK G234
BHCK 3283
BHCA P865
BHCK P839
BHCK 3283
BHCK 3283
BHCK 3283
BHCK 3283
BHCK 3283
BHCK G234
BHCK 3283
BHCK 3000
BHCK 3283
BHCK G234
BHCK 3283
CACIY567
CACIY568
CACIY569
CACIY570
CACIY571
CACIY572
CACIY573
CACIY574
CACIY575
CACIY576
CACIY577
CACIY578
CACIY579
CACIY580
CACIY581
CACIY582
CACIY583
CACIY584
CACIY585
CACIY586
CACIY587
CACIY588
CACIY589
CACIY590
CACIY591
CACIY592
CACIY593
CACIY594
CACIY595
PQ 1
PQ 2
PQ 3
PQ 4
PQ 5
PQ 6
PQ 7
PQ 8
PQ 9
Amount Recognized in Regulatory Capital
Projected
Actual As of date
CACIY567
CACIY568
CACIY569
CACIY570
CACIY571
CACIY572
CACIY573
CACIY574
CACIY575
CACIY576
CACIY577
CACIY578
CACIY579
CACIY580
CACIY581
CACIY582
CACIY583
CACIY584
CACIY585
CACIY586
CACIY587
CACIY588
CACIY589
CACIY590
CACIY591
CACIY592
CACIY593
CACIY594
CACIY595
PQ 1
PQ 2
PQ 3
PQ 4
PQ 5
PQ 6
PQ 7
PQ 8
PQ 9
Page Reference in the
Capital Plan
Comments
Notional Amount
Revised regulatory capital treatment
FR Y‐9C, Schedule HC
Reference
Actual As of date
PQ 1
PQ 2
PQ 3
Capital Balances
88
89
90
91
92
93
94
95
Common Stock (CS)
CS Warrants
CS USG Investment
Capital Instrument Issued by Subsidiary
Other Common Equity Tier 1
Non‐Cumulative Perpetual Preferred (NCPP)
NCPP Convertible
Mandatory Convertible Preferred (MCP)
96 MCP USG Preferred
97
98
99
100
101
Capital Instrument Issued by Subsidiary
Other Additional Tier 1
Cumulative Perpetual Preferred (CPP)
CPP TARP Preferred
Mandatory Convertible Preferred (MCP)
Common Equity Tier 1
Common Equity Tier 1
Common Equity Tier 1
Common Equity Tier 1
Common Equity Tier 1
Additional Tier 1
Additional Tier 1
Additional Tier 1
Additional Tier 1
Additional Tier 1
Additional Tier 1
Non‐qualifying Instrument in Tier 1
Non‐qualifying Instrument in Tier 1
Non‐qualifying Instrument in Tier 1
102 MCP USG Preferred
Non‐qualifying Instrument in Tier 1
103 Cumulative Dated Preferred (TRUPS)
Non‐qualifying Instrument in Tier 1
104 USG Preferred TRUPS
Non‐qualifying Instrument in Tier 1
105
106
107
108
109
110
111
Non‐qualifying Instrument in Tier 1
Tier 2
Tier 2
Tier 2
Non‐qualifying Instrument in Tier 2
Non‐qualifying Instrument in Tier 2
Non‐qualifying Instrument in Tier 2
Other Non‐qualifying Instrument in Tier 1
Subordinated Debt
Capital Instrument Issued by Subsidiary
Other Tier 2
Cumulative Perpetual Preferred (CPP)
CPP TARP Preferred
Mandatory Convertible Preferred (MCP)
112 MCP USG Preferred
Non‐qualifying Instrument in Tier 2
113 Cumulative Dated Preferred (TRUPS)
Non‐qualifying Instrument in Tier 2
114 USG Preferred TRUPS
Non‐qualifying Instrument in Tier 2
115 Other Non‐qualifying Instrument in Tier 2
Non‐qualifying Instrument in Tier 2
116 Cash dividends declared on preferred stock
117 Cash dividends declared on common stock
118 Common shares outstanding (Millions)
119
120
121
122
123
Common dividends per share ($)
Common equity tier 1 capital ratio
Tier 1 capital ratio
Total capital ratio
Net income
BHCK 3230 + BHCK 3240 +
BHCK A130 ‐ BHCK G235
BHCK 3230 + BHCK 3240
BHCK 3230 +BHCK G235
BHCK P839
BHCK 3283
BHCK 3283
BHCK 3283
BHCK 3283
BHCK 3283
BHCK G234
BHCK P839
BHCK 3283
BHCK 3283
BHCK 3283
BHCK 3283
BHCK 3283
BHCK G234
BHCK 3283
BHCK 3000
BHCK 3283
BHCK G234
BHCK 3283
BHCA P865
BHCK P839
BHCK 3283
BHCK 3283
BHCK 3283
BHCK 3283
BHCK 3283
BHCK G234
BHCK 3283
BHCK 3000
BHCK 3283
BHCK G234
BHCK 3283
BHCK4598
BHCK4460
BHCAP793
BHCA7206
BHCA7205
BHCK4340
CACIY596
CACIY597
CACIY598
CACIY599
CACIY600
CACIY601
CACIY602
CACIY603
Sum (PQ1 Items 1, 2, 30, 31 , 59, 60) + (Actual Item 88) Sum (PQ2 Items 1, 2, 30, 31 , 59, 60) + (PQ1 Item 88)
Sum (PQ1 Items 3, 32, 61) + (Actual Item 89)
Sum (PQ2 Items 3, 32, 61) + (PQ1 Item 89)
Sum (PQ1 Items 4, 33, 62) + (Actual Item 90)
Sum (PQ2 Items 4, 33, 62) + (PQ1 Item 90)
Sum (PQ2 Items 5, 34, 63) + (PQ1 Item 91)
Sum (PQ1 Items 5, 34, 63) + (Actual Item 91)
Sum (PQ1 Items 6, 35, 64) + (Actual Item 92)
Sum (PQ2 Items 6, 35, 64) + (PQ1 Item 92)
Sum (PQ1 Items 7, 36, 65) + (Actual Item 93)
Sum (PQ2 Items 7, 36, 65) + (PQ1 Item 93)
Sum (PQ1 Items 8, 37, 66) + (Actual Item 94)
Sum (PQ2 Items 8, 37, 66) + (PQ1 Item 94)
Sum (PQ2 Items 9, 38, 67) + (PQ1 Item 95)
Sum (PQ1 Items 9, 38, 67) + (Actual Item 95)
Sum (PQ3 Items 1, 2, 30, 31 , 59, 60) + (PQ2 Item 88)
Sum (PQ3 Items 3, 32, 61) + (PQ2 Item 89)
Sum (PQ3 Items 4, 33, 62) + (PQ2 Item 90)
Sum (PQ3 Items 5, 34, 63) + (PQ2 Item 91)
Sum (PQ3 Items 6, 35, 64) + (PQ2 Item 92)
Sum (PQ3 Items 7, 36, 65) + (PQ2 Item 93)
Sum (PQ3 Items 8, 37, 66) + (PQ2 Item 94)
Sum (PQ3 Items 9, 38, 67) + (PQ2 Item 95)
CACIY604
Sum (PQ1 Items 10, 39, 68) + (Actual Item 96)
Sum (PQ2 Items 10, 39, 68) + (PQ1 Item 96)
Sum (PQ3 Items 10, 39, 68) + (PQ2 Item 96)
CACIY605
CACIY606
CACIY607
CACIY608
CACIY609
Sum (PQ1 Items 11, 40, 69) + (Actual Item 97)
Sum (PQ1 Items 12, 41, 70) + (Actual Item 98)
Sum (PQ1 Items 13, 42, 71) + (Actual Item 99)
Sum (PQ1 Items 14, 43, 72) + (Actual Item 100)
Sum (PQ1 Items 15, 44, 73) + (Actual Item 101)
Sum (PQ2 Items 11, 40, 69) + (PQ1 Item 97)
Sum (PQ2 Items 12, 41, 70) + (PQ1 Item 98)
Sum (PQ2 Items 13, 42, 71) + (PQ1 Item 99)
Sum (PQ2 Items 14, 43, 72) + (PQ1 Item 100)
Sum (PQ2 Items 15, 44, 73) + (PQ1 Item 101)
Sum (PQ3 Items 11, 40, 69) + (PQ2 Item 97)
Sum (PQ3 Items 12, 41, 70) + (PQ2 Item 98)
Sum (PQ3 Items 13, 42, 71) + (PQ2 Item 99)
Sum (PQ3 Items 14, 43, 72) + (PQ2 Item 100)
Sum (PQ3 Items 15, 44, 73) + (PQ2 Item 101)
CACIY610
Sum (PQ1 Items 16, 45, 74) + (Actual Item 102)
Sum (PQ2 Items 16, 45, 74) + (PQ1 Item 102)
Sum (PQ3 Items 16, 45, 74) + (PQ2 Item 102)
CACIY611
Sum (PQ1 Items 17, 46, 75) + (Actual Item 103)
Sum (PQ2 Items 17, 46, 75) + (PQ1 Item 103)
Sum (PQ3 Items 17, 46, 75) + (PQ2 Item 103)
CACIY612
Sum (PQ1 Items 18, 47, 76) + (Actual Item 104)
Sum (PQ2 Items 18, 47, 76) + (PQ1 Item 104)
Sum (PQ3 Items 18, 47, 76) + (PQ2 Item 104)
CACIY613
CACIY614
CACIY615
CACIY616
CACIY617
CACIY618
CACIY619
Sum (PQ1 Items 19, 48, 77) + (Actual Item 105)
Sum (PQ1 Items 20, 49, 78) + (Actual Item 106)
Sum (PQ1 Items 21, 50, 79) + (Actual Item 107)
Sum (PQ1 Items 22, 51, 80) + (Actual Item 108)
Sum (PQ1 Items 23, 52, 81) + (Actual Item 109)
Sum (PQ1 Items 24, 53, 82) + (Actual Item 110)
Sum (PQ1 Items 25, 54, 83) + (Actual Item 111)
Sum (PQ2 Items 19, 48, 77) + (PQ1 Item 105)
Sum (PQ2 Items 20, 49, 78) + (PQ1 Item 106)
Sum (PQ2 Items 21, 50, 79) + (PQ1 Item 107)
Sum (PQ2 Items 22, 51, 80) + (PQ1 Item 108)
Sum (PQ2 Items 23, 52, 81) + (PQ1 Item 109)
Sum (PQ2 Items 24, 53, 82) + (PQ1 Item 110)
Sum (PQ2 Items 25, 54, 83) + (PQ1 Item 111)
Sum (PQ3 Items 19, 48, 77) + (PQ2 Item 105)
Sum (PQ3 Items 20, 49, 78) + (PQ2 Item 106)
Sum (PQ3 Items 21, 50, 79) + (PQ2 Item 107)
Sum (PQ3 Items 22, 51, 80) + (PQ2 Item 108)
Sum (PQ3 Items 23, 52, 81) + (PQ2 Item 109)
Sum (PQ3 Items 24, 53, 82) + (PQ2 Item 110)
Sum (PQ3 Items 25, 54, 83) + (PQ2 Item 111)
CACIY620
Sum (PQ1 Items 26, 55, 84) + (Actual Item 112)
Sum (PQ2 Items 26, 55, 84) + (PQ1 Item 112)
Sum (PQ3 Items 26, 55, 84) + (PQ2 Item 112)
CACIY621
Sum (PQ1 Items 27, 56, 85) + (Actual Item 113)
Sum (PQ2 Items 27, 56, 85) + (PQ1 Item 113)
Sum (PQ3 Items 27, 56, 85) + (PQ2 Item 113)
CACIY622
Sum (PQ1 Items 28, 57, 86) + (Actual Item 114)
Sum (PQ2 Items 28, 57, 86) + (PQ1 Item 114)
Sum (PQ3 Items 28, 57, 86) + (PQ2 Item 114)
CACIY623
Sum (PQ1 Items 29, 58, 87) + (Actual Item 115)
Sum (PQ2 Items 29, 58, 87) + (PQ1 Item 115)
Sum (PQ3 Items 29, 58, 87) + (PQ2 Item 115)
CACI4470
CACI4460
CACIQ946
CACIQ282
CACIP793
CACI7206
CACI7205
CACI4340
Notional Amount
Projected
Revised regulatory capital treatment
FR Y‐9C, Schedule HC
Reference
PQ 4
PQ 5
PQ 6
Capital Balances
88
89
90
91
92
93
94
95
Common Stock (CS)
CS Warrants
CS USG Investment
Capital Instrument Issued by Subsidiary
Other Common Equity Tier 1
Non‐Cumulative Perpetual Preferred (NCPP)
NCPP Convertible
Mandatory Convertible Preferred (MCP)
96 MCP USG Preferred
97
98
99
100
101
Capital Instrument Issued by Subsidiary
Other Additional Tier 1
Cumulative Perpetual Preferred (CPP)
CPP TARP Preferred
Mandatory Convertible Preferred (MCP)
Common Equity Tier 1
Common Equity Tier 1
Common Equity Tier 1
Common Equity Tier 1
Common Equity Tier 1
Additional Tier 1
Additional Tier 1
Additional Tier 1
Additional Tier 1
Additional Tier 1
Additional Tier 1
Non‐qualifying Instrument in Tier 1
Non‐qualifying Instrument in Tier 1
Non‐qualifying Instrument in Tier 1
102 MCP USG Preferred
Non‐qualifying Instrument in Tier 1
103 Cumulative Dated Preferred (TRUPS)
Non‐qualifying Instrument in Tier 1
104 USG Preferred TRUPS
Non‐qualifying Instrument in Tier 1
105
106
107
108
109
110
111
Non‐qualifying Instrument in Tier 1
Tier 2
Tier 2
Tier 2
Non‐qualifying Instrument in Tier 2
Non‐qualifying Instrument in Tier 2
Non‐qualifying Instrument in Tier 2
Other Non‐qualifying Instrument in Tier 1
Subordinated Debt
Capital Instrument Issued by Subsidiary
Other Tier 2
Cumulative Perpetual Preferred (CPP)
CPP TARP Preferred
Mandatory Convertible Preferred (MCP)
112 MCP USG Preferred
Non‐qualifying Instrument in Tier 2
113 Cumulative Dated Preferred (TRUPS)
Non‐qualifying Instrument in Tier 2
114 USG Preferred TRUPS
Non‐qualifying Instrument in Tier 2
115 Other Non‐qualifying Instrument in Tier 2
Non‐qualifying Instrument in Tier 2
116 Cash dividends declared on preferred stock
117 Cash dividends declared on common stock
118 Common shares outstanding (Millions)
119
120
121
122
123
Common dividends per share ($)
Common equity tier 1 capital ratio
Tier 1 capital ratio
Total capital ratio
Net income
BHCK 3230 + BHCK 3240 +
BHCK A130 ‐ BHCK G235
BHCK 3230 + BHCK 3240
BHCK 3230 +BHCK G235
BHCK P839
BHCK 3283
BHCK 3283
BHCK 3283
BHCK 3283
BHCK 3283
BHCK G234
BHCK P839
BHCK 3283
BHCK 3283
BHCK 3283
BHCK 3283
BHCK 3283
BHCK G234
BHCK 3283
BHCK 3000
BHCK 3283
BHCK G234
BHCK 3283
BHCA P865
BHCK P839
BHCK 3283
BHCK 3283
BHCK 3283
BHCK 3283
BHCK 3283
BHCK G234
BHCK 3283
BHCK 3000
BHCK 3283
BHCK G234
BHCK 3283
BHCK4598
BHCK4460
BHCAP793
BHCA7206
BHCA7205
BHCK4340
Sum (PQ4 Items 1, 2, 30, 31 , 59, 60) + (PQ3 Item 88)
Sum (PQ4 Items 3, 32, 61) + (PQ3 Item 89)
Sum (PQ4 Items 4, 33, 62) + (PQ3 Item 90)
Sum (PQ4 Items 5, 34, 63) + (PQ3 Item 91)
Sum (PQ4 Items 6, 35, 64) + (PQ3 Item 92)
Sum (PQ4 Items 7, 36, 65) + (PQ3 Item 93)
Sum (PQ4 Items 8, 37, 66) + (PQ3 Item 94)
Sum (PQ4 Items 9, 38, 67) + (PQ3 Item 95)
Sum (PQ5 Items 1, 2, 30, 31 , 59, 60) + (PQ4 Item 88)
Sum (PQ5 Items 3, 32, 61) + (PQ4 Item 89)
Sum (PQ5 Items 4, 33, 62) + (PQ4 Item 90)
Sum (PQ5 Items 5, 34, 63) + (PQ4 Item 91)
Sum (PQ5 Items 6, 35, 64) + (PQ4 Item 92)
Sum (PQ5 Items 7, 36, 65) + (PQ4 Item 93)
Sum (PQ5 Items 8, 37, 66) + (PQ4 Item 94)
Sum (PQ5 Items 9, 38, 67) + (PQ4 Item 95)
Sum (PQ6 Items 1, 2, 30, 31 , 59, 60) + (PQ5 Item 88)
Sum (PQ6 Items 3, 32, 61) + (PQ5 Item 89)
Sum (PQ6 Items 4, 33, 62) + (PQ5 Item 90)
Sum (PQ6 Items 5, 34, 63) + (PQ5 Item 91)
Sum (PQ6 Items 6, 35, 64) + (PQ5 Item 92)
Sum (PQ6 Items 7, 36, 65) + (PQ5 Item 93)
Sum (PQ6 Items 8, 37, 66) + (PQ5 Item 94)
Sum (PQ6 Items 9, 38, 67) + (PQ5 Item 95)
Sum (PQ4 Items 10, 39, 68) + (PQ3 Item 96)
Sum (PQ5 Items 10, 39, 68) + (PQ4 Item 96)
Sum (PQ6 Items 10, 39, 68) + (PQ5 Item 96)
Sum (PQ4 Items 11, 40, 69) + (PQ3 Item 97)
Sum (PQ4 Items 12, 41, 70) + (PQ3 Item 98)
Sum (PQ4 Items 13, 42, 71) + (PQ3 Item 99)
Sum (PQ4 Items 14, 43, 72) + (PQ3 Item 100)
Sum (PQ4 Items 15, 44, 73) + (PQ3 Item 101)
Sum (PQ5 Items 11, 40, 69) + (PQ4 Item 97)
Sum (PQ5 Items 12, 41, 70) + (PQ4 Item 98)
Sum (PQ5 Items 13, 42, 71) + (PQ4 Item 99)
Sum (PQ5 Items 14, 43, 72) + (PQ4 Item 100)
Sum (PQ5 Items 15, 44, 73) + (PQ4 Item 101)
Sum (PQ6 Items 11, 40, 69) + (PQ5 Item 97)
Sum (PQ6 Items 12, 41, 70) + (PQ5 Item 98)
Sum (PQ6 Items 13, 42, 71) + (PQ5 Item 99)
Sum (PQ6 Items 14, 43, 72) + (PQ5 Item 100)
Sum (PQ6 Items 15, 44, 73) + (PQ5 Item 101)
Sum (PQ4 Items 16, 45, 74) + (PQ3 Item 102)
Sum (PQ5 Items 16, 45, 74) + (PQ4 Item 102)
Sum (PQ6 Items 16, 45, 74) + (PQ5 Item 102)
Sum (PQ4 Items 17, 46, 75) + (PQ3 Item 103)
Sum (PQ5 Items 17, 46, 75) + (PQ4 Item 103)
Sum (PQ6 Items 17, 46, 75) + (PQ5 Item 103)
Sum (PQ4 Items 18, 47, 76) + (PQ3 Item 104)
Sum (PQ5 Items 18, 47, 76) + (PQ4 Item 104)
Sum (PQ6 Items 18, 47, 76) + (PQ5 Item 104)
Sum (PQ4 Items 19, 48, 77) + (PQ3 Item 105)
Sum (PQ4 Items 20, 49, 78) + (PQ3 Item 106)
Sum (PQ4 Items 21, 50, 79) + (PQ3 Item 107)
Sum (PQ4 Items 22, 51, 80) + (PQ3 Item 108)
Sum (PQ4 Items 23, 52, 81) + (PQ3 Item 109)
Sum (PQ4 Items 24, 53, 82) + (PQ3 Item 110)
Sum (PQ4 Items 25, 54, 83) + (PQ3 Item 111)
Sum (PQ5 Items 19, 48, 77) + (PQ4 Item 105)
Sum (PQ5 Items 20, 49, 78) + (PQ4 Item 106)
Sum (PQ5 Items 21, 50, 79) + (PQ4 Item 107)
Sum (PQ5 Items 22, 51, 80) + (PQ4 Item 108)
Sum (PQ5 Items 23, 52, 81) + (PQ4 Item 109)
Sum (PQ5 Items 24, 53, 82) + (PQ4 Item 110)
Sum (PQ5 Items 25, 54, 83) + (PQ4 Item 111)
Sum (PQ6 Items 19, 48, 77) + (PQ5 Item 105)
Sum (PQ6 Items 20, 49, 78) + (PQ5 Item 106)
Sum (PQ6 Items 21, 50, 79) + (PQ5 Item 107)
Sum (PQ6 Items 22, 51, 80) + (PQ5 Item 108)
Sum (PQ6 Items 23, 52, 81) + (PQ5 Item 109)
Sum (PQ6 Items 24, 53, 82) + (PQ5 Item 110)
Sum (PQ6 Items 25, 54, 83) + (PQ5 Item 111)
Sum (PQ4 Items 26, 55, 84) + (PQ3 Item 112)
Sum (PQ5 Items 26, 55, 84) + (PQ4 Item 112)
Sum (PQ6 Items 26, 55, 84) + (PQ5 Item 112)
Sum (PQ4 Items 27, 56, 85) + (PQ3 Item 113)
Sum (PQ5 Items 27, 56, 85) + (PQ4 Item 113)
Sum (PQ6 Items 27, 56, 85) + (PQ5 Item 113)
Sum (PQ4 Items 28, 57, 86) + (PQ3 Item 114)
Sum (PQ5 Items 28, 57, 86) + (PQ4 Item 114)
Sum (PQ6 Items 28, 57, 86) + (PQ5 Item 114)
Sum (PQ4 Items 29, 58, 87) + (PQ3 Item 115)
Sum (PQ5 Items 29, 58, 87) + (PQ4 Item 115)
Sum (PQ6 Items 29, 58, 87) + (PQ5 Item 115)
Notional Amount
Revised regulatory capital treatment
FR Y‐9C, Schedule HC
Reference
PQ 7
PQ 8
PQ 9
Capital Balances
88
89
90
91
92
93
94
95
Common Stock (CS)
CS Warrants
CS USG Investment
Capital Instrument Issued by Subsidiary
Other Common Equity Tier 1
Non‐Cumulative Perpetual Preferred (NCPP)
NCPP Convertible
Mandatory Convertible Preferred (MCP)
96 MCP USG Preferred
97
98
99
100
101
Capital Instrument Issued by Subsidiary
Other Additional Tier 1
Cumulative Perpetual Preferred (CPP)
CPP TARP Preferred
Mandatory Convertible Preferred (MCP)
Common Equity Tier 1
Common Equity Tier 1
Common Equity Tier 1
Common Equity Tier 1
Common Equity Tier 1
Additional Tier 1
Additional Tier 1
Additional Tier 1
Additional Tier 1
Additional Tier 1
Additional Tier 1
Non‐qualifying Instrument in Tier 1
Non‐qualifying Instrument in Tier 1
Non‐qualifying Instrument in Tier 1
102 MCP USG Preferred
Non‐qualifying Instrument in Tier 1
103 Cumulative Dated Preferred (TRUPS)
Non‐qualifying Instrument in Tier 1
104 USG Preferred TRUPS
Non‐qualifying Instrument in Tier 1
105
106
107
108
109
110
111
Non‐qualifying Instrument in Tier 1
Tier 2
Tier 2
Tier 2
Non‐qualifying Instrument in Tier 2
Non‐qualifying Instrument in Tier 2
Non‐qualifying Instrument in Tier 2
Other Non‐qualifying Instrument in Tier 1
Subordinated Debt
Capital Instrument Issued by Subsidiary
Other Tier 2
Cumulative Perpetual Preferred (CPP)
CPP TARP Preferred
Mandatory Convertible Preferred (MCP)
112 MCP USG Preferred
Non‐qualifying Instrument in Tier 2
113 Cumulative Dated Preferred (TRUPS)
Non‐qualifying Instrument in Tier 2
114 USG Preferred TRUPS
Non‐qualifying Instrument in Tier 2
115 Other Non‐qualifying Instrument in Tier 2
Non‐qualifying Instrument in Tier 2
116 Cash dividends declared on preferred stock
117 Cash dividends declared on common stock
118 Common shares outstanding (Millions)
119
120
121
122
123
Common dividends per share ($)
Common equity tier 1 capital ratio
Tier 1 capital ratio
Total capital ratio
Net income
BHCK 3230 + BHCK 3240 +
BHCK A130 ‐ BHCK G235
BHCK 3230 + BHCK 3240
BHCK 3230 +BHCK G235
BHCK P839
BHCK 3283
BHCK 3283
BHCK 3283
BHCK 3283
BHCK 3283
BHCK G234
BHCK P839
BHCK 3283
BHCK 3283
BHCK 3283
BHCK 3283
BHCK 3283
BHCK G234
BHCK 3283
BHCK 3000
BHCK 3283
BHCK G234
BHCK 3283
BHCA P865
BHCK P839
BHCK 3283
BHCK 3283
BHCK 3283
BHCK 3283
BHCK 3283
BHCK G234
BHCK 3283
BHCK 3000
BHCK 3283
BHCK G234
BHCK 3283
BHCK4598
BHCK4460
BHCAP793
BHCA7206
BHCA7205
BHCK4340
Sum (PQ7 Items 1, 2, 30, 31 , 59, 60) + (PQ6 Item 88)
Sum (PQ7 Items 3, 32, 61) + (PQ6 Item 89)
Sum (PQ7 Items 4, 33, 62) + (PQ6 Item 90)
Sum (PQ7 Items 5, 34, 63) + (PQ6 Item 91)
Sum (PQ7 Items 6, 35, 64) + (PQ6 Item 92)
Sum (PQ7 Items 7, 36, 65) + (PQ6 Item 93)
Sum (PQ7 Items 8, 37, 66) + (PQ6 Item 94)
Sum (PQ7 Items 9, 38, 67) + (PQ6 Item 95)
Sum (PQ8 Items 1, 2, 30, 31 , 59, 60) + (PQ7 Item 88)
Sum (PQ8 Items 3, 32, 61) + (PQ7 Item 89)
Sum (PQ8 Items 4, 33, 62) + (PQ7 Item 90)
Sum (PQ8 Items 5, 34, 63) + (PQ7 Item 91)
Sum (PQ8 Items 6, 35, 64) + (PQ7 Item 92)
Sum (PQ8 Items 7, 36, 65) + (PQ7 Item 93)
Sum (PQ8 Items 8, 37, 66) + (PQ7 Item 94)
Sum (PQ8 Items 9, 38, 67) + (PQ7 Item 95)
Sum (PQ9 Items 1, 2, 30, 31 , 59, 60) + (PQ8 Item 88)
Sum (PQ9 Items 3, 32, 61) + (PQ8 Item 89)
Sum (PQ9 Items 4, 33, 62) + (PQ8 Item 90)
Sum (PQ9 Items 5, 34, 63) + (PQ8 Item 91)
Sum (PQ9 Items 6, 35, 64) + (PQ8 Item 92)
Sum (PQ9 Items 7, 36, 65) + (PQ8 Item 93)
Sum (PQ9 Items 8, 37, 66) + (PQ8 Item 94)
Sum (PQ9 Items 9, 38, 67) + (PQ8 Item 95)
Sum (PQ7 Items 10, 39, 68) + (PQ6 Item 96)
Sum (PQ8 Items 10, 39, 68) + (PQ7 Item 96)
Sum (PQ9 Items 10, 39, 68) + (PQ8 Item 96)
Sum (PQ7 Items 11, 40, 69) + (PQ6 Item 97)
Sum (PQ7 Items 12, 41, 70) + (PQ6 Item 98)
Sum (PQ7 Items 13, 42, 71) + (PQ6 Item 99)
Sum (PQ7 Items 14, 43, 72) + (PQ6 Item 100)
Sum (PQ7 Items 15, 44, 73) + (PQ6 Item 101)
Sum (PQ8 Items 11, 40, 69) + (PQ7 Item 97)
Sum (PQ8 Items 12, 41, 70) + (PQ7 Item 98)
Sum (PQ8 Items 13, 42, 71) + (PQ7 Item 99)
Sum (PQ8 Items 14, 43, 72) + (PQ7 Item 100)
Sum (PQ8 Items 15, 44, 73) + (PQ7 Item 101)
Sum (PQ9 Items 11, 40, 69) + (PQ8 Item 97)
Sum (PQ9 Items 12, 41, 70) + (PQ8 Item 98)
Sum (PQ9 Items 13, 42, 71) + (PQ8 Item 99)
Sum (PQ9 Items 14, 43, 72) + (PQ8 Item 100)
Sum (PQ9 Items 15, 44, 73) + (PQ8 Item 101)
Sum (PQ7 Items 16, 45, 74) + (PQ6 Item 102)
Sum (PQ8 Items 16, 45, 74) + (PQ7 Item 102)
Sum (PQ9 Items 16, 45, 74) + (PQ8 Item 102)
Sum (PQ7 Items 17, 46, 75) + (PQ6 Item 103)
Sum (PQ8 Items 17, 46, 75) + (PQ7 Item 103)
Sum (PQ9 Items 17, 46, 75) + (PQ8 Item 103)
Sum (PQ7 Items 18, 47, 76) + (PQ6 Item 104)
Sum (PQ8 Items 18, 47, 76) + (PQ7 Item 104)
Sum (PQ9 Items 18, 47, 76) + (PQ8 Item 104)
Sum (PQ7 Items 19, 48, 77) + (PQ6 Item 105)
Sum (PQ7 Items 20, 49, 78) + (PQ6 Item 106)
Sum (PQ7 Items 21, 50, 79) + (PQ6 Item 107)
Sum (PQ7 Items 22, 51, 80) + (PQ6 Item 108)
Sum (PQ7 Items 23, 52, 81) + (PQ6 Item 109)
Sum (PQ7 Items 24, 53, 82) + (PQ6 Item 110)
Sum (PQ7 Items 25, 54, 83) + (PQ6 Item 111)
Sum (PQ8 Items 19, 48, 77) + (PQ7 Item 105)
Sum (PQ8 Items 20, 49, 78) + (PQ7 Item 106)
Sum (PQ8 Items 21, 50, 79) + (PQ7 Item 107)
Sum (PQ8 Items 22, 51, 80) + (PQ7 Item 108)
Sum (PQ8 Items 23, 52, 81) + (PQ7 Item 109)
Sum (PQ8 Items 24, 53, 82) + (PQ7 Item 110)
Sum (PQ8 Items 25, 54, 83) + (PQ7 Item 111)
Sum (PQ9 Items 19, 48, 77) + (PQ8 Item 105)
Sum (PQ9 Items 20, 49, 78) + (PQ8 Item 106)
Sum (PQ9 Items 21, 50, 79) + (PQ8 Item 107)
Sum (PQ9 Items 22, 51, 80) + (PQ8 Item 108)
Sum (PQ9 Items 23, 52, 81) + (PQ8 Item 109)
Sum (PQ9 Items 24, 53, 82) + (PQ8 Item 110)
Sum (PQ9 Items 25, 54, 83) + (PQ8 Item 111)
Sum (PQ7 Items 26, 55, 84) + (PQ6 Item 112)
Sum (PQ8 Items 26, 55, 84) + (PQ7 Item 112)
Sum (PQ9 Items 26, 55, 84) + (PQ8 Item 112)
Sum (PQ7 Items 27, 56, 85) + (PQ6 Item 113)
Sum (PQ8 Items 27, 56, 85) + (PQ7 Item 113)
Sum (PQ9 Items 27, 56, 85) + (PQ8 Item 113)
Sum (PQ7 Items 28, 57, 86) + (PQ6 Item 114)
Sum (PQ8 Items 28, 57, 86) + (PQ7 Item 114)
Sum (PQ9 Items 28, 57, 86) + (PQ8 Item 114)
Sum (PQ7 Items 29, 58, 87) + (PQ6 Item 115)
Sum (PQ8 Items 29, 58, 87) + (PQ7 Item 115)
Sum (PQ9 Items 29, 58, 87) + (PQ8 Item 115)
Amount Recognized in Regulatory Capital
Revised regulatory capital treatment
FR Y‐9C, Schedule HC
Reference
Actual As of date
PQ 1
PQ 2
PQ 3
Capital Balances
88
89
90
91
92
93
94
95
Common Stock (CS)
CS Warrants
CS USG Investment
Capital Instrument Issued by Subsidiary
Other Common Equity Tier 1
Non‐Cumulative Perpetual Preferred (NCPP)
NCPP Convertible
Mandatory Convertible Preferred (MCP)
96 MCP USG Preferred
97
98
99
100
101
Capital Instrument Issued by Subsidiary
Other Additional Tier 1
Cumulative Perpetual Preferred (CPP)
CPP TARP Preferred
Mandatory Convertible Preferred (MCP)
Common Equity Tier 1
Common Equity Tier 1
Common Equity Tier 1
Common Equity Tier 1
Common Equity Tier 1
Additional Tier 1
Additional Tier 1
Additional Tier 1
Additional Tier 1
Additional Tier 1
Additional Tier 1
Non‐qualifying Instrument in Tier 1
Non‐qualifying Instrument in Tier 1
Non‐qualifying Instrument in Tier 1
102 MCP USG Preferred
Non‐qualifying Instrument in Tier 1
103 Cumulative Dated Preferred (TRUPS)
Non‐qualifying Instrument in Tier 1
104 USG Preferred TRUPS
Non‐qualifying Instrument in Tier 1
105
106
107
108
109
110
111
Non‐qualifying Instrument in Tier 1
Tier 2
Tier 2
Tier 2
Non‐qualifying Instrument in Tier 2
Non‐qualifying Instrument in Tier 2
Non‐qualifying Instrument in Tier 2
Other Non‐qualifying Instrument in Tier 1
Subordinated Debt
Capital Instrument Issued by Subsidiary
Other Tier 2
Cumulative Perpetual Preferred (CPP)
CPP TARP Preferred
Mandatory Convertible Preferred (MCP)
112 MCP USG Preferred
Non‐qualifying Instrument in Tier 2
113 Cumulative Dated Preferred (TRUPS)
Non‐qualifying Instrument in Tier 2
114 USG Preferred TRUPS
Non‐qualifying Instrument in Tier 2
115 Other Non‐qualifying Instrument in Tier 2
Non‐qualifying Instrument in Tier 2
116 Cash dividends declared on preferred stock
117 Cash dividends declared on common stock
118 Common shares outstanding (Millions)
119
120
121
122
123
Common dividends per share ($)
Common equity tier 1 capital ratio
Tier 1 capital ratio
Total capital ratio
Net income
BHCK 3230 + BHCK 3240 +
BHCK A130 ‐ BHCK G235
BHCK 3230 + BHCK 3240
BHCK 3230 +BHCK G235
BHCK P839
BHCK 3283
BHCK 3283
BHCK 3283
BHCK 3283
BHCK 3283
BHCK G234
BHCK P839
BHCK 3283
BHCK 3283
BHCK 3283
BHCK 3283
BHCK 3283
BHCK G234
BHCK 3283
BHCK 3000
BHCK 3283
BHCK G234
BHCK 3283
BHCA P865
BHCK P839
BHCK 3283
BHCK 3283
BHCK 3283
BHCK 3283
BHCK 3283
BHCK G234
BHCK 3283
BHCK 3000
BHCK 3283
BHCK G234
BHCK 3283
BHCK4598
BHCK4460
BHCAP793
BHCA7206
BHCA7205
BHCK4340
CACIY596
CACIY597
CACIY598
CACIY599
CACIY600
CACIY601
CACIY602
CACIY603
Sum (PQ1 Items 1, 2, 30, 31 , 59, 60) + (Actual Item 88) Sum (PQ2 Items 1, 2, 30, 31 , 59, 60) + (PQ1 Item 88)
Sum (PQ1 Items 3, 32, 61) + (Actual Item 89)
Sum (PQ2 Items 3, 32, 61) + (PQ1 Item 89)
Sum (PQ1 Items 4, 33, 62) + (Actual Item 90)
Sum (PQ2 Items 4, 33, 62) + (PQ1 Item 90)
Sum (PQ1 Items 5, 34, 63) + (Actual Item 91)
Sum (PQ2 Items 5, 34, 63) + (PQ1 Item 91)
Sum (PQ2 Items 6, 35, 64) + (PQ1 Item 92)
Sum (PQ1 Items 6, 35, 64) + (Actual Item 92)
Sum (PQ1 Items 7, 36, 65) + (Actual Item 93)
Sum (PQ2 Items 7, 36, 65) + (PQ1 Item 93)
Sum (PQ1 Items 8, 37, 66) + (Actual Item 94)
Sum (PQ2 Items 8, 37, 66) + (PQ1 Item 94)
Sum (PQ1 Items 9, 38, 67) + (Actual Item 95)
Sum (PQ2 Items 9, 38, 67) + (PQ1 Item 95)
Sum (PQ3 Items 1, 2, 30, 31 , 59, 60) + (PQ2 Item 88)
Sum (PQ3 Items 3, 32, 61) + (PQ2 Item 89)
Sum (PQ3 Items 4, 33, 62) + (PQ2 Item 90)
Sum (PQ3 Items 5, 34, 63) + (PQ2 Item 91)
Sum (PQ3 Items 6, 35, 64) + (PQ2 Item 92)
Sum (PQ3 Items 7, 36, 65) + (PQ2 Item 93)
Sum (PQ3 Items 8, 37, 66) + (PQ2 Item 94)
Sum (PQ3 Items 9, 38, 67) + (PQ2 Item 95)
CACIY604
Sum (PQ1 Items 10, 39, 68) + (Actual Item 96)
Sum (PQ2 Items 10, 39, 68) + (PQ1 Item 96)
Sum (PQ3 Items 10, 39, 68) + (PQ2 Item 96)
CACIY605
CACIY606
CACIY607
CACIY608
CACIY609
Sum (PQ1 Items 11, 40, 69) + (Actual Item 97)
Sum (PQ1 Items 12, 41, 70) + (Actual Item 98)
Sum (PQ1 Items 13, 42, 71) + (Actual Item 99)
Sum (PQ1 Items 14, 43, 72) + (Actual Item 100)
Sum (PQ1 Items 15, 44, 73) + (Actual Item 101)
Sum (PQ2 Items 11, 40, 69) + (PQ1 Item 97)
Sum (PQ2 Items 12, 41, 70) + (PQ1 Item 98)
Sum (PQ2 Items 13, 42, 71) + (PQ1 Item 99)
Sum (PQ2 Items 14, 43, 72) + (PQ1 Item 100)
Sum (PQ2 Items 15, 44, 73) + (PQ1 Item 101)
Sum (PQ3 Items 11, 40, 69) + (PQ2 Item 97)
Sum (PQ3 Items 12, 41, 70) + (PQ2 Item 98)
Sum (PQ3 Items 13, 42, 71) + (PQ2 Item 99)
Sum (PQ3 Items 14, 43, 72) + (PQ2 Item 100)
Sum (PQ3 Items 15, 44, 73) + (PQ2 Item 101)
CACIY610
Sum (PQ1 Items 16, 45, 74) + (Actual Item 102)
Sum (PQ2 Items 16, 45, 74) + (PQ1 Item 102)
Sum (PQ3 Items 16, 45, 74) + (PQ2 Item 102)
CACIY611
Sum (PQ1 Items 17, 46, 75) + (Actual Item 103)
Sum (PQ2 Items 17, 46, 75) + (PQ1 Item 103)
Sum (PQ3 Items 17, 46, 75) + (PQ2 Item 103)
CACIY612
Sum (PQ1 Items 18, 47, 76) + (Actual Item 104)
Sum (PQ2 Items 18, 47, 76) + (PQ1 Item 104)
Sum (PQ3 Items 18, 47, 76) + (PQ2 Item 104)
CACIY613
CACIY614
CACIY615
CACIY616
CACIY617
CACIY618
CACIY619
Sum (PQ1 Items 19, 48, 77) + (Actual Item 105)
Sum (PQ1 Items 20, 49, 78) + (Actual Item 106)
Sum (PQ1 Items 21, 50, 79) + (Actual Item 107)
Sum (PQ1 Items 22, 51, 80) + (Actual Item 108)
Sum (PQ1 Items 23, 52, 81) + (Actual Item 109)
Sum (PQ1 Items 24, 53, 82) + (Actual Item 110)
Sum (PQ1 Items 25, 54, 83) + (Actual Item 111)
Sum (PQ2 Items 19, 48, 77) + (PQ1 Item 105)
Sum (PQ2 Items 20, 49, 78) + (PQ1 Item 106)
Sum (PQ2 Items 21, 50, 79) + (PQ1 Item 107)
Sum (PQ2 Items 22, 51, 80) + (PQ1 Item 108)
Sum (PQ2 Items 23, 52, 81) + (PQ1 Item 109)
Sum (PQ2 Items 24, 53, 82) + (PQ1 Item 110)
Sum (PQ2 Items 25, 54, 83) + (PQ1 Item 111)
Sum (PQ3 Items 19, 48, 77) + (PQ2 Item 105)
Sum (PQ3 Items 20, 49, 78) + (PQ2 Item 106)
Sum (PQ3 Items 21, 50, 79) + (PQ2 Item 107)
Sum (PQ3 Items 22, 51, 80) + (PQ2 Item 108)
Sum (PQ3 Items 23, 52, 81) + (PQ2 Item 109)
Sum (PQ3 Items 24, 53, 82) + (PQ2 Item 110)
Sum (PQ3 Items 25, 54, 83) + (PQ2 Item 111)
CACIY620
Sum (PQ1 Items 26, 55, 84) + (Actual Item 112)
Sum (PQ2 Items 26, 55, 84) + (PQ1 Item 112)
Sum (PQ3 Items 26, 55, 84) + (PQ2 Item 112)
CACIY621
Sum (PQ1 Items 27, 56, 85) + (Actual Item 113)
Sum (PQ2 Items 27, 56, 85) + (PQ1 Item 113)
Sum (PQ3 Items 27, 56, 85) + (PQ2 Item 113)
CACIY622
Sum (PQ1 Items 28, 57, 86) + (Actual Item 114)
Sum (PQ2 Items 28, 57, 86) + (PQ1 Item 114)
Sum (PQ3 Items 28, 57, 86) + (PQ2 Item 114)
CACIY623
Sum (PQ1 Items 29, 58, 87) + (Actual Item 115)
Sum (PQ2 Items 29, 58, 87) + (PQ1 Item 115)
Sum (PQ3 Items 29, 58, 87) + (PQ2 Item 115)
CACI4470
CACI4460
CACIQ946
CACIQ282
CACIP793
CACI7206
CACI7205
CACI4340
Amount Recognized in Regulatory Capital
Projected
Revised regulatory capital treatment
FR Y‐9C, Schedule HC
Reference
PQ 4
PQ 5
PQ 6
Sum (PQ4 Items 1, 2, 30, 31 , 59, 60) + (PQ3 Item 88)
Sum (PQ4 Items 3, 32, 61) + (PQ3 Item 89)
Sum (PQ4 Items 4, 33, 62) + (PQ3 Item 90)
Sum (PQ4 Items 5, 34, 63) + (PQ3 Item 91)
Sum (PQ4 Items 6, 35, 64) + (PQ3 Item 92)
Sum (PQ4 Items 7, 36, 65) + (PQ3 Item 93)
Sum (PQ4 Items 8, 37, 66) + (PQ3 Item 94)
Sum (PQ4 Items 9, 38, 67) + (PQ3 Item 95)
Sum (PQ5 Items 1, 2, 30, 31 , 59, 60) + (PQ4 Item 88)
Sum (PQ5 Items 3, 32, 61) + (PQ4 Item 89)
Sum (PQ5 Items 4, 33, 62) + (PQ4 Item 90)
Sum (PQ5 Items 5, 34, 63) + (PQ4 Item 91)
Sum (PQ5 Items 6, 35, 64) + (PQ4 Item 92)
Sum (PQ5 Items 7, 36, 65) + (PQ4 Item 93)
Sum (PQ5 Items 8, 37, 66) + (PQ4 Item 94)
Sum (PQ5 Items 9, 38, 67) + (PQ4 Item 95)
Sum (PQ6 Items 1, 2, 30, 31 , 59, 60) + (PQ5 Item 88)
Sum (PQ6 Items 3, 32, 61) + (PQ5 Item 89)
Sum (PQ6 Items 4, 33, 62) + (PQ5 Item 90)
Sum (PQ6 Items 5, 34, 63) + (PQ5 Item 91)
Sum (PQ6 Items 6, 35, 64) + (PQ5 Item 92)
Sum (PQ6 Items 7, 36, 65) + (PQ5 Item 93)
Sum (PQ6 Items 8, 37, 66) + (PQ5 Item 94)
Sum (PQ6 Items 9, 38, 67) + (PQ5 Item 95)
Sum (PQ4 Items 10, 39, 68) + (PQ3 Item 96)
Sum (PQ5 Items 10, 39, 68) + (PQ4 Item 96)
Sum (PQ6 Items 10, 39, 68) + (PQ5 Item 96)
Sum (PQ4 Items 11, 40, 69) + (PQ3 Item 97)
Sum (PQ4 Items 12, 41, 70) + (PQ3 Item 98)
Sum (PQ4 Items 13, 42, 71) + (PQ3 Item 99)
Sum (PQ4 Items 14, 43, 72) + (PQ3 Item 100)
Sum (PQ4 Items 15, 44, 73) + (PQ3 Item 101)
Sum (PQ5 Items 11, 40, 69) + (PQ4 Item 97)
Sum (PQ5 Items 12, 41, 70) + (PQ4 Item 98)
Sum (PQ5 Items 13, 42, 71) + (PQ4 Item 99)
Sum (PQ5 Items 14, 43, 72) + (PQ4 Item 100)
Sum (PQ5 Items 15, 44, 73) + (PQ4 Item 101)
Sum (PQ6 Items 11, 40, 69) + (PQ5 Item 97)
Sum (PQ6 Items 12, 41, 70) + (PQ5 Item 98)
Sum (PQ6 Items 13, 42, 71) + (PQ5 Item 99)
Sum (PQ6 Items 14, 43, 72) + (PQ5 Item 100)
Sum (PQ6 Items 15, 44, 73) + (PQ5 Item 101)
Sum (PQ4 Items 16, 45, 74) + (PQ3 Item 102)
Sum (PQ5 Items 16, 45, 74) + (PQ4 Item 102)
Sum (PQ6 Items 16, 45, 74) + (PQ5 Item 102)
Sum (PQ4 Items 17, 46, 75) + (PQ3 Item 103)
Sum (PQ5 Items 17, 46, 75) + (PQ4 Item 103)
Sum (PQ6 Items 17, 46, 75) + (PQ5 Item 103)
Sum (PQ4 Items 18, 47, 76) + (PQ3 Item 104)
Sum (PQ5 Items 18, 47, 76) + (PQ4 Item 104)
Sum (PQ6 Items 18, 47, 76) + (PQ5 Item 104)
Sum (PQ4 Items 19, 48, 77) + (PQ3 Item 105)
Sum (PQ4 Items 20, 49, 78) + (PQ3 Item 106)
Sum (PQ4 Items 21, 50, 79) + (PQ3 Item 107)
Sum (PQ4 Items 22, 51, 80) + (PQ3 Item 108)
Sum (PQ4 Items 23, 52, 81) + (PQ3 Item 109)
Sum (PQ4 Items 24, 53, 82) + (PQ3 Item 110)
Sum (PQ4 Items 25, 54, 83) + (PQ3 Item 111)
Sum (PQ5 Items 19, 48, 77) + (PQ4 Item 105)
Sum (PQ5 Items 20, 49, 78) + (PQ4 Item 106)
Sum (PQ5 Items 21, 50, 79) + (PQ4 Item 107)
Sum (PQ5 Items 22, 51, 80) + (PQ4 Item 108)
Sum (PQ5 Items 23, 52, 81) + (PQ4 Item 109)
Sum (PQ5 Items 24, 53, 82) + (PQ4 Item 110)
Sum (PQ5 Items 25, 54, 83) + (PQ4 Item 111)
Sum (PQ6 Items 19, 48, 77) + (PQ5 Item 105)
Sum (PQ6 Items 20, 49, 78) + (PQ5 Item 106)
Sum (PQ6 Items 21, 50, 79) + (PQ5 Item 107)
Sum (PQ6 Items 22, 51, 80) + (PQ5 Item 108)
Sum (PQ6 Items 23, 52, 81) + (PQ5 Item 109)
Sum (PQ6 Items 24, 53, 82) + (PQ5 Item 110)
Sum (PQ6 Items 25, 54, 83) + (PQ5 Item 111)
Sum (PQ4 Items 26, 55, 84) + (PQ3 Item 112)
Sum (PQ5 Items 26, 55, 84) + (PQ4 Item 112)
Sum (PQ6 Items 26, 55, 84) + (PQ5 Item 112)
Sum (PQ4 Items 27, 56, 85) + (PQ3 Item 113)
Sum (PQ5 Items 27, 56, 85) + (PQ4 Item 113)
Sum (PQ6 Items 27, 56, 85) + (PQ5 Item 113)
Sum (PQ4 Items 28, 57, 86) + (PQ3 Item 114)
Sum (PQ5 Items 28, 57, 86) + (PQ4 Item 114)
Sum (PQ6 Items 28, 57, 86) + (PQ5 Item 114)
Sum (PQ4 Items 29, 58, 87) + (PQ3 Item 115)
Sum (PQ5 Items 29, 58, 87) + (PQ4 Item 115)
Sum (PQ6 Items 29, 58, 87) + (PQ5 Item 115)
Capital Balances
88
89
90
91
92
93
94
95
Common Stock (CS)
CS Warrants
CS USG Investment
Capital Instrument Issued by Subsidiary
Other Common Equity Tier 1
Non‐Cumulative Perpetual Preferred (NCPP)
NCPP Convertible
Mandatory Convertible Preferred (MCP)
96 MCP USG Preferred
97
98
99
100
101
Capital Instrument Issued by Subsidiary
Other Additional Tier 1
Cumulative Perpetual Preferred (CPP)
CPP TARP Preferred
Mandatory Convertible Preferred (MCP)
Common Equity Tier 1
Common Equity Tier 1
Common Equity Tier 1
Common Equity Tier 1
Common Equity Tier 1
Additional Tier 1
Additional Tier 1
Additional Tier 1
Additional Tier 1
Additional Tier 1
Additional Tier 1
Non‐qualifying Instrument in Tier 1
Non‐qualifying Instrument in Tier 1
Non‐qualifying Instrument in Tier 1
102 MCP USG Preferred
Non‐qualifying Instrument in Tier 1
103 Cumulative Dated Preferred (TRUPS)
Non‐qualifying Instrument in Tier 1
104 USG Preferred TRUPS
Non‐qualifying Instrument in Tier 1
105
106
107
108
109
110
111
Non‐qualifying Instrument in Tier 1
Tier 2
Tier 2
Tier 2
Non‐qualifying Instrument in Tier 2
Non‐qualifying Instrument in Tier 2
Non‐qualifying Instrument in Tier 2
Other Non‐qualifying Instrument in Tier 1
Subordinated Debt
Capital Instrument Issued by Subsidiary
Other Tier 2
Cumulative Perpetual Preferred (CPP)
CPP TARP Preferred
Mandatory Convertible Preferred (MCP)
112 MCP USG Preferred
Non‐qualifying Instrument in Tier 2
113 Cumulative Dated Preferred (TRUPS)
Non‐qualifying Instrument in Tier 2
114 USG Preferred TRUPS
Non‐qualifying Instrument in Tier 2
115 Other Non‐qualifying Instrument in Tier 2
Non‐qualifying Instrument in Tier 2
116 Cash dividends declared on preferred stock
117 Cash dividends declared on common stock
118 Common shares outstanding (Millions)
119
120
121
122
123
Common dividends per share ($)
Common equity tier 1 capital ratio
Tier 1 capital ratio
Total capital ratio
Net income
BHCK 3230 + BHCK 3240 +
BHCK A130 ‐ BHCK G235
BHCK 3230 + BHCK 3240
BHCK 3230 +BHCK G235
BHCK P839
BHCK 3283
BHCK 3283
BHCK 3283
BHCK 3283
BHCK 3283
BHCK G234
BHCK P839
BHCK 3283
BHCK 3283
BHCK 3283
BHCK 3283
BHCK 3283
BHCK G234
BHCK 3283
BHCK 3000
BHCK 3283
BHCK G234
BHCK 3283
BHCA P865
BHCK P839
BHCK 3283
BHCK 3283
BHCK 3283
BHCK 3283
BHCK 3283
BHCK G234
BHCK 3283
BHCK 3000
BHCK 3283
BHCK G234
BHCK 3283
BHCK4598
BHCK4460
BHCAP793
BHCA7206
BHCA7205
BHCK4340
Amount Recognized in Regulatory Capital
Revised regulatory capital treatment
FR Y‐9C, Schedule HC
Reference
PQ 7
PQ 8
PQ 9
Capital Balances
88
89
90
91
92
93
94
95
Common Stock (CS)
CS Warrants
CS USG Investment
Capital Instrument Issued by Subsidiary
Other Common Equity Tier 1
Non‐Cumulative Perpetual Preferred (NCPP)
NCPP Convertible
Mandatory Convertible Preferred (MCP)
96 MCP USG Preferred
97
98
99
100
101
Capital Instrument Issued by Subsidiary
Other Additional Tier 1
Cumulative Perpetual Preferred (CPP)
CPP TARP Preferred
Mandatory Convertible Preferred (MCP)
Common Equity Tier 1
Common Equity Tier 1
Common Equity Tier 1
Common Equity Tier 1
Common Equity Tier 1
Additional Tier 1
Additional Tier 1
Additional Tier 1
Additional Tier 1
Additional Tier 1
Additional Tier 1
Non‐qualifying Instrument in Tier 1
Non‐qualifying Instrument in Tier 1
Non‐qualifying Instrument in Tier 1
102 MCP USG Preferred
Non‐qualifying Instrument in Tier 1
103 Cumulative Dated Preferred (TRUPS)
Non‐qualifying Instrument in Tier 1
104 USG Preferred TRUPS
Non‐qualifying Instrument in Tier 1
105
106
107
108
109
110
111
Non‐qualifying Instrument in Tier 1
Tier 2
Tier 2
Tier 2
Non‐qualifying Instrument in Tier 2
Non‐qualifying Instrument in Tier 2
Non‐qualifying Instrument in Tier 2
Other Non‐qualifying Instrument in Tier 1
Subordinated Debt
Capital Instrument Issued by Subsidiary
Other Tier 2
Cumulative Perpetual Preferred (CPP)
CPP TARP Preferred
Mandatory Convertible Preferred (MCP)
112 MCP USG Preferred
Non‐qualifying Instrument in Tier 2
113 Cumulative Dated Preferred (TRUPS)
Non‐qualifying Instrument in Tier 2
114 USG Preferred TRUPS
Non‐qualifying Instrument in Tier 2
115 Other Non‐qualifying Instrument in Tier 2
Non‐qualifying Instrument in Tier 2
116 Cash dividends declared on preferred stock
117 Cash dividends declared on common stock
118 Common shares outstanding (Millions)
119
120
121
122
123
Common dividends per share ($)
Common equity tier 1 capital ratio
Tier 1 capital ratio
Total capital ratio
Net income
BHCK 3230 + BHCK 3240 +
BHCK A130 ‐ BHCK G235
BHCK 3230 + BHCK 3240
BHCK 3230 +BHCK G235
BHCK P839
BHCK 3283
BHCK 3283
BHCK 3283
BHCK 3283
BHCK 3283
BHCK G234
BHCK P839
BHCK 3283
BHCK 3283
BHCK 3283
BHCK 3283
BHCK 3283
BHCK G234
BHCK 3283
BHCK 3000
BHCK 3283
BHCK G234
BHCK 3283
BHCA P865
BHCK P839
BHCK 3283
BHCK 3283
BHCK 3283
BHCK 3283
BHCK 3283
BHCK G234
BHCK 3283
BHCK 3000
BHCK 3283
BHCK G234
BHCK 3283
BHCK4598
BHCK4460
BHCAP793
BHCA7206
BHCA7205
BHCK4340
Sum (PQ7 Items 1, 2, 30, 31 , 59, 60) + (PQ6 Item 88)
Sum (PQ7 Items 3, 32, 61) + (PQ6 Item 89)
Sum (PQ7 Items 4, 33, 62) + (PQ6 Item 90)
Sum (PQ7 Items 5, 34, 63) + (PQ6 Item 91)
Sum (PQ7 Items 6, 35, 64) + (PQ6 Item 92)
Sum (PQ7 Items 7, 36, 65) + (PQ6 Item 93)
Sum (PQ7 Items 8, 37, 66) + (PQ6 Item 94)
Sum (PQ7 Items 9, 38, 67) + (PQ6 Item 95)
Sum (PQ8 Items 1, 2, 30, 31 , 59, 60) + (PQ7 Item 88)
Sum (PQ8 Items 3, 32, 61) + (PQ7 Item 89)
Sum (PQ8 Items 4, 33, 62) + (PQ7 Item 90)
Sum (PQ8 Items 5, 34, 63) + (PQ7 Item 91)
Sum (PQ8 Items 6, 35, 64) + (PQ7 Item 92)
Sum (PQ8 Items 7, 36, 65) + (PQ7 Item 93)
Sum (PQ8 Items 8, 37, 66) + (PQ7 Item 94)
Sum (PQ8 Items 9, 38, 67) + (PQ7 Item 95)
Sum (PQ9 Items 1, 2, 30, 31 , 59, 60) + (PQ8 Item 88)
Sum (PQ9 Items 3, 32, 61) + (PQ8 Item 89)
Sum (PQ9 Items 4, 33, 62) + (PQ8 Item 90)
Sum (PQ9 Items 5, 34, 63) + (PQ8 Item 91)
Sum (PQ9 Items 6, 35, 64) + (PQ8 Item 92)
Sum (PQ9 Items 7, 36, 65) + (PQ8 Item 93)
Sum (PQ9 Items 8, 37, 66) + (PQ8 Item 94)
Sum (PQ9 Items 9, 38, 67) + (PQ8 Item 95)
Sum (PQ7 Items 10, 39, 68) + (PQ6 Item 96)
Sum (PQ8 Items 10, 39, 68) + (PQ7 Item 96)
Sum (PQ9 Items 10, 39, 68) + (PQ8 Item 96)
Sum (PQ7 Items 11, 40, 69) + (PQ6 Item 97)
Sum (PQ7 Items 12, 41, 70) + (PQ6 Item 98)
Sum (PQ7 Items 13, 42, 71) + (PQ6 Item 99)
Sum (PQ7 Items 14, 43, 72) + (PQ6 Item 100)
Sum (PQ7 Items 15, 44, 73) + (PQ6 Item 101)
Sum (PQ8 Items 11, 40, 69) + (PQ7 Item 97)
Sum (PQ8 Items 12, 41, 70) + (PQ7 Item 98)
Sum (PQ8 Items 13, 42, 71) + (PQ7 Item 99)
Sum (PQ8 Items 14, 43, 72) + (PQ7 Item 100)
Sum (PQ8 Items 15, 44, 73) + (PQ7 Item 101)
Sum (PQ9 Items 11, 40, 69) + (PQ8 Item 97)
Sum (PQ9 Items 12, 41, 70) + (PQ8 Item 98)
Sum (PQ9 Items 13, 42, 71) + (PQ8 Item 99)
Sum (PQ9 Items 14, 43, 72) + (PQ8 Item 100)
Sum (PQ9 Items 15, 44, 73) + (PQ8 Item 101)
Sum (PQ7 Items 16, 45, 74) + (PQ6 Item 102)
Sum (PQ8 Items 16, 45, 74) + (PQ7 Item 102)
Sum (PQ9 Items 16, 45, 74) + (PQ8 Item 102)
Sum (PQ7 Items 17, 46, 75) + (PQ6 Item 103)
Sum (PQ8 Items 17, 46, 75) + (PQ7 Item 103)
Sum (PQ9 Items 17, 46, 75) + (PQ8 Item 103)
Sum (PQ7 Items 18, 47, 76) + (PQ6 Item 104)
Sum (PQ8 Items 18, 47, 76) + (PQ7 Item 104)
Sum (PQ9 Items 18, 47, 76) + (PQ8 Item 104)
Sum (PQ7 Items 19, 48, 77) + (PQ6 Item 105)
Sum (PQ7 Items 20, 49, 78) + (PQ6 Item 106)
Sum (PQ7 Items 21, 50, 79) + (PQ6 Item 107)
Sum (PQ7 Items 22, 51, 80) + (PQ6 Item 108)
Sum (PQ7 Items 23, 52, 81) + (PQ6 Item 109)
Sum (PQ7 Items 24, 53, 82) + (PQ6 Item 110)
Sum (PQ7 Items 25, 54, 83) + (PQ6 Item 111)
Sum (PQ8 Items 19, 48, 77) + (PQ7 Item 105)
Sum (PQ8 Items 20, 49, 78) + (PQ7 Item 106)
Sum (PQ8 Items 21, 50, 79) + (PQ7 Item 107)
Sum (PQ8 Items 22, 51, 80) + (PQ7 Item 108)
Sum (PQ8 Items 23, 52, 81) + (PQ7 Item 109)
Sum (PQ8 Items 24, 53, 82) + (PQ7 Item 110)
Sum (PQ8 Items 25, 54, 83) + (PQ7 Item 111)
Sum (PQ9 Items 19, 48, 77) + (PQ8 Item 105)
Sum (PQ9 Items 20, 49, 78) + (PQ8 Item 106)
Sum (PQ9 Items 21, 50, 79) + (PQ8 Item 107)
Sum (PQ9 Items 22, 51, 80) + (PQ8 Item 108)
Sum (PQ9 Items 23, 52, 81) + (PQ8 Item 109)
Sum (PQ9 Items 24, 53, 82) + (PQ8 Item 110)
Sum (PQ9 Items 25, 54, 83) + (PQ8 Item 111)
Sum (PQ7 Items 26, 55, 84) + (PQ6 Item 112)
Sum (PQ8 Items 26, 55, 84) + (PQ7 Item 112)
Sum (PQ9 Items 26, 55, 84) + (PQ8 Item 112)
Sum (PQ7 Items 27, 56, 85) + (PQ6 Item 113)
Sum (PQ8 Items 27, 56, 85) + (PQ7 Item 113)
Sum (PQ9 Items 27, 56, 85) + (PQ8 Item 113)
Sum (PQ7 Items 28, 57, 86) + (PQ6 Item 114)
Sum (PQ8 Items 28, 57, 86) + (PQ7 Item 114)
Sum (PQ9 Items 28, 57, 86) + (PQ8 Item 114)
Sum (PQ7 Items 29, 58, 87) + (PQ6 Item 115)
Sum (PQ8 Items 29, 58, 87) + (PQ7 Item 115)
Sum (PQ9 Items 29, 58, 87) + (PQ8 Item 115)
Page Reference in the
Capital Plan
Comments
CACIY814
CACIQ750
FR Y‐14A Schedule E ‐ Operational Risk
Institution Name:
RSSD ID:
Source:
Submission Date (MM/DD/YYYY):
Firm
FR Y‐14A Schedule E.1 ‐ Legal Reserves Reporting
Annual Reporting of Legal Reserves
a. For each year in the chart below, report the total dollar value of the institution’s legal reserve balance, representing the total legal reserve balance that was included on the institution’s financial statements for the as‐of quarter. The
firm's initial submission should contain annual legal reserve balances from Q4 of the as‐of reporting quarter as well as Q4 from the prior four years.
Total Legal Reserve Balance
Year
Total Legal Reserves:
$ Balance (Millions)
As‐of Q4
CAORW923
Q4 ‐ HY1
CAORW924
Q4 ‐ HY2
CAORW925
Q4 ‐ HY3
CAORW926
Q4 ‐ HY4
CAORW927
*HY = Historical Year
b. Legal Reserves Pertaining to Repurchase Litigation (Voluntary): For the as‐of quarter, on a voluntary basis, report the total dollar value of the institution’s legal reserves pertaining to repurchase litigation which was
included on the institution’s financial statements as part of the total legal reserve for the as‐of quarter. Also please report the subset of this amount which is related only to contractual Representation and Warranty
(R&W) claims (excluding any amounts set aside for damages, penalties, etc).
Total Repurchase Litigation Reserve Balance
As of Quarter
Voluntary Reporting of Legal Reserves Pertaining to Repurchase Litigation:
Q4
$ Balance (Millions)
CAORW928
Repurchase Litigation Reserve
Balance related only to
contractual R&W claims
$ Balance (Millions)
CAORW929
FR Y‐14A Schedule E.2 ‐ Material Operational Risk Identification
Material Operational Risk Identification
List all material operational risks identified within the firm, the lines of business in which each risk appears, and the loss projection amount for each risk/risk segment combination. Add additional rows when necessary.
Material Operational Risk Name
A. Material Operational Risks included in the loss projections:
…
B. Material Operational Risks not included in loss projections:
…
Brief Description of Material Operational Risk
Business Line(s)/Firm‐wide
Loss Estimation
Methodology(ies)
Internal Baseline Projection
Amount ‐ 9 Quarter Loss
Projection ($MM)
Internal Stress Projection
Amount ‐ 9 Quarter Loss
Projection ($MM)
FR Y‐14A Schedule E.3 ‐ Operational Risk Scenarios
Operational Risk Scenarios
Firm name:
Operational Risk Scenario Name
Scenario
Number
1
2
3
Percentage of operational loss estimates generated using scenarios:
T1
T2
Total number of operational risk scenarios used in loss projections
Internal Stress
Internal Baseline Projection Amount ‐ 9 Projection Amount ‐ 9
Quarter Loss Projection ($MM)
Quarter Loss Projection
($MM)
0
0
0
0
0
0
0
0
0
0
0
0
%
%
0
0
FR Y‐14A Schedule F.2 ‐ Pro Forma Combining Balance Sheet Mergers and Material Acquisitions
Amounts in Millions
Purchase
Accounting
Pre‐Acquisition Book Value
Adjustments
on as‐of date
Fair Value
Adjustments
4
5
SECURITIES
Held to Maturity (HTM) (1)
Available for Sale (AFS)
Equity Securities with Readily Determinable Fair Values
Total Securities
Of which:
Securitizations (investment grade)
Securitizations (non‐investment grade)
6
Total Loans and Leases
Real Estate Loans (in Domestic Offices)
CBPLP643
CBPMP643
CBPNP643
7
First Lien Mortgages
CBPL5367
CBPM5367
CBPN5367
8
First Lien Mortgages
CBPLP644
CBPMP644
CBPNP644
9
First Lien HELOAN
CBPLP645
CBPMP645
CBPNP645
10
Second / Junior Lien Mortgages
CBPLP646
CBPMP646
CBPNP646
11
Closed‐End Junior Liens
CBPL5368
CBPM5368
CBPN5368
12
HELOCs
CBPL1797
CBPM1797
CBPN1797
13
CRE Loans
CBPLP647
CBPMP647
CBPNP647
14
Construction
CBPLP648
CBPMP648
CBPNP648
CBPM1460
CBPN1460
1
2(a)
2(b)
3
CBPL1754
CBPL1773
CBPLJA22
CBPLP640
CBPM1754
CBPM1773
CBPMJA22
CBPMP640
CBPN1754
CBPN1773
CBPNJA22
CBPNP640
CBPLP641
CBPLP642
CBPMP641
CBPMP642
CBPNP641
CBPNP642
Multifamily
CBPL1460
16
Nonfarm, Non‐residential
CBPLP649
CBPMP649
CBPNP649
17
Owner‐Occupied
CBPLF160
CBPMF160
CBPNF160
18
Non‐Owner‐Occupied
CBPLF161
CBPMF161
CBPNF161
19
Loans Secured by Farmland
CBPL1420
CBPM1420
CBPN1420
20
Real Estate Loans (Not in Domestic Offices)
CBPLP650
CBPMP650
CBPNP650
21
First Lien Mortgages
CBPLP651
CBPMP651
CBPNP651
15
22
Second / Junior Lien Mortgages
CBPLP652
CBPMP652
CBPNP652
23
CRE Loans
CBPLP653
CBPMP653
CBPNP653
Construction
CBPLP654
CBPMP654
CBPNP654
25
Multifamily
CBPLP655
CBPMP655
CBPNP655
26
Nonfarm, Non‐residential
CBPLP656
CBPMP656
CBPNP656
Owner‐Occupied
CBPLP657
CBPMP657
CBPNP657
28
Non‐Owner‐Occupied
CBPLP658
CBPMP658
CBPNP658
29
Loans Secured by Farmland
CBPLP659
CBPMP659
CBPNP659
24
27
FR Y‐14A Schedule F.2 ‐ Pro Forma Combining Balance Sheet Mergers and Material Acquisitions
Amounts in Millions
Purchase
Accounting
Pre‐Acquisition Book Value
Adjustments
on as‐of date
30
Fair Value
Adjustments
C&I Loans
CBPLP660
CBPMP660
CBPNP660
CBPMP661
CBPNP661
31
C&I Graded
CBPLP661
32
Small Business (Scored/Delinquency Managed)
CBPLP662
CBPMP662
CBPNP662
33
Corporate Card
CBPLP663
CBPMP663
CBPNP663
Business Card
CBPLP664
CBPMP664
CBPNP664
34
35
Credit Cards
CBPLP665
CBPMP665
CBPNP665
36
Charge Card
CBPLP666
CBPMP666
CBPNP666
37
Bank Card
CBPLP667
CBPMP667
CBPNP667
Other Consumer
Auto Loans
Student Loans
Other loans backed by securities (non‐purpose lending)
Other
Other Loans and Leases
Loans to Foreign Governments
Agricultural Loans
Loans for purchasing or carrying securities (secured or
unsecured)
Loans to Depositories and Other Financial Institutions
All Other Loans and Leases
All Other Loans (exclude consumer loans)
All Other Leases
Total Loans and Leases
CBPLP668
CBPMP668
CBPNP668
CBPLK137
CBPLP669
CBPLP670
CBPLP671
CBPLP672
CBPL2081
CBPL1590
CBPL1545
CBPMK137
CBPMP669
CBPMP670
CBPMP671
CBPMP672
CBPM2081
CBPM1590
CBPM1545
CBPNK137
CBPNP669
CBPNP670
CBPNP671
CBPNP672
CBPN2081
CBPN1590
CBPN1545
CBPLP673
CBPLP674
CBPLJ451
CBPLF163
CBPLP675
CBPMP673
CBPMP674
CBPMJ451
CBPMF163
CBPMP675
CBPNP673
CBPNP674
CBPNJ451
CBPNF163
CBPNP675
38
39
40
41
42
43
44
45
46
47
48
49
50
51
FR Y‐14A Schedule F.2 ‐ Pro Forma Combining Balance Sheet Mergers and Material Acquisitions
Amounts in Millions
Purchase
Accounting
Pre‐Acquisition Book Value
Adjustments
on as‐of date
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
LOANS HELD FOR INVESTMENT AT AMORTIZED COST
Real Estate Loans (in Domestic Offices)
First Lien Mortgages
First Lien Mortgages
First Lien HELOAN
Second / Junior Lien Mortgages
Closed‐End Junior Liens
HELOCs
CRE Loans
Construction
Multifamily
Nonfarm, Non‐residential
Owner‐Occupied
Non‐Owner‐Occupied
Loans Secured by Farmland
Real Estate Loans (Not in Domestic Offices)
First Lien Mortgages
Second / Junior Lien Mortgages
CRE Loans
Construction
Multifamily
Nonfarm, Non‐residential
Owner‐Occupied
Non‐Owner‐Occupied
Loans Secured by Farmland
C&I Loans
C&I Graded
Small Business (Scored/Delinquency Managed)
Business and Corporate Card
Credit Cards
Other Consumer
Auto Loans
Student Loans
Other loans backed by securities (non‐purpose lending)
Other
CBPLP676
CBPLP677
CBPLP381
CBPLP389
CBPLP678
CBPLP397
CBPLP405
CBPLP679
CBPLP680
CBPLP681
CBPLP682
CBPLP683
CBPLP684
CBPLP685
CBPLP686
CBPLP415
CBPLP423
CBPLP687
CBPLP688
CBPLP689
CBPLP690
CBPLP691
CBPLP692
CBPLP693
CBPLP694
CBPLP695
CBPLP696
CBPLP697
CBPLP698
CBPLP699
CBPLP700
CBPLP491
CBPLP701
CBPLP702
CBPMP676
CBPMP677
CBPMP381
CBPMP389
CBPMP678
CBPMP397
CBPMP405
CBPMP679
CBPMP680
CBPMP681
CBPMP682
CBPMP683
CBPMP684
CBPMP685
CBPMP686
CBPMP415
CBPMP423
CBPMP687
CBPMP688
CBPMP689
CBPMP690
CBPMP691
CBPMP692
CBPMP693
CBPMP694
CBPMP695
CBPMP696
CBPMP697
CBPMP698
CBPMP699
CBPMP700
CBPMP491
CBPMP701
CBPMP702
Fair Value
Adjustments
CBPNP676
CBPNP677
CBPNP381
CBPNP389
CBPNP678
CBPNP397
CBPNP405
CBPNP679
CBPNP680
CBPNP681
CBPNP682
CBPNP683
CBPNP684
CBPNP685
CBPNP686
CBPNP415
CBPNP423
CBPNP687
CBPNP688
CBPNP689
CBPNP690
CBPNP691
CBPNP692
CBPNP693
CBPNP694
CBPNP695
CBPNP696
CBPNP697
CBPNP698
CBPNP699
CBPNP700
CBPNP491
CBPNP701
CBPNP702
FR Y‐14A Schedule F.2 ‐ Pro Forma Combining Balance Sheet Mergers and Material Acquisitions
Amounts in Millions
Purchase
Accounting
Pre‐Acquisition Book Value
Adjustments
on as‐of date
86 Other Loans and Leases
87 Loans to Foreign Governments
88 Agricultural Loans
Loans for purchasing or carrying securities (secured or
89 unsecured)
90 Loans to Depositories and Other Financial Institutions
91 All Other Loans and Leases
92 All Other Loans (exclude consumer loans)
93 All Other Leases
94 Total Loans and Leases
95
96
97
98
99
100
101
102
103
104
105
106
107
108
Loans Held for Sale and Loans Accounted for under the Fair
Value Option
Real Estate Loans (in Domestic Offices)
First Lien Mortgages
Second / Junior Lien Mortgages
CRE Loans
Loans Secured by Farmland
Real Estate Loans (Not in Domestic Offices)
Residential Mortgages
CRE Loans
Loans Secured by Farmland
C&I Loans
Credit Cards
Other Consumer
Other Loans and Leases
Total Loans Held for Sale and Loans Accounted for under the
Fair Value Option
109 Unearned Income on Loans
110 Allowance for Loan and Lease Losses (2)
Loans and Leases (Held for Investment and Held for Sale), Net
111 of Unearned Income and Allowance for Loan and Lease Losses
(3)
Fair Value
Adjustments
CBPLP703
CBPLP704
CBPLP705
CBPLP706
CBPMP703
CBPMP704
CBPMP705
CBPMP706
CBPNP703
CBPNP704
CBPNP705
CBPNP706
CBPLP707
CBPLP708
CBPLP709
CBPLP710
CBPLP711
CBPMP707
CBPMP708
CBPMP709
CBPMP710
CBPMP711
CBPNP707
CBPNP708
CBPNP709
CBPNP710
CBPNP711
CBPLP712
CBPLP713
CBPLP714
CBPLP715
CBPLP716
CBPLP717
CBPLP718
CBPLP719
CBPLP720
CBPLP721
CBPLP722
CBPLP723
CBPLP724
CBPLP725
CBPMP712
CBPMP713
CBPMP714
CBPMP715
CBPMP716
CBPMP717
CBPMP718
CBPMP719
CBPMP720
CBPMP721
CBPMP722
CBPMP723
CBPMP724
CBPMP725
CBPNP712
CBPNP713
CBPNP714
CBPNP715
CBPNP716
CBPNP717
CBPNP718
CBPNP719
CBPNP720
CBPNP721
CBPNP722
CBPNP723
CBPNP724
CBPNP725
CBPL2123
CBPL3123
CBPLP726
CBPM2123
CBPM3123
CBPMP726
CBPN2123
CBPN3123
CBPNP726
FR Y‐14A Schedule F.2 ‐ Pro Forma Combining Balance Sheet Mergers and Material Acquisitions
Amounts in Millions
Purchase
Accounting
Pre‐Acquisition Book Value
Adjustments
on as‐of date
TRADING
112 Trading Assets
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
INTANGIBLES
Goodwill
Mortgage Servicing Rights
Not applicable
All Other Identifiable Intangible Assets
Total Intangible Assets
OTHER
Cash and cash equivalent
Federal funds sold
Securities purchased under agreements to resell (4)
Premises and Fixed Assets
OREO
Commercial
Residential
Farmland
Collateral Underlying Operating Leases for Which the Bank is
the Lessor (5)
Autos
Other
Other Assets (6)
Total Other
131 TOTAL ASSETS
Fair Value
Adjustments
CBPL3545
CBPM3545
CBPN3545
CBPL3163
CBPL3164
CBPM3163
CBPM3164
CBPN3163
CBPN3164
CBPL5507
CBPLP727
CBPM5507
CBPMP727
CBPN5507
CBPNP727
CBPLP728
CBPLB987
CBPLB989
CBPL2145
CBPL2150
CBPLP729
CBPLP730
CBPLP731
CBPLP732
CBPMP728
CBPMB987
CBPMB989
CBPM2145
CBPM2150
CBPMP729
CBPMP730
CBPMP731
CBPMP732
CBPNP728
CBPNB987
CBPNB989
CBPN2145
CBPN2150
CBPNP729
CBPNP730
CBPNP731
CBPNP732
CBPLP733
CBPLP734
CBPLP735
CBPLP736
CBPMP733
CBPMP734
CBPMP735
CBPMP736
CBPNP733
CBPNP734
CBPNP735
CBPNP736
CBPL2170
CBPM2170
CBPN2170
FR Y‐14A Schedule F.2 ‐ Pro Forma Combining Balance Sheet Mergers and Material Acquisitions
Amounts in Millions
Purchase
Accounting
Pre‐Acquisition Book Value
Adjustments
on as‐of date
Fair Value
Adjustments
132 Deposits in domestic offices
Deposits in foreign offices, Edge and Agreement subsidiaries,
133 and IBFs
134 Deposits
Federal funds purchased and securities sold under agreements
135 to repurchase
136 Trading Liabilities
137 Other Borrowed Money
138 Subordinated Notes and Debentures
Subordinated Notes Payable to Unconsolidated Trusts Issuing
TruPS and TruPS Issued by Consolidated Special Purpose
139 Entities
140 Other Liabilities
141 Memo: Allowance for off‐balance sheet credit exposures
142 Total Liabilities
CBPLP737
CBPLP738
CBPMP737
CBPMP738
CBPNP737
CBPNP738
CBPLP739
CBPLP740
CBPMP739
CBPMP740
CBPNP739
CBPNP740
CBPL3548
CBPL3190
CBPL4062
CBPLC699
CBPM3548
CBPM3190
CBPM4062
CBPMC699
CBPN3548
CBPN3190
CBPN4062
CBPNC699
CBPL2750
CBPLB557
CBPL2948
CBPM2750
CBPMB557
CBPM2948
CBPN2750
CBPNB557
CBPN2948
143
144
145
146
147
148
149
CBPL3283
CBPL3230
CBPL3240
CBPL3247
CBPLB530
CBPLA130
CBPL3210
CBPM3283
CBPM3230
CBPM3240
CBPM3247
CBPMB530
CBPMA130
CBPM3210
CBPN3283
CBPN3230
CBPN3240
CBPN3247
CBPNB530
CBPNA130
CBPN3210
CBPL3000
CBPM3000
CBPN3000
CBPLG105
CBPMG105
CBPNG105
Perpetual Preferred Stock and Related Surplus
Common Stock (Par Value)
Surplus (Exclude All Surplus Related to Preferred Stock)
Retained Earnings
Accumulated Other Comprehensive Income (AOCI)
Other Equity Capital Components
Total BHC Equity Capital
Noncontrolling (Minority) Interests in Consolidated
150 Subsidiaries
151 Total Equity Capital
(1)
(2)
(3)
(4)
(5)
(6)
Footnotes to the Balance Sheet Worksheet
Institutions that have adopted ASU 2016‐13 should report item 1 net of any applicable allowance for credit losses.
For institutions that adopted ASU 2016‐13, this item will represent the allowance for credit losses on loans and leases.
For institutions that adopted ASU 2016‐13, this item will be net of unearned income and allowance for credit losses on loans and leases.
Institutions that adopted ASU 2016‐13 should report item 120 net of any applicable allowance for credit losses.
Refers to the balance sheet carrying amount of any equipment or other asset rented to others under operating leases, net of accumulated depreciation.
Institutions that adopted ASU 2016‐13, should report item 129 net of any applicable allowance for credit losses.
Collection of Supplemental CECL Information
Effect of Changes in Accounting Principles
Item
First quarter of CECL adoption
1
Institutions applying CECL transition provisions
2
Institutions applying CECL transition provisions: Retained
2a Earnings
Institutions applying CECL transition provisions: DTAs from
2b temporary differences
Institutions applying CECL transition provisions: credit loss
2c allowances eligible for inclusion in regulatory capital
2d
3
4
5
6
Institutions applying CECL transition provisions: average
total consolidated assets
Institutions applying CECL transition provisions: total
2e leverage exposure
Adoption of Current Expected Credit Loss Methodology –
ASC Topic 326
Allowances for credit losses recognized upon the acquisition
of purchased credit‐deteriorated assets
Effect of adoption of current expected credit losses
methodology on allowances for credit losses on loans and
leases held for investment and held‐to‐maturity debt
securities
Total allowance for credit losses
Allowance for credit losses on loans and leases held for
6a investment
6b Allowance for credit losses on held‐to‐maturity securities
6c Allowance for credit losses on available‐for‐sale securities
MDRM
CASTLC05
CASTLC06
CASTLC07
CASTLC08
CASTLC09
CASTLC10
CASTLC11
CASTJJ26
CASTLC12
CASTLC13
CASTLC14
CASTLC15
CASTLC16
CASTLC17
Actual in
$Millions as
of date
| File Type | application/pdf |
| File Modified | 2022-09-20 |
| File Created | 2022-08-26 |